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Summary 
Small amounts of a large variety of substances normally regarded as foreign to the 
body are always existent in the environment. These are often toxic and occur frequently. 
In the modern world, man is increasingly dependent upon the use of synthetic chemicals 
and other domestic products in larger number. 
Benzene is frequently used as an industrial solvent of the modem time. Its excellent 
solvent properties and its use as a starting material for wide ranging chemicals and 
domestic products of commercial importance has made it indispensable. Its value in our 
modern society is great, but due to its toxic nature, the use of t)enzene would undoubtedly 
have an impact on our way of life. The use of benzene has been on the rise and 
obviously the risk of exposure is also increasing. Though the exposure levels to benzene 
can be brought down to acceptable levels but can not be eliminated. 
Benzene is a well known genotoxic and carcinogenic agent. But the precise 
mechanism of its genotoxicity and carcinogenicity are yet to be known. Therefore, in this 
study an attempt has been made to explain the probable metabolite(s) of benzene to 
induce haematotoxicity and role of transition metal ions (iron and copper) to explain the 
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possible biochemical mechanisms of genoloxicity and carcinogenicity expressed during 
benzene exposure. 
Release of iron from ferritin by 1,2,4-benzenetriol 
Iron is a vital metallic cofactor of several important biomolecules. It is normally 
localized in ferritin (main iron storage protein) or transferrin (iron transport protein). But 
this iron, when it gets decompartmentalized manifests lethally by triggering off free radical 
reactions by means of Fenton and Haber-Weiss type of reactions: 
Fe(lll) + Reductant > Fe(ll) + Oxidized Reductant 
2Fe(ll) + O2+ 2H* > 2Fe(lll) + H A 
Fe(ll) + HjOj -— > Fe(lll) +-OH + OH" 
Large human prospective studies suggest that excess body free iron is associated 
v/ith carcinogenesis, such as primary hepatocellular carcinoma, colon cancer, lung cancer, 
bladder cancer, acute lymphocytic leukemia and neuroblastoma. Bleomycin detectable 
iron has been shown to accumulate in significant concentrations in the bone marrow of 
benzene exposed rats. Polyphenolic metabolite of benzene, particularly 1,2,4-
benzenetriol (a Irihydroxy benzene) was found to release significant amount of iron from 
horse spleen ferritin under aerobic and anaerobic conditions. The release of iron from 
ferritin during autooxidation of 1,2,4-benzenetriol in wvo may result in increased 
intracellular concentrations of free iron. Although, the physiological mechanism of iron 
mobilization from ferritin is pooriy understood, the observed iron release from ferritin by 
1,2,4-benzenetriol could occur through the direct reduction of iron by the hydroxy 
hydroquinone form or via its autooxidation intermediates i.e., superoxide radical and 
semiquinone It was observed that the iron released from ferritin in the presence of 
1,2,4-benzenelriol was capable of inducing lipid peroxidation and catalyzing 
bleomycin-dependenl calf thymus DNA degradation. The mechanism by which iron is 
released from bone marrow cells and whether it acts as a prooxidant during benzene 
toxicity is not known. However, the present observation offer a new mechanism that the 
iron released from ferntin by 1,2,4-benzenetriol could contribute to the better 
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Polyphenol-iron complex: A probable toxic metabolite of benzene 
An attempt was made to examine in vitro formation of polyphenoi:iron complex. 
Complex formation was fractionated on Sephadex G-10 column chromatography. Results 
clearly show the formation of polyphenoUron complex under in vitro condition. Polyphenol 
iron complex formation was also observed during the release of iron from ferritin in the 
presence of 1,2,4-benzenetriol. Although, benzene exposure leads to accumulation of 
iron as well as polyphenolic metabolites of benzene in the bone marrow against the 
concentration gradient, the formation of such complex in vivo is yet to be identified. 
We evaluated the haematotoxicity of hydroquinone:iron complex as a possible 
haematotoxic intermediate during benzene exposure. Results indicate that hydroquinone 
iron chelate showed marginal increase in haematological parameters in experimental 
animals But Ihe precise mechanism of marginal, yet significant increase in haema-
tological indices is not clear, Atleast, some of the effects observed in hydroquinone:iron 
treated group showed similarities to some extent with what has been shown to occur 
following exposure of benzene to mice. 
Glutathionyl hydroquinone: A possible toxic metabolite of 
benzene 
Glutathionyl hydroquinone has been isolated as one of the urinary metabolites of 
hydroquinone, indicating that glutathionyl hydroquinone formation occurs in vivo and 
autooxidized at several fold higher than the parent hydroquinone to glutathionyl 
benzoquinone We noticed that glutathionyl hydroquinone is a potent prooxidant to 
damage both calf thymus as well as plasmid pUC 18 DNA and this observation may be 
of toxicological importance in relation to benzene induced genotoxicity. 
Haematotoxicity of glutathionyl hydroquinone was studied in male mice at dose 100 
mg/kg body weight, intraperitoneally for one month. Increased pattern of relative liver and 
spleen weight and WBC were noticed, but these results were not conclusive to explain 
GHQ as potent haematotoxic metabolite of benzene The pharmacokinetics and 
distribution of administered GHQ Is not known. Whether GHQ administered I.p. reaches 
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understanding of the toxicity of benzene. Further, elucidation of the mechanisms of 
iron-mediated oxidative damage may be important for the prevention of carcinogenesis. 
Prooxidant and antioxidant properties of iron: polyphenol 
complex 
Polyphenolic metabolites of benzene viz, hydroquinone and 1,2,4- benzenetriol have 
been shown to be toxic and the suggested mechanism includes free radical fonnation via 
superoxide during their autooxidation and the covalent binding of semiquinone to DNA, 
RNA and other cellular macromolecules. Benzene exposure also leads to an 
accumulation of bleomycin sensitive iron in bone marrow. 1,2.4-Benzenetriol, a trihydroxy 
metabolite of benzene was capable of releasing iron from horse spleen ferritin, which may 
lead to accumulation of iron in bone marrow during benzene exposure, as the 
polyphenolic metabolites are accumulated against the concentration gradient in the bone 
marrow. The ferrous iron may be chelated to the polyhydroxy metabolites of benzene viz. 
hydroquinone and 1,2,4-benzenetriol. 
Studies carried out with hydroquinone/1,2,4-benzenetriol and iron showed several 
fold increase in iron-catalyzed bleomycin- dependent degradation of calf thymus DNA as 
compared to iron alone. Complex formation some how increase the availability of iron to 
degrade DNA. It is also possible that the hydroquinone and 1,2,4-benzenetriol possess 
combined iron-chelating and iron ion reducing properties to stimulate DNA degradation 
in the presence of bleomycin. Further, iron:polyphenol complex appears to be stable and 
intact as the recovery from bone marrow lysate was complete. On the other hand, 
iron polyphenol complexes have shown an antioxidant activity by inhibiting of 
iron-dependent lipid peroxidation in rat brain homogenate and glutamate degradation. 
This is similar to the antioxidant properties exhibited by flavonoids due to their ability to 
chelate iron. Thus the polyphenolic chelates limiting the availability of iron for lipid 
peroxidation and at the same time facilitate bleomycin- dependent degradation of DNA. 
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the target organ i.e. bone marrow is yet to be evaluated. Other reason may be due to 
difference in sensitivity of species towards different benzene metabolites. 
Role of transition metal ions (Fe.Cu) during benzene toxicity 
Earlier studies have provided enough evidence that transition metals including iron 
and copper at^ e capable of directly mediating the activation or metabolism of several 
xenobiotics via a metal redox mechanism, which leads to the formation of more reactive 
oxygen and other organic free radicals. We observed that exposure to benzene leads to 
increase in total iron content in liver and isolated rat liver nuclei. Benzene metabolites 
induced the DNA damage particularly in the presence of iron and copper. This study 
would help in better understanding of the chromosomal aberrations/abnormalities 
associated with benzene exposure. Copper which is associated with DNA, may play a 
potential role in nuclear DNA damage in presence of hydroquinone. However, the 
molecular mechanism of its damage is not well understood. Significant increase in iron 
content in liver and in isolated liver nuclei during benzene exposure and the copper which 
is associated with DNA may have toxicological implications for cytotoxicity of liver cells 
and liver nuclear DNA damage in wVo. 
In the light of our investigations following conclusions can be made; 
• 1,2,4-Benzenetriol is a potent reductant of ferric iron of ferritin and releases iron from 
ferritin core. The release of iron from bone marrow lysate by 1,2,4-benzenetriol may 
be of toxicological significance during benzene exposure as this could lead to 
disruption of intracellular iron homeostasis in bone marrow cells. 
• The iron:polyphenol chelate, on one hand, is a more potent DNA cleaving agent in 
the presence of bleomycin, and on the other hand, it is a less effective free radical 
generator as compared to iron alone. However, the formation of such a complex in 
VIVO IS not known. Further studies are needed to characterize such complexes in 
vivo and evaluate their toxicological significance during benzene exposure. 
B Polyphenol forms complex with iron under in vitro condition and may be a possible 
h««»rri8t!iit©i«iQ interma^iista during benzene exposure. 
Siunmary 
The present in vitro studies revealed that glutathionyl hydroquinone is a potent toxic 
metabolite of benzene and acts as a prooxidant due to its faster autooxidation to 
glutathionyl benzoquinone and oxyradicals which may induce DNA damage. 
Exposure to benzene resulted in significant increase in total iron content in liver 
tissue and in isolated liver nuclei. 
Benzene metabolites (particularly hydroquinone) induced genotoxic effect in 
presence of copper which is associated with the nuclear DNA. However, further 
studies are needed to explain the precise mechanism of DNA damage and 
chromosomal aberration in wVo during benzene exposure and effect of transition 
metal ions in benzene induced genotoxicity and human leukemia. 
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After the advent of industrial revolution there has tjeen a massive 
proliferation of industries to cater to the needs of the modern society But, 
unfortunately man has been exposed knowlingly and unknowlingly to many 
hazardous chemicals. Benzene is a v^ /eil known xenobiotic environmental pollutant 
and is a natural constituent of crude oil. 
Benzene is extensively used as an industrial solvent and a common additive 
in gasoline and other solvents. Emissions from burning coal and oil, benzene 
waste and storage operations motor vehicle exhaust, evaporation from gasoline 
service stations and use of industrial solvents increase benzene level in the air. 
Since tobacco contains high level of benzene, tobacco smoke is another source 
of benzene in air. People living around hazardous waste sites, petroleum refining 
operations, petrochemical manu-facturing sites, or gas station may be exposed to 
higher levels of benzene in air. 
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Benzene causes disorder in the blood and is well known human leukemogen. 
People who breath benzene for long periods may experience hannful effects in the 
tissues that form blood cells. Understanding and preventing the threat of benzene 
to human health is one of the most important environmental issues facing national 
and international regulatory authorities. Uncertainties about health effects must 
be balanced against the potential for substantial economic and societal costs in 
regulating benzene. 
Despite the extensive research in the field of benzene induced genotoxicity 
and carcinogenesis, the precise mechanism of its toxicity is largely unknown. 
Therefore, we studied in this respect to explain the possible mechanisms of 
benzene toxicity and role of metal ions (particulariy iron and copper) in benzene 
induced genotoxicity and carcinogenesis. 
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INTRODUCTION 
Benzene (CgHg) is the smallest and most stable aromatic hydrocarbon. It is a 
colourless liquid with a sweet odor. Due to high vapour pressure, benzene evaporates 
into air very quickly and is highly flammable. Today benzene is commercially recovered 
from both coal and petroleum sources. In the past benzene was widely used as a solvent 
but this use is now decreasing due to its toxic nature. The major uses of benzene are in 
the production of ethylbenzene, cumene, cyclohexane, styrene, caprolactam, linear alkyl 
benzene, phenol, maleic anhydride, DDT, BHC and various chemical synthesis. Other 
industrial use of the benzene is in the production of rubber plastics, paints, adhesives, 
nylon fibers and artificial leather (Eveleth, 1990). Benzene is also a component of 
gasoline since it occurs naturally in crude oil and since it is a by product of oil refining 
processes. Benzene is especially important for unleaded gasoline because of its 
anti-knock characteristics. For this reason, the concentration of aromatics such as 
benzene in unleaded fuels has increased (Brief et al., 1980). 
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EXPOSURE 
Benzene is a ubiquitous agent. As a component of petroleum it is widely distributed. 
Virtually all (99.9%) of the benzene released into the environment is emitted into the air. 
Benzene exposure occurs in the workplace, in the general environment, and through the 
use of consumer products. Occupational exposures present the highest risks, but most 
individuals are exposed through the use of petrochemicals, including gasoline evaporation 
and automobile exhaust, and through direct or indirect exposure to cigarette smoke. The 
general population may also be exposed to t)enzene in a number of ways. 
(a) Cigarette smoking 
Cigarette smoking is the most significant source of t>enzene exposure for the general 
population from tx)th active and passive smoke. Smoking accounts for about half of the 
total population burden of exposure to benzene (Wallace, 1989). Blood benzene levels 
have been shown to be higher in smokers than in nonsmokers (Brugnone et al., 1989). 
One pack a day contributes about 600 ug benzene to the smoker (WHO, 1987). 
(b) Home use of solvents or gasoline 
Gasoline is frequently used in daily domestic purpose, particularly those who work 
on gasoline-fueled machinery. Gasoline contain variable amount of benzene and can be 
a significant source of exposure to the individual, involving dermal exposure as well as 
inhalation. Other source of benzene exposure include consumer products such as 
paints, adhesives rubber products, tapes and household cleaning agents. 
(c) Leaky underground storage tanks 
Leakage of underground storage tanks of gasoline is a major source of water 
contamination with benzene. Contamination of ground water has occurred, leading to 
human exposure through the three routes of ingestion, inhalation and skin absorption. 
General population may be exposed with benzene through the supply of contaminated 
drinking water supply. 
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some exposure to benzene, 60-70% indicate a dangerous level of exposure, and less 
than 60% indicate an extremely hazardous exposure. Urinary sulphate levels are 
however, quite variable, and are not being used to identify exposure levels of benzene 
associated with minimal toxic effect. Additionally, the test for urinary sulphates is not 
specific for benzene. 
Urinary phenol measurements have routinely been used for monitoring occupational 
exposure to benzene, and there is some evidence that urinary levels can be correlated 
with exposure level (Inoue et al., 1988a; Karacic et at., 1987). However, correlating 
urinary phenol with benzene exposure is complicated by potentially high and variable 
background levels that result from ingestion of vegetables, exposure to other aromatic 
compounds, ingestion of ethanol, and inhalation of cigarette smoke (Nakajima et al., 
1987). In addition, coexposure to toluene, a common solvent, has been shown to inhibit 
transformation of benzene to phenol (Inoue et al., 1988a). Analysis of data collected for 
49 chemical woricers in the coke oven industry led the examiners to conclude that urinary 
phenol could not be used as an indicator of benzene uptake for exposures of about 1 
ppm or less (Drummond et al., 1988). The American Conference of Governmental 
Industrial Hygienists has established 50 mg phenol/liter urine as the biological exposure 
indices for benzene exposure in the workplace (Lowry, 1986), 
Other urinary metabolites of benzene have been measured, but it is not clear if any 
of these additional metabolites can be used to monitor exposure to benzene. In addition 
to phenol, other phenolic metabolites have been investigated as biomarkers of benzene 
exposure (Inoue et al., 1988b). Results from data collected on 152 chemical workers 
indicated that, for benzene concentrations greater than 10 ppm, there was a linear 
relationship between the concentration of benzene in breathing zone air and urinary 
concentrations of catechol and quinol. Urinary trans, trans-muconic acid (an open-ring 
benzene metabolite) has also been investigated as an indicator of benzene exposure 
(Inoue et al., 1989a). In a study of 152 shoe and paint manufacturers exposed to 
benzene, it was shown that urinary trans, trans-muconic acid correlated linearty with the 
time weighted averages of benzene. Measurements of trans, trans-muconic acid were 
able to distinguish the groups of workers exposed to benzene at concentrations of 6-7 
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(d) Automobile source 
Automobile emissions remain a substantial source of community exposure to 
benzene. However, release of benzene and ottier gasoline vapors during refueling 
remains a significant source of community t>enzene exposure as well as exposure to the 
individual doing the refueling. The general population is exposed to t^enzene mainly 
through inhalation of contaminated air particularly in areas of heavy motor traffic and 
around gas stations. All outdoor source, including automobile exhaust and stationary 
source emissions, account for only at>out 20% of the total population exposure to 
benzene (Wallace, 1989). 
ROUTE OF EXPOSURE 
Benzene exposure occurs through inhalation, ingestion and dermal routes. 
Inhalation is the dominant pathv*/ay of human exposure, accounting for more than 99% 
of the total daily intake of benzene (Hattemer-Frey et al., 1990). Benzene is readily 
absorbed in the lung, directly entering the blood stream and taeing distributed to the 
tissues. Benzene within the blood is in direct equilibrium with the tsenzene in expired air. 
Thus, measurement of end alveolar breath l>enzene concentration is a good indicator 
of body benzene concentration. Approximately 50% of benzene taken up into the body 
by any route is eventually exhaled, the extent being dependent on benzene dose and the 
rate of metabolism and respiratory mechanics. Ingested benzene is also assumed to be 
fully absort>ed but the dermal absorption of t>enzene is likely to be minimal (P<1.0%) 
(Loden, 1986; Susten et al., 1985). 
BIOMARKERS 
Biomarkers of exposure are available for tsenzene. One selective test is the urinary 
sulphate ratio test which is based on the premise that with increasing exposure there will 
be an increase in benzene metabolites conjugated with sulphate moieties (Hammond 
and Herman, 1960). Estimates of benzene exposure can be made by comparing the 
ratio of inorganic to organic sulphates in the urine. Inorganic sulphate levels amounting 
to 80-95% of total urinary sulphates are considered nomnal background, 70-80% indicate 
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ppm from the group of nonexposed workers. The high sensitivity of trans, trans-muconic 
acid is due to the very low urinary background levels of trans, trans-muconic acid among 
the general population in contrast to the high background levels found for phenol, 
catechol, and quinol. Inoue ef a/., (1989a) determined that, while trans, trans-muconic 
acid measurements were useful for determining group exposures to benzene, they could 
not t>e used to monitor individual exposure because of the large variations in individuals 
urinary trans, trans-muconic acid values. In addition, urinary trans, trans-muconic acid 
excretion was suppressed by coexposure \o toluene. However, recent studies (Bartczak 
et al., 1994; Weaver et al., 1996) supported that trans, trans-muconic acid may be useful 
in the evaluation of environmental benzene exposure. Weaver et al., (1996) assessed 
benzene exposure by monitoring urinary trans, trans-muconic add in urban children with 
elevated blood lead level. Inoue et al., (1989b) reported that the urinary concentration 
of 1,2,4-t)enzenetriol related lineariy to the intensity of exposure to benzene both in men 
and women workers exposed to benzene and however was suppressed by toluene 
coexposure among male workers exposed to a mixture of benzene and toluene. 
Another b>enzene-specific urinary metabolite is S-phenyl-N-acetylcysteine (Jonge-
neelen et al., 1987). No background excretion of S-phenyl-N-acetylcysteine was found 
in rats or in humans. However, the authors concluded that biological monitoring of 
industrial exposure to benzene by the determination of S-phenyl-N-acetylcysteine in the 
urine is not better than the determination of phenol in urine. An improvement in the 
biological monitoring of benzene exposure at levels even <1 ppm has been indicated by 
determining S-phenylmercapturic acid in the urine (Stommel et al., 1989), 
Red and white blood cell counts have been used as an indicator of high occupational 
exposures. Monitoring of benzene exposed wori<ers has included monthly blood counts, 
with workers being removed from areas of potential exposure when white blood cell 
counts fell below 4,000/mm^ or erythrocyte counts fell below 4,000,000/mm' (OSHA, 
1987). Additionally, it has been suggested that chromosomal aberrations in the peripheral 
lymphocytes and sister chromatid exchanges could be used as monitoring end points for 
benzene effects (Van Sitter! and de Jong, 1985). Benzene metabolites have also been 
found to form adducts with DNA (Lutz and Schlatter, 1977, Norpoth et al., 1988; Snyder 
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et ai, 1987). Furthermore, quantitation of benzene derived adducts on haemoglobin 
shows potential as a marker for assessing the possible health effects of occupational 
exposure to inhaled benzene (Sun et al., 1990). Measurement of protein adducts in 
blood also offers the potential for monitoring the bioavailability of reactive, and 
presumably toxic metabolites of benzene in workers and other persons. Recently 
Yeowell-O'Connell et al., (1996) reported a method for measuring cysteinyl adducts of 
the benzene metabolite benzene oxide with haemoglobin in blood from humans or 
rodents exposed to benzene. This new procedure is currently being applied to the 
analysis of albumin adducts of benzene oxide in rats. 
Exposure to benzene causes toxic effects in the bone marrow, either from benzene 
or its metabolites (Eastmond et al., 1987). Therefore, it is possible that haematological 
tests could be used as markers of haernatotoxicity. To date, surveillance and eariy 
diagnosis of benzene haematotoxicity depend primarily on the complete blood count, 
including haemoglobin, hematocrit, erythrocyte indices, erythrocyte count, white blood cell 
count, and differential and platelet count. In effect, complete blood counts and marrow 
examinations should be good for eariy detection of preleukemic lesions. Additionally, 
cytogenetic tests of marrow cell are being used more often, but are not yet of diagnostic 
significance. Workers exposed to benzene in the air have shown elevated levels of 
6-aminolevulinic acid in erythrocytes and elevated levels of coproporphyrin in the urine 
(Khan and Muzyka, 1973). These may be biomari<ers for disruption of porphyrin synthesis 
and may be eariy indicators of adverse haematological effects. 
HEALTH HAZARDS 
(I) Acute exposure effects 
High concentration of benzene inhaled affect the central nervous system. At high 
levels benzene has an anesthetic effect (Walker, 1976). Fatalities due to benzene are 
the result of its concentration in the lipid of brain cells, effecting circulating problems, 
some instances of convulsions and/or paralysis, the loss of consciousness, coma and 
finally death. Damage to brain has been found to be a primary cause of death. At times 
death wasprecededby periods of violent convulsion (Feil, 1933). The narcotic threshold 
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concentration for laboratory animals is approximately 4,000 ppm and concentrations 
above 10,000 ppm are usually fatal. Acute LDM value for new bom rats is as low as 1.0 
ml/kg, while for adult rats it is in the range of 5.6-6.8 ml/kg (Kimura e^  a/., 1971). The 
experimental results obtained indicate that the putative mechanism of acute benzene 
toxicity is the rapid release of the adrenal hormones,epinephrine and nor-epinephrine, 
into the blood stream, sensitizing the myocardium to its action and the most prominent 
effect is central nervous system stimulation followed by depression and respiratory 
failure. Direct exposure to high benzene concentration may lead to tissue destruction 
due to its lipid solubility. 
(II) Chronic exposure effects 
(a) Haematotoxjcity 
Benzene is a myelotoxin, chronic exposure of humans and experimental animals 
results in a wide vanety of blood dyscrasias including; aplastic anemia, leukopenia, 
pancytopenia, thrombocytopenia etc. (Snyder etai, 1977; Aksoy, 1989). 
Le Noir (1897) and Selling (1910) were the first to report on haematopoietic disorders 
associated with benzene in humans. These disorders were usually manifested by a 
decrease in the number of one or more of the three major circulating blood cell types. 
Irons et al., (1979) and Snyder et al., (1982) have shown that lymphocytes to be the most 
susceptible of all the blood elements and granulocytes to be the most resistant of the 
circulating cells to benzene toxicity. Granulocyte levels got depressed only on doses, 880 
mg/day for 10 days (Irons et al., 1979). On the other hand exposures to concentration 
sufficient to produce lymphocytopenia and anemia, even for life time, failed to effect the 
granulocyte levels (Snyder, 1982). 
Evidence that benzene acts primarily on committed progenitor cells was indicated 
by a decrease in the number of differentiating erythroid and myeloid progenitors in the 
bone man-ow (Irons e/a/., 1979). Studies by Bolcsack and Nerland (1983) have shown 
that phenol, catechol and hydroquinone reduce the ^'Fe incorporation into developing 
erythrocytes. The macrophages, which are a major source of polypeptide growth factors 
required for the proliferation, development and survival of progenitor cells may be the 
possible target of benzene toxicity (Moore, 1978). Post era/., (1986) demonstrated that 
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phenol is metabolized in adherent mouse marrow maaophages by a peroxidase activity 
to one or more covalently binding species and that micromolar concentrations of 
hydroquinone, p-benzoquinone inhibit macrophage RNA synthesis. Later on Lewis et al., 
(1988 a) showed that benzene metabolites, catechol, hydroquinone, p-t)enzoquinone and 
1,2,4-benzenetriol have potent and varied toxic effects on macrophage function and 
activation. Sabourin et al., (1990) showed that inhalation exposure of mice resulted in 
benzene metabolite DNA and haemoglobin adducts formation. 
(b) Genotoxicity 
Evidence for the genotoxicity of benzene in humans comes from studies of 
occupationally exposed populations (Sasiadek et al., 1989; Yardley-Jones et al., 1990). 
The convenient parameters that have been monitored include chromosomal abnor-
malities, sister chromatid exchanges and micronuclei induction. Benzene induced 
cytogenetic effects, including chromosome and chromatid at>errations, sister chromatid 
exchanges, and micronuclei, have been consistently found in in vivo animal studies 
(Erexson eta!.. 1986, Toftetal., 1982). 
Forni et al., (1971) observed chromosomal aberrations in workers occupationally 
exposed to benzene. Siou et al., (1981) demonstrated that nicks and breaks were the 
most common in the chromosomal aben-ations studied in mice. Tice et al., (1980) have 
presented evidence that the sister chromatid exchanges were due to both persistent and 
new chromosomal lesions. Morimoto et al., (1983) observed that benzene biotrans-
formation is a prerequisite for inducing sister chromatid exchange in human whole blood 
cultures. Tunek and coworkers (1982) have related benzene ability to induce micronuclei 
in bone marrow cells with benzene biotransformation In vivo. Zhang et al., (1993) 
investigated that induction of both kinetochore-positive and kinetochore-negative 
micronuclei by 1,2,4-benzenetriol was mediated via active oxygen species formation. 
These data indicate the involvement of active oxygen species in 1,2,4-benzenetriol-
induced DNA damage and implicate the potential importance of 1,2,4-benzenetriol-
mediated genetic damage in benzene-induced human leukemia. Toft et al., (1982) 
exposed male mice to benzene vapours (1 to 200 ppm) for varying periods of time and 
reported that continuous exposure to 14 ppm benzene after one week resulted in a 
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significant elevation in micronuclei. Gad-EI-Karim et al., (1984) while studying the 
clastogenic effects of benzene, observed two fold increase in miaonuclei in bone man-ow 
of CD-1 mice. Luke et al., (1988) evaluated the genotoxic effects of benzene (3,000 
ppm) on DBA/2 mice by evaluation of micronuclei frequencies in peripheral blood, 
polychromatic erythrocytes and non-chromatic erythrocytes. Delayed cell cycle in mouse 
bone marrow and DMA adducts with benzene metabolites in mouse and rat haemoglobin 
adducts or rat liver cell DNA adducts were also found after benzene inhalation (Tice et 
al.. 1982; Sabourin et al., 1990). Recently Pathak et al., (1995) have noticed the DNA 
adduct formation in the bone marrow of Isenzene administered mice. Futher Levay et al., 
(1996) hypothesized that the DNA adduct formation might depend on both the dose and 
duration of benzene exposure. DNA adduct formation was also observed in HL-60 cell 
culture treated with hydroquinone (Hedii et al., 1996; Pongracz and Bodell, 1996). 
Further HedIi e^  al., (1996) demonstrated that hydroquinone and 1,2,4-t)enzenetriol, each 
inhibits retinoic acid-induced granulocytic differentation in HL-60 treated cells but, DNA 
adducts formation was only observed in case of hydroquinone. These findings suggest 
that adduct formation might play a significant role in hydroquinone but not in 1,2,4-
benzenetriol toxicity, and that different mechanisms might be responsible for the 
contributions of each metabolite to benzene toxicity. 
(c) Carcinogenicity 
Benzene is a well known leukemogenic and carcinogenic agent. Goldstein (1977) 
and Aksoy (1985) have demonstrated that acute myelogenous leukemia (AML) and its 
variants are commonly associated with t>enzene exposed workers. Paradoxically, the 
occun^ence of myeloid leukemia in rats and mice is exceedingly low. But for a few stray 
reports of myeloid leukemia in rats, most of them, instead, exhibited tumors. The first 
example of malignant tumors experimentally produced by tjenzene was reported by 
Maltoni and Scarnato (1979). The predominant tumor was not of haematopoietic origin 
but rather a carcinoma of the rat zymbal gland. Further studies by Maltoni et al., (1985), 
demonstrated the formation of zymbal gland carcinoma by administering benzene 
through different routes. Studies by Cronkite (1987) confirmed that benzene is multipotent 
carcinogen in experimental animals. The first experimental demonstration of lympho-
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reticular tumors produced by benzene was reported by Snyder et al., (1980). Life time 
exposures of C57B1 mice to 300 ppm benzene (6hr/for 5 days/week) produced 6 out of 
40 cases of thymic lymphoma. Cronkite et al., (1984) later showed that a shorter 
exposure period (16 weeks) to 300 ppm was sufficient to produce thymic lymphoma in 
these animals, although the tumor induction time was lengthened 
In rodents, benzene induces a variety of tumors in organs including the zymbal 
gland, harderian gland, mammary gland, lung, liver, nose and oral cavity (Maltoni e^  al., 
1983). Despite extensive research the mechanisms of benzene induced myelotoxicity 
and leukemogenicity are unclear. Bone marrow cells contain high levels of peroxidase 
activity, most of which is attributed to myeloperoxidase (MPO) and eosinophilperoxidase 
(EPO) (Kariya et al., 1987). It is interesting that several target organs of benzene induced 
carcinogenesis contain appreciable levels of peroxidase activity. Subrahmanyam e^  al., 
(1991a) have shown that phenolic metabolites of benzene are substrates for human 
MPO, and that their interactions result in enhanced production of 1,4-benzoquinone. But 
the toxicological significance of such reactions is not clear. They suggested that inter-
action of phenolic compounds, presumably by hydrogen-bonding with the activity limiting 
distal amino acid residue(s) or with the ferryl oxygen of peroxidase may be an important 
contributing factor in the enhanced myeloperoxidase-dependent metabolism of 
hydroquinone in the presence of other phenolic compounds. In sum, these provide ample 
evidence to demonstrate that benzene is a carcinogen for rats and mice. 
(d) Immunotoxicity 
Animal studies show that benzene affects humoral and cellular immunity. Benzene 
decreases the fonnation of the lymphocytes that produce the seaim immunoglobulins or 
antibodies. Exposure to benzene at 10 ppm and above for 6 days decreased the ability 
of bone man-ow cells to produce mature B-lymphocytes of C57BL/6 mice (Rozen et al., 
1984). The spleen was also inhibited from forming mature T-lymphocytes at exposure 
levels of 31 ppm and above. Mitogen-induced blastogenesis B-and T-lymphocytes was 
depressed at 10 ppm and above. Peripheral lymphocyte counts were depressed at all 
levels, whereas erythrocyte counts were depressed only at 100-300 ppm (Rozen and 
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Snyder, 1985). A continuation of this line of study for 6 and 23 weeks at 300 ppm 
showed continuous decreases in numt)ers of mature B- and T- lymphocytes produced in 
the bone marrow, spleen, and thymus. Another series of experiments revealed that 
exposures as low as 25 ppm for 2 weeks caused decrease in the numbers of circulating 
lymphocytes (Cronkite e^  a/., 1989). Intemiediate-duration exposure to benzene also 
deaeased leukocyte counts in rats and mice exposed to 300 ppm for 2-13 weeks (Ward 
ef a/., 1985). Chronic exposure to benzene caused bone marrow hypoplasia, 
lymphocytopenia, and anemia in mice exposed to 100 ppm for a lifetime (Snyder e^  a/., 
1980). 
Studies by Irons et al., (1981) and Pfeifer and Irons (1983) have shown that phenol, 
hydroquinone and catechol to suppress lymphocyte growth and function in vitro, which 
correlates with their capacity to undergo autooxidation and with their concentration in the 
bone man^ ow or lymphoid organs. They also showed that hydroquinone and its oxidation 
product, p-benzoquinone inhibit proliferation and differentiation in lectin stimulated 
lymphocytes in culture. Further, they showed that these compounds interfere with 
microtubule assembly at concentrations that are not cytotoxic, while, phenol and catechol 
suppress lymphocyte activation only at cytotoxic concentrations. They postulated that the 
suppression of lymphocyte blastogenesis by hydroquinone to be mediated by the 
interaction of p-benzoquinone with sulphahydryl groups on tubulin. This binding interferes 
with microtubular integrity, which is essential in cell division via spindle formation and in 
the regulation of surface receptor movement and signal transduction across the plasma 
membrane. 
Wierda and Irons (1982) showed that hydroquinone and catechol also to be 
immunotoxic in vivo. Benzene, if metabolized in the lymphocyte to a reactive inter-
mediate such as p-benzoquinone, could inhibit the production of lymphokines. Post et 
al.. (1985) demonstrated that hydroquinone and p-benzoquinone affected the dose-
dependent inhibition of RNA synthesis in mouse spleen lymphocytes in vitro at micromolar 
concentrations that were not cytotoxic. They also showed that exposure to p-
benzoquinone completely inhibited the proliferation and production of the T-cell 
lymphokine, interieukin-2 by concanavalin A stimulated T-lymphocytes. It has been 
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observed that benzene can modify both host resistance to a bacterial infectious agent 
and T-cell mediated tumor resistance (Rosenthal and Snyder, 1986). Pandya et al., 
(1986) observed that the immunosuppressive effects of benzene have been modulated 
by the prior administration of fungal product 6-MFA from Aspergillus ochraceous and 
polyinosinic-polycytidilic acid (Pandya et al., 1989) that have interferon inducing 
properties. 
HUMAN EXPOSURE 
Inhalation is the dominant pathway of human exposure. Occupational exposure to 
benzene has been associated with aplastic anemia, leukemia, and other related blood 
disorders (Aksoy, 1988). For certain cancers, increased mortality was noted among 
benzene exposed males in comparison with that among unexposed male. Lung cancer, 
stomach cancer and primary hepatocarcinoma were reported by numerous investigators 
during the benzene exposure, whereas, for female only leukemia occun'ed in excess 
among the exposed (Yin et al., 1989). Risk of leukemia rose as duration of benzene 
exposure increases. In acute myeloid leukemia (AML) there is diminished production of 
normal erythrocytes, granulocytes, and platelets, which leads to death by anemia, 
infection, or hemorrhage. Whereas in chronic myeloid leukemia (CML) the leukemic cells 
retain the ability to differentiate and perform function; later there is a loss of ability to 
differentiate. Case reports and epidemiological studies of workers have established as 
a causal relationship between benzene exposure and AML. Study by Yin et al., (1996) 
of benzene-exposed workers in China provides further support for the association of 
tjenzene exposure with an increased risk for myelogenous leukemia. While some studies 
have implicated other types of leukemia or even lymphomas, only the incidence of AML 
and its variants has consistently been increased In groups of workers with excess 
benzene exposure (Goldstein, 1988). The evidence linking benzene exposure with 
leukemia was considered sufficient proof of human carcinogenicity (Dosemeci et al., 
1994). Haematotoxicity among Chinese workers were also observed who were exposed 
to high concentration of benzene (Rothman et al., 1996) But precise mechanism for 
benzene toxicity is not known. 
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Benzene and its metabolites do, however, produce chromosomal damage in a 
variety of systems. The incidence of chromatid deletions and gaps v\/ere slightly increased 
in workers exposed to benzene levels of 10-100 ppm compared with control groups 
(Yardley-Jones et ai, 1990). Many investigators (Glatt et at., 1989; Witz et at., 1990; 
Yager et ai, 1990) have demonstrated that benzene exposure induce chromosomal 
aben'ations, micronuclei and sister chromatid exchanges in human lymphocytes in vitro. 
Benzene and some of its metabolites have been tested for genotoxicity in Salmonella 
typhimurium and V79 Chinese hamster cells Dihydrodiol, hydroquinone, 1,2,4- benzene-
triol and catechol, the potent benzene metabolites showed genotoxic and mutagenic 
effects in V79 cells as well as sister chromatid exchanges (Glatt et al., 1989). It was 
further suggested that metabolites of b>enzene can induce heritable functional changes 
(gene mutation) in bacterial and mammalian cells. Cytogenetic studies of benzene 
exposed wori<ers have reported a similar profile of genotoxicity. Increased frequencies 
of structural chromosomal aberration in the lymphocytes of l)enzene-exposed workers 
have been reported (Sorsa and Yager, 1987). Fenech and Morley (1988) investigated 
the ability of the principal phenolic and quinoid metabolites of benzene to induce staictural 
and numerical chromosomal aben-ation by utilizing a cytokinesis-block micronuclei assay 
in treated human peripheral lymphocytes. The higher efficacy of hydroquinone in inducing 
both total micronuclei and kinetochore-positive miaonucleated cell when compared with 
catechol, phenol and 1,4-benzoquinone suggests that hydroquinone is a major contributor 
to the clastogenicity and aneuploidy observed in the lymphocytes of benzene-exposed 
workers. However, other metabolites of benzene may also contribute to the genetic 
effect caused by exposure to benzene. 
Since consistent chromosomal aben-ations are often observed in human leukemias, 
the ability of phenolic metabolites of benzene to induce chromosomal damage in human 
cell also implicates them in benzene induced leukemia (Yager e/a/., 1990). Many studies 
have also shown that benzene produces both structural and numerical chromosomal 
aberration in the peripheral blood lymphocytes of occupationally exposed individual (Ding 
et a/., 1983). Linear regression analysis demonstrated significant decrease in white and 
red blood cell counts, as well as haemoglobin content (Kipen et al., 1989). 
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Because consistent chromosomal aberrations have Ijeen observed in human 
leukemias and lymphomas, the induction of chromosomal damage by benzene or its 
metabolites may be critical in the development of benzene induced leukemia. However, 
the nature of mutations produced at specific gene site in the bone marrow, the target 
organ for benzene toxicity, has not been studied to date in humans (Rothman et al., 
1995). Recently, Chen and Eastmond (1995) demonstrated that inhibition of enzymes 
involved in DNA replication and repair, such as topoisomerase enzymes, by the 
metabolites of benzene represent a potential mechanism for the formation of chro-
mosomal al)en-ations. Further in vitro and in vivo studies will be required to demonstrate 
the involvement of topoisomerase inhibition in the myelotoxic and carcinogenic effects 
of benzene. Earlier, Levay et a!., (1993) demonstrated the DNA adduct fomnation by the 
benzene metabolites, hydroquinone and 1,4-benzoquinone in human bone marrow, and 
suggested that in human bone marrow also, as in other model system, peroxidase 
enzymes play an important role in the activation of hydroquinone to form DNA adducts. 
These results support the general hypothesis that benzene metabolites are activated to 
form DNA adducts that may contribute to the myelotoxicity and leukemia observed in 
workers occupationally exposed to benzene (Cronkite et a!., 1989; Goldstein, 1977). 
Besides the genotoxic and carcinogenic effect, adverse immunological effects have 
been reported in human with occupational exposure to tjenzene. There are two types of 
acquired immunity, humoral and cellular and benzene damages both. First, benzene has 
been shown to alter humoral immunity, i.e. to produce changes in blood levels of 
antibodies. Painters who were exposed to benzene (3-7 ppm), toluene, and xylene in the 
workplace for 1-21 years showed increased serum immunoglobulin values for IgM and 
decreased values for IgG and IgA (Lange et a!., 1973a). Other adverse reaction, 
characterized by a reaction between leukocyte agglutinins and autoleukocytes, occurred 
in 10 out of 35 of these workers (Lange et al., 1973b). One of the problems with these 
studies is that the workers were exposed io multiple solvents, so that benzene alone may 
not be responsible for the noted effects. 
The second type of immunity, cellular immunity, is affected by changes in circulating 
leukocytes (White blood cells) and a subcategory of leukocytes, called lymphocytes. 
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Loss of leukocytes was found in a series of studies of workers exposed to benzene at 
levels as low as 30 ppm in various manufacturing processes (Aksoy et ai, 1987). Other 
studies in chronically exposed workers also showed loss of lynnphocytes and other blood 
elements (Kipen et ai, 1989; Yin et al.. 1987). 
METABOLISM 
Benzene itself is not the actual toxicant and is relatively inert to confer chemical 
reactivity to the aromatic ring. Benzene requires metabolism to induce its toxic effects 
and follows similar pathways in humans and animals. The metabolism of benzene 
occurs in the liver and, to a lesser extent in the bone marrow by cytochrome P-450 
dependent mixed-function oxidase enzymes. Although, the metabolism of benzene is 
very complex, but is well understood. 
Schrenk et al.. (1941) studied the absorption, distribution and elimination of benzene 
after exposure of benzene to the dog. The purpose of the study was to gain better 
understanding of the physicochemical phenomena underiying the physiological action of 
benzene. They observed that benzene concentration in fat and fatty tissue was many 
times than that in blood and vital organs. The fat, acting as a reservoir, apparently is 
saturated slowly and loses its benzene slowly. In a way this makes the fat, the master 
tissue as regards absorption, distribution, and elimination of benzene by the body tissues 
and fluids. This phenomenon may be a partial explanation of the fundamental action of 
benzene on the body, namely, its deleterious effect on the haematopoietic system. 
Moreover, the high benzene concentration in the urine indicates that benzene is 
concentrated by the kidneys. Porteous and Williams (1949) found that phenol, catechol, 
quinol and hydroxyquinol are excreted as ethereal sulphates in the unne of rabbits orally 
exposed with benzene. However, the first metabolite of benzene is phenol which may 
then be oxidized to catechol and quinol. One or both of these dihydric phenols may then 
give rise to hydroxyquinol. It is clear that the longer benzene remains in the body, the 
greater will be the extent of its oxidation to the toxic polyhydnc phenols, and continuous 
feeding to benzene will give rise to a continuous and increased production of catechol 
and quinol 
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According to Fabre (1947a; 1947b) rat liver tissue oxidizes tDenzene to phenol in vitro 
more rapidly than any other rat tissue. Under same conditions toluene is not oxidized to 
phenolic substances. On the basis of this difference in toxicity between benzene and 
toluene and in their metabolic fates, support to the view that benzene is toxic because 
of its, phenolic metabolites. Later on urinary benzene metabolites were quantified in a 
series of studies by Parke and Williams (1953). Rabbits treated orally with '*C-labelled 
benzene, eliminated about 43% of the dose as unchanged benzene in the expired air and 
excreted about 35% of the radioactivity in the urine in the form of metabolites. Phenol 
accounted for the largest percentage of radioactivity (68%) followed by hydroquinone 
(14%), catechol (6%), trans, trans-muconic acid (1%). The similar general profile of 
urinary metabolites was subsequently observed in rats (Cornish and Ryan, 1965), mice 
(Longacreefa/., 1981), cats and dog (Oehme, 1969), and human (Teisingere/a/., 1952). 
Capel et al., (1972) have studied the variation in the metabolic fate of '"C-labelled phenol 
in eight different species namely the rat, mouse, jerboes, gerbil, hamster, lemming, 
guinea pig and man. In most of the species examined, phenylglucuronide and phenyl 
sulphate are indeed the main metabolites except in the case of cat and guinea-pig due 
to a defective glucuronic acid and sulphate conjugation mechanism respectively (Dutton, 
1966: Capel e/a/., 1972). 
Initially, benzene is metabolized to benzene oxide by P-450 IIE1 monooxygenase 
enzymes in the liver. Benzene oxide gives rise to phenolic metabolites, such as phenol, 
catechol, hydroquinone, 1,2,4-ben2enetriol and open-ring products, such as trans, 
trans-muconaldehyde and trans, trans-muconic acid (Subrahmanyam e/a/., 1991b). The 
majority of these phenolic metabolites are excreted in unne as glucuronide and sulphate 
conjugates . In experiments with rabbits, accumulation of several phenolic metabolites 
of benzene have been observed in bone marrow against the concentration gradient 
(Greenlee ef a/., 1981a). 
The major pathv^ays of benzene metabolism are shown in Figure-1.1. The formation 
of benzene oxide is the initial step and it is further metabolized by one of the four 
pathways. The first metabolite is formed by rearrangement of the benzene oxide to 
phenol spontaneously. Phenol is either conjugated to glucuronide and sulphate directly 
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or is oxidized to hydroquinone and followed by conjugation to hydroquinone glucuronide 
or sulphate (Huff et al., 1989). The second pathway for benzene oxide metabolism 
consisted of reaction with glutathione and subsequent modification of the mercapturic acid 
(Henderson et al., 1989). The third pathway for t>enzene metabolism involved in 
conversion of benzene oxide into tjenzene dihydrodiol by epoxide hydrase (Tunek et al., 
1981). Benzene dihydrodiol is converted into catechol by oxidation of benzene 
dihydrodiol by a soluble NADP*- dependent enzyme, tjenzene dihydrodiol dehydrogenase 
(Ayengar et al., 1959) and finally conjugation to glucuronide and sulphate. Benzene 
dihydrodiol is also converted into 1,2,4-b)enzenetriol by some unknown mechanism, which 
is one of the potent toxic metabolites of t>enzene. However, Inoue et al., (1989b) 
observed that phenol and hydroquinone, but not catechol, are precursors of 
1,2,4-benzenetriol in urine after the intraperitoneal injection of the three phenolic 
compounds to rats followed by urine analysis for 1,2,4-benzenetriol. A similar result was 
also observed in case of rabbits (Inoue ef a/., 1989c). The fourth pathway of benzene 
oxide metabolism consists of the ring opening reaction resulting in the fonmation of trans, 
trans-muconic acid. However, the metabolic pathway of trans, trans-muconic acid in vivo 
is yet to be identified (Latriano et al., 1986). The corresponding dialdehyde, trans, 
trans-muconaldehyde has been shown to be a precursor of muconic acid in vivo (Witz 
etal., 1990). 
Although, the pathway of benzene ring opening is not known, but a number of 
possible mechanisms for oxidation of benzene ring-opening have been postulated 
(Snyder and Chatterjee, 1991). One such postulated pathway involves the formation of 
trans, trans-muconaldehyde from benzene dihydrodiol in a Fenton system, presumably 
via hydroxyl radical-mediated ring-opening (Latriano et al., 1985; Zhang et al., 1995a). 
Zhang et al., (1995b) further demonstrated the role of iron in the mechanism of ring-
opening of benzene in a mouse liver microsomal system. 
TOXICITY 
Benzene is a well known xenobiotic environmental pollutant. Exposure to benzene 
leads to the development of bone marrow depression characterized by progressive 
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leucopenia, anemia and pancytopenia (Snyder, 1987). The responses to chronic 
benzene exposure have been classified as either bone marrow depression and aplastic 
anemia or the generation of acute myeloblastic leukemia (AML) and related forms of acute 
lymphocytic/non-lymphocytic leukemia. Collectively, these abnonnalities have been 
termed as preleukemic syndrome or myelodysplastic syndrome (Tricot, 1991). Irons 
(1988) and Tricot (1991) suggested that the spectrum of bone marrow toxicities produced 
by exposure to benzene represented a form of myelodysplastic syndrome resulted in 
bone marrow depression and that might lead to fatal aplastic anemia. Anon (1982) 
reported that benzene is a human leukemogen. Chronic tjenzene poisoning exhibited a 
variety of changes in the number of basophils, eosinophils, lymphocytes and other bone 
marrow function in workers (Aksoy ef a/., 1971). 
Goldstein et al., (1982) reported on the production of a limited number of 
myelogenous leukemias in rats and mice exposed to benzene by inhalation. The reports 
by Maltoni et al., (1989) and Huff ef al., (1989) of Ijenzene induced carcinogenicity in rats 
and mice given benzene orally focussed on solid tumors and multiple carcinogenic foci. 
The zymbal gland was a primary carcinogenic site in both sexes of both species. Later 
studies using the inhalation route (Maltoni ef al., 1989) also demonstrated the 
multipotential carcinogenic activity of benzene. Excluding the studies by Yin ef al., (1987) 
there is no strong evidence for benzene-induced solid tumors of these types in human. 
Snyder ef al., (1980) also reported the production of thymic lymphoma after inhalation of 
benzene in C57B1/6J mice but not in AKR mice. Fanis ef al., (1993) observed the 
malignant lymphoma along with preputial gland carcinomas and lung adenomas in 
CBA/Ca mice exposed to benzene through inhalation. Neither the Cronkite ef al. (1989) 
nor the Fams etal., (1993) studies demonstrated acute granulocytic leukemia in tjenzene 
inhaled mice. 
Snyder and Chatterjee (1991) and Yardley-Jones ef al., (1991) have studied the 
pathway of benzene metabolism and the role of benzene metabolites in the production 
of benzene toxicity. Lee ef al., (1981) reported that early erythroblasts are sensitive to 
benzene and its metabolites. Benzene has long l5een known to produce chromosomal 
abnormalities (Eastmond, 1993) and suggested that benzene may have caused 
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chromosome breakages and rearrangements in a stem cell that proliferated, leading to 
erythroleukemia. Eastmond (1993) also observed that the quinone metabolites of 
benzene can cause aneuploidy to chromosome nondisjunction and nonrandom chromo-
somal alteration in individuals with advanced forms of Isenzene-induced myelotoxicity. 
The association between chromosomal abnormalities and leukemia in tienzene exposed 
rats has been reviewed by Le Beau and Larson (1991). Tice et al.. (1980) exposed mice 
to benzene by inhalation and demonstrated an increased frequency of sister chromatid 
exchanges in bone marrow cells and suggested that benzene metabolites were 
responsible for these effects. Muconaldehyde, a hypothesized ring open benzene 
metabolite also produced sister chromatid exchanges in B6C3F1 mice (Witz et al., 
1990). 
The highly electrophilic metabolites such as 1,4-benzoquinone and others are 
generated during Ijenzene exposure in experimental animals and form covalently bound 
adducts with both nuclear and mitochondrial DNA (Eastmond, 1993). Kolachana et al., 
(1993) have demonstrated that benzene and its phenolic metabolites; phenol, hydro-
quinone and 1,2,4-benzenetriol induce oxidative damage in the genome in the form of 8-
hydroxydeoxyguanosine in HL-60 promyelocytic leukemic cells and in the bone marrow 
of mice. Cheng et al., (1992) demonstrated that benzene induced active oxygen radical 
production resulted in 8-hydroxydeoxyguanosine formation in vivo which may play a role 
in genotoxicity and leukemogenesis. Formation of 8-hydroxydeoxyguanosine adduct is 
known to cause G-T and A-C base substitutions. 
MECHANISM OF TOXICITY 
Any hypothesis of benzene toxicity must account for the requirement of hepatic 
metabolism and selective toxicity of benzene in the bone marrow. As mentioned above, 
benzene is metabolized in the liver mainly to one or more phenolic metabolites and 
accumulated against the concentration gradient in bone man-ow and exerts its toxic 
effects (Smith et al., 1989). It is believed that the effect of benzene is likely to be exerted 
through the action of multiple metabolites on multiple targets through multiple biological 
pathways (Goldstein, 1989). 
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Rao and Pandya (1989) observed that polyphenolic metabolites as the toxic inter-
mediates due to their capability to undergo autooxidation. One mechanism by which 
benzene induces the toxic effects may be mediated by the generation of one more active 
oxygen species such as superoxide anion radical (Oj), hydrogen peroxide {Hfii), 
hydroxyl radical (HO) and singlet oxygen C^fii) (Subrahmanyam et al., 1991b). 
Myeloperoxidase and eosinophil peroxidase are the two principal enzymes in bone 
man-ow which are responsible for the formation of quinone and semiquinone free radicals 
and activation of oxygen to superoxide radicals. These free radical metabolites of 
benzene with dioxygen and cellular targets such as DNA, GSH, protein and lipid are 
responsible for the benzene-induced myelotoxicity and leukemia (Subrahmanyam et al., 
1991b). Legathe et al., (1994) have demonstrated pharmacokinetic interaction between 
benzene metabolites, phenol and hydroquinone, in B6C3F1 mice. The consequence of 
which may be a higher quantity of 1,4-benzoquinone formation from hydroquinone. 
Hydroquinone and catechol have been shown to be much more toxic to bone marrow 
cell cultures than benzene (Parmentier and Dustin, 1953). Phenol and hydroquinone 
have been shown to cause significant decrease in bone man-ow cellularity when 
coadminis-tered to mice (Eastmond et al., 1987). Since the bone man'ow is rich in 
peroxidative enzymes including myeloperoxidase and potential oxidants such as 
hydrogen peroxide derived from leukocytes, it has been suggested (Eastmond et al., 
1987; Smith et al., 1989) that a bone man-ow-localized phenol-dependent stimulation of 
hydroquinone metabolism results in the fomnation of 1,4-benzoquinone, the ultimate toxic 
metabolite of benzene. 1,4-Benzoquinone has been shown to induce single strand breaks 
in DNA of cultured cells (Pellak-Walker and Blumer 1986), genotoxic in V79 cells (Glatt 
et al., 1989), inhibit DNA and RNA synthesis (kalf, 1987) and mitogen stimulation of 
lymphocyte growth (Wierda and Irons, 1982). Levay et al., (1993) observed the DNA 
adduct formation in all cell types tested in presence of 1,4-benzoquinone. Recently Sze 
et al., (1996) noticed that 1,4- benzoquinone is more potent to induce DNA strand breaks 
in Chinese Hamster Ovary cell. However, hydroquinone also exhibited a significant 
effect as well. Although, only less than 1-5% of the benzene inhaled is metabolized to 
1,4-benzoquinone in the body (Huff et al., 1989), the amount of 1,4-benzoquinone 
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produced is perhaps sufficient to cause significant biological effects. On the other hand, 
hydroquinone has been known to undergo autooxidation or myeloperoxidase-catalyzed 
oxidation to form 1,4-benzoquinone (Subrahmanyam et al., 1991b). As such, the 
cytotoxicity of hydroquinone could be due, in part, to the production of 1,4-t)enzoquinone 
in the Chinese Hamster Overay cells (Sze et al., 1996). 
Quinone and semiquinone metabolites of polyphenols, through their capacity to react 
with nucleophilic groups of amino acids are reported to inactivate critical enzymes like 
DMA polymerase (Graham et al., 1978), RNA polymerase II (Nagaraja and Shaw, 1982) 
and reverse transcriptase (Wick and Fitzgerald, 1981). Quinone or semiquinone 
metabolites of hydroquinone and 1,2,4-benzerietriol have been shown to inhibit mRNA 
synthesis (Kalf et al., 1982), microtubule polymerization (Irons and Neptun, 1980), 
mitogen stimulation of lymphocyte growth (Wierda and Irons, 1982), effect macrophage 
function and activation (Lewis et al., 1988a) and form adducts with DlslA (Jowa et al., 
1986). Autooxidation of polyphenolic compounds in presence of low concentrations of 
transition metal ion copper resulted in an increased production of active oxygen species 
which can release aldehydic products from glutamate or DNA (Rao and Pandya, 1989). 
Experimental studies have suggested that involvement of iron or copper in benzene 
metabolite induced DNA damage through a mechanism involving the generation of 
organic free radicals (Kawanishi et al., 1989; Rao and Pandya, 1989). In vitro studies 
by Rahman et al., (1989) and Ahmad et al., (1992) have shown that naturally occurring 
flavonoid, quercetin, in the presence of Cu(ll) and molecular oxygen caused breakage 
of calf thymus DNA, supercoiled pBR 322 plasmid DNA and single stranded Ml 3 phage 
DNA. Copper is distributed throughout the body with the liver and bone marrow being the 
two major copper storage organs (Linder, 1991). Copper has been identified as the 
essential redox-active centre in a variety of metalloproteins such as ceruloplasmin, 
Cu-Zn superoxide dismutase, cytochrome oxidase, dopamine p-hydroxylase, tyrosinase, 
lysyloxidase and ascorbate oxidase (Linder, 1991). Since copper also exists in the 
nucleus and is closely associated with chromosomes and DNA (particulariy Guanine) 
(Prutz et al., 1990) the chemical-metal redox system might be responsible for strand 
breaks in vivo during benzene exposure. In vitro, among hydroquinone, 1,2,4-
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benzenetriol, catechol and phenol; hydroquinone/Cu^* and 1.2,4-benzenetrioiyCu^* were 
the two efficient DNA cleaving systems (Li and Trush, 1993a). Recently Zhang et al., 
(1996) described that the oxidation of 1,2,4-benzenetriol and catalysis by Cu^* may play 
an important role in 1,2,4-ben2enetriol-induced genotoxicity. 
It was also observed that Cu(ll) strongly induces the oxidation of hydroquinone as 
such may be factor involved in the oxidative action and toxic to primary bone marrow 
stromal cells of DBA/2 J mice (Li and Trush, 1993b). They further observed that Cu(ll) 
is capable of directly reacting with hydroquinone, causing the one electron oxidation of 
hydroquinone to semiquinone radical (SQ) and reactive oxygen species generated in 
chemical metal redox system were responsible for in vitro plasmid DNA damage (Li et 
al., 1995). 
Many investigators have shown that t>enzene exposure interferes with iron 
metabolism and heme biosynthesis in experimental animals. These studies include 
decreased incorporation of ^^ Fe into circulating erythrocytes (Lee et al., 1974), inhibition 
of heme biosynthesis enzyme at the level of 6-aminolevulinic acid (ALA) dehydratase 
resulting in ALA accumulation and its loss in urine (Rao and Pandya, 1980), and 
depletion of the regulatory heme pool (Siddiqui et al., 1988). Abraham et al., (1986) 
demonstrated that benzene exposure leads to increase in heme oxygenase activity, a 
rate limiting enzyme for heme degradation. Existence of an intracellular pool of low 
molecular weight iron (LMI) compounds maintaining a dynamic equilibrium between iron 
uptake, iron storage and iron incorporation into its final biochemical form have been 
described (Jacobs, 1977). Benzene administration led to an accumulation of iron in bone 
marrow cells which can catalyze the formation of aldehydic products (base propenal) 
from DNA in presence of bleomycin (Rao et al., 1990). In all probability benzene alters 
heme metabolism of erythroid cells resulting in the increased internalization of iron 
transferrin-receptor complex and uptake of internalized iron is almost entirely restricted 
to erythroblasts. In an/n v/fro study, Rao (1991) observed that hemin catalyzed the 
autooxidation of hydroquinone or 1,2,4- benzenetriol in the presence of reducing agent 
and resulted in the formation of aldehydic products from glutamate, deoxyuridine or DNA 
through the formation of reactive oxygen species. Hemin is essential for the erythroid 
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differentiation process and accumulates in the immature red blood cells in nanomolar 
quantities as these cells differentiate (Lo et aJ., 1981). In immature red blood cells in bone 
marrow, it has been noted that heme accumulates in the nucleus as these cells 
differentiate and nicking of nuclear DMA has been reported as it binds covalently to both 
protein and DNA (Mager and Bernstein, 1979; Lo et al., 1981). it has been postulated 
that this action of hemin might account for its influence in the differentiation of these and 
other cell types (Chen and London, 1981). n view of the accumulation of polyphenolic 
metabolites after exposure to benzene and the presence of excessive amounts of heme 
in bone marrow cells which may catalyze autooxidation of polyphenols and offer an 
alternative mechanism for the bone marrow depressant effect of benzene (Rao, 1991). 
CURRENT TREND AND FUTURE RESEARCH 
Benzene metabolism in experimental animals are well understood, but the precise 
mechanism of benzene toxicity remain largely unknown. The problem of attempting to 
extrapolate to the humans is complicated by the lack of metabolism or toxicity data in 
humans. In attempt to bridge the data gap, Sabourin et al. (1992) examined benzene 
metabolism in cynomolgus monkey and chimpanzee. They concluded that the mouse 
forms the highest levels of hydroquinone conjugate and the chimpanzee forms the 
lowest. It will be important to determine the sensitivity of the monkeys and the 
chimpanzees to benzene. Although, the relative sensitivity of humans to benzene toxicity 
is unknown, a study of benzene metabolism in humans exposed in an industrial setting 
to evaluate the urinary excretion of phenyl conjugates vs polyhydroxylate and ring open 
metabolites might help to estimate how humans relate to test species in this respect 
(Sabounnef al., 1992). 
Since no single ring hydroxylated metabolite of benzene can produce the whole 
spectrum of benzene toxicity, more and more attention has focused on the interactions 
of benzene metabolites (Kolachana et al., 1993), reactive ring-opened metabolite i.e., 
trans, trans-muconaldehyde (Goon et al., 1992). Further studies are needed to 
demonstrate that trans, trans-muconaldehyde is a precursor of trans, trans-muconic acid 
in vivo. Recently Zhang ef al., (1995b) demonstrated the involvement of iron in the 
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mechanism of ring opening of benzene in mouse liver microsomal system. Although it 
is generally believed that there is no "free" iron in vh/o, there is large body of evidence that 
supports the existence of a so-called "lov»/-moiecular weight-iron pool" in cells, including 
hepatocytes. Earlier Rao et al., (1990) demonstrated the accumulation of bleomycin 
detectable low molecular weight iron components in bone marrow in experimental rats 
during benzene exposure. The liver is a tissue rich in iron, which is stored in ferritin and 
present in many heme containing proteins. Under normal condition, the mobilization of 
iron is strictly regulated. However, recently Ahmad et al.. (1995) observed the reductive 
release of iron from horse spleen femtin by 1,2,4-benzenetriol. Oxidative stress produces 
conditions that interfere with this regulation, and which may result in the release of iron 
from femtin. Since there is an animal model for iron accumulation (Nielsen et al., 1993) 
and since methods for assessing benzene haematotoxicity and for measuring 
metabolism are available, it would be of interest to evaluate the role of iron in benzene 
haematotoxicity in vivo. 
The molecular mechanism of benzene toxicity is also not very well understood. 
Many studies suggest that DNA damage may be playing a role in the myelotoxicity during 
benzene exposure. Further studies measuring the formation of both DNA adducts and 
oxidative base damage will be required to evaluate the contribution of each of these 
forms of DNA damage to the myelotoxic effects of benzene. Accordingly, the interaction 
oi phenolic compound with DNA associated copper may result in a spectrum of lesion 
in DNA, including site specific oxidative DNA base modifications, DNA strand breaks, and 
DNA adducts of phenolic intermediates (Li et al., 1995; Zhang et al., 1996). These 
lesions in DNA might contribute to mutation in DNA and to the initiation of carcinogenesis 
induced by phenolic compounds. However, benzene induced DNA strand-breaks in vivo 
is yet to be identified. 
Further studies are needed of large populations of exposed workers to produce 
benzene-induced leukemia and to examine the ability of benzene metabolites to induce 
mitotic recombination in human cells. Recently Chen and Eastmond (1995) have shown 
that a number of polyphenolic metabolites or postulated metabolites (such as 2,2'- and 
4,4'-biphenol) of benzene inhibit human topo isomerase II enzyme in vitro when activated 
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by a peroxidase metabolizing system and hypothesized that the quinone and phenolic 
metabolites of benzene might exert their clastogenic effects through inhibition of topo-
isomerase enzymes. Topoisomerases are major chromosomal proteins which modulate 
the topological state of DNA by breaking and releasing DNA strands (Pommier and 
Bertrand, 1993). These enzymes participate in a range of cellular processes including 
DNA replication and transcription (Anderson and Rot)erge, 1992) and DNA repair 
(Stevnsner and Bohr, 1993; Thielmann et a/., 1993). Topoisomerase II also play a role 
in maintaining genomic stability (Wang et al., 1990). The inhibition or interference with 
topoisomerase II activity at critical stages of the cell cycle could lead to chromosome 
breakage, aneuploidy or cell death. Several inhibitors of topoisomerase II are quinone 
or quinone-forming compounds which exhibit some structural similarity to metabolites of 
benzene possessing hydroxyl or keto groups on the aromatic ring (Li et al., 1993; 
Stoyanovsky ef a/., 1993). Furthermore, quinone and phenolic compounds have been 
identified at relatively high concentrations in the peripheral blood and bone marrow of 
rodents following benzene exposure (Rickert et al., 1981). Additional In vitro and In vivo 
studies will be required to demonstrate the involvement of topoisomerase inhibition in the 
myelotoxic and carcinogenic effects of benzene. 
Finally, the possible mechanisms of benzene-induced leukemogenesis are 
suggested and areas of further research are indicated that may provide new information 
as well as permit the application of existing knowledge to the understanding of the 
leukemogenic process. 
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CHEMICALS 
Benzene of high purity was obtained from Glaxo Laboratories India (ANLAR). 
Ferritin (horse spleen), ferrozine (3-(2-pyhdyl)-5,6-bis(4-phenyl sulfonic acid)-1,2,4-
tnazine), bathocuproine, dopamine, 6-hydroxydopamine, catalase (bovine liver; 
2,000-5,000 units/mg protein), superoxide dismutase (bovine erythrocytes; 2,500-5,000 
units/mg protein), bovine serum albumin, calf thymus DNA, 5,5'-dithiobis-(2-nitrobenzoic 
acid), Sephadex G-10 beads, agarose gel and L-glutamate monosodium were obtained 
from Sigma Chemical Company, St, Louis, MO, USA. Hydroquinone, 1,2,4-benzenethol 
and 1,4-benzoquinone were obtained from Aldrich, Milwaukee, USA, Bleomycin 
hydrochloride was obtained from Nippon Kayaku Co, Ltd., Japan, 2-Thiobarbituric acid 
was obtained from BDH Chemical Limited, England, Supercoiled plasmid pUC 18 DNA 
was obtained from Bangalore GENE! Pvt, Ltd., India, whereas tris-hydroxymethyl amino 
methane, glutathione reduced, Folin-Ciocalteu reagent and tnchloroacetic acid (TCA) 
were obtained from Sisco Laboratohes, India, All other chemicals were either obtained 
from CSIR Centre for Biochemicals, New Delhi, India or were of analytical grade. 
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INSTRUMENTS 
Spectronic-2001 spectrophotometer, Bausch and Lomb, Ultra Turrax T-25 
homogenizer, UV-transilluminator Poloroid MP4*, gel electrophoretic apparatus, electro-
phoresis power supply SPS-3000, mettler balance, digital pH meter, and microcentrifuge 
(REMI) were the major instruments used in this study. 
ANIMALS 
Male mice of 25-30 gms bred at the animal house unit of Industrial Toxicology 
Research Centre were divided into four groups (10 mice in each group). One group was 
kept as control which received only 0.1 ml normal saline. Second and third groups 
received hydroquinone or iron (25 mg each/kg body weight) for 20 days (single dose i.p). 
The last group received hydroquinone : iron complex (25 mg hydroquinone ; 25 mg 
iron/kg body weight) 1:1 ratio intraperitoneally for 20 days (single dose). After the 
termination of the treatment blood was collected into clean heparinized tuljes from jugular 
vein and kept at 4°C for haematological studies. Liver homogenate was made in 0.15 
M KCI for the estimation of sulphahydryl content and lipid peroxidation. 
Female albino rats were treated with FeS04.7H20 (100 mg/kg body weight, i.p.) for 
three days consecutively. Rats were sacrificed on 4th day and ferritin was isolated from 
liver to study the mobilization of iron from ferritin by 1,2,4-benzenetriol. Bone marrow 
cells were flushed out by 0.15 M NaCI from four femurs of control female rats to evaluate 
the mobilizationof iron by 1,2,4-benzenetriol. The cells of bone marrow pellet were lysed 
by resuspension in approximately 1.5 ml distilled water. This suspension was homo-
genized in Ultra Turrax T-25 for 30 sec. and the volume was made upto 2.0 ml with 
acetate buffer to a final buffer concentration of 0.033 M, Brain homogenate (2%) of 
control rat was made in 0.15 M KCI for 1,2,4-t>enzenetriol concentration dependent iron 
release and subsequent lipid peroxidation in the presence of ferritin. 
Femur bone marrow cells were also isolated from control albino rats and cell lysate 
was made to demonstrate the reco\jevj of iron.polyphenol complex from bone marrow 
lysate. 
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Albino rats of either sex (Swiss wistar strain, 100-110 gm) were treated with 
benzene (0.5 ml/kg body weight) intraperitoneally daily for 10 days. Control and 
experimental rats were sacrificed by cervical dislocation and liver were immediately 
excised and liver homogenate (4 gm liver/30 ml of 50 mM Tris -10 mM EDTA buffer, pH 
8.0) was prepared to isolate nuclei. 
In another set of experiment male mice (25-30 gm) were exposed with glutathionyl 
hydroquinone (GHQ) (100 mg/kg body weight) in 0.1 ml normal saline intraperitoneally 
daily for one month (single dose) and control group received only 0.1 ml normal saline. 
After the termination of the treatment mice were sacrificed and haematological as well 
as other parameters were studied. 
EXPERIMENTAL PROCEDURES 
Release of thiobarbituric acid reactive products (TBAR) from DNA 
Iron-catalyzed bleomycin-dependent DNA degradation was performed according to 
the method of Gutteridge (1987). Principally, bleomycin in the presence of low molecular 
weight iron degrades DNA with the release of base propenals which react with 
2-thiobarbituric acid (TBA) to give a chromogen similar to that given by malonaldehyde 
on reaction with TBA. Briefly, the assay system in a total volume of 3.0 ml consisted of 
0.033 M acetate buffer of pH 5.3, 500 pg calf thymus DNA, 50 pg bleomycin hydro-
chloride and the reaction was initiated by the addition of 20 pM iron or a complex of iron 
with polyphenol or of endogenous chelators, such as citrate, glucose, fructose, glycine, 
glutamic acid, cysteine, aspartic acid, adenosine monophosphate, adenosine diphos-
phate, adenosine triphosphate and dithiothreitol(20 pM:40 pM) which were made 
immediately before use. The contents were incubated at 37°C for 30 min and the 
reaction was terminated by the addition of 1.0 ml of 10% (w/v) ice-cold trichloroacetic acid 
(TCA). The contents were centrifuged at 3000 rpm for 15 min. To the clear supematants, 
an equal volume of 0.67% (w/v) TBA was added and heated for 15 min in a boiling 
watertDath. The resultant TBA chromogen was read at 532 nm using a Spectronic-2001 
spectrophotometer. The values are expressed as nmoles of malonaldehyde equivalents 
generated by using £532=1.56 x 10^ cm' MV 
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Formation of thiobarbituric acid reactive products (TBAR) from 
glutamate 
Release of thiobarbituric acid reactive products from glutamate was followed 
according to the method described (Gutteridge, 1981). Briefly, the reaction mixture (total 
volume 1.5 ml) contained 0.033 M sodium phosphate buffer of pH 7.4 in 0.15 M NaCI, 
4 mM glutamate and the reaction was started by the addition of 20 IJM iron or a complex 
of iron:polyphenol (20 \iM : 40 \iM). The contents were incubated for 15 min at 37°C and 
the reaction was terminated by the addition of 1.0 ml of 10% (w/v) ice-cold TCA. The 
contents were centrifuged at 3000 rpm for 15 min and to the clear supematants, an equal 
volume of 0,67% (w/v) TBA was added and heated for 15 min in a tx)iling waterbath. The 
resultant TBA chromogen formed from glutamate was measured at 532 nm using a 
Spectronic-2001 spectrophotometer. The values are expressed as nmoles of 
malonaldehyde equivalents generated by using E532 = 1.56 x 10* cm ' MV 
Release of Iron from ferritin 
Iron release from horse spleen ferritin was investigated by using the assay procedure 
previously descrifc)ed by Kadir et al., (1992). Briefly, the assay system (total volume 1.5 
ml) contained 100 pg ferritin, 500 pM fen-ozine and the desired concentration of 
hydroquinone/1,2,4-benzenetriol/1,2,3-benzenetriol(pyrogallol)/1,3,5-t»enzenetriol(phloro-
glucinol)/1,4-benzoquinone/phenoiyglutathionyl hydroquinone/uric acid (each 330 pM) or 
dopamine/6-hydroxydopmaine (125 pM) in 0.033 M acetate buffer of pH 5.6. The reaction 
was started by the addition of different reducing agent and the formation of 
(Fe(ferrozine)J^* complex was monitored by recording the increase in absorbance at 562 
nm with time and the amount of iron released from ferritin is expressed as pM Fe^Vmin. 
The effect of oxyradical scavengers was studied by the addition of oxyradical 
scavenger before the addition of polyphenol. The complete reaction mixture contained 
in a final volume of 1.5 ml, femtin (100 pg), 1,2,4-benzenetriol (330 pM), ferrozine (500 
pM), 0.033 M sodium acetate buffer of pH 5.6 and oxygen radical scavengers, such as, 
urea and thiourea (5 mM), mannitol (50 mM), albumin, catalase and superoxide dismutase 
(150 pg). The time course of formation of [Fe(ferrozine)3]^* release from bone marrow 
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cell lysate was assayed in a total volume of 1.5 ml containing 100 pi bone marrow cell 
lysate, 500 |JM fen-ozine, 330 pM 1,2,4-benzenetriol in 0.1 M acetate buffer of pH 5.6 (0.5 
ml). The amount of iron released is expressed as (JM Fe^Vmg protein. 
Lipid peroxidation in brain homogenate 
Lipid peroxidation in rat brain homogenate (2% in 0.15 M KCI) was assayed 
according to the method of Bemheim et a/., (1948). 
(a) In presence of iron or Jron:polyphenol 
The assay mixture was incubated either with 20 pM iron, iron-polyphenol (20 pM : 
40 pM) or none and 2.0 ml of brain homogenate (2%) in a metabolic shaker at 37°C, 
Aliquots (1.0 ml) were taken at intervals and the reaction was terminated by the addition 
of 1.0 ml of 10% ice-cold TCA. 
(b) In presence of ferritin and 1,2,4-benzenetriol 
The assay system (total volume 1.5 ml) contained 100 pg ferritin and 1,2,4-
benzenetriol (0-330 pM) in 0.033 M acetate buffer of pH 5.6. The contents were 
incubated for 30 min, after which 2.0 ml of 2% brain homogenate was added and 
incubated for 1 hr at 37°C. After 1 hr incubation, aliquots (1.0 ml) were taken out and the 
reaction was terminated by the addition of 1.0 ml of 10% ice-cold TCA. 
The contents in the above experiments were centrifuged and to the clear 
supematants, an equal volume of 0.67% (w/v) TBA was added and heated for 15 min in 
a boiling waterbath. The resultant TBA chromogen was read at 532 nm using a 
Spectronic-2001 spectrophotometer. The values are expressed as nmoles of malon-
aldehyde equivalents generated by using E^^ = 1.56 x 10^ cm' M'. 
Bleomycin-dependent degradation of DNA by 1,2,4-benzenetriol in presence of 
ferritin 
The effect of increasing concentrations of 1,2,4-benzenetriol on iron catalyzed 
bleomycin-dependent degradation of calf thymus DNA in the presence of ferritin was 
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evaluated. Briefly, the assay system (total volume 1.5 ml) contained 100 J^g ferritin and 
1,2,4-benzenetriol (0.165 pM) in 0.033 M acetate buffer of pH 5.6. The contents were 
incubated for 30 min, after v\/hich 250 |jg calf thymus DNA and 50 MQ bleomycin-
hydrochloride in 0.3 ml was added and incubated for additional 30 min at 37°C. The 
reaction was tenninated by addition of 10% ice-cold TCA and to a dear supernatant add 
an equal volume TBA. The resultant TBA chromogen formed from DNA was measured 
and the values are expressed as described eariier. 
Isolation of ferritin from rat liver and mobilization of Iron by 1,2,4-
benzenetriol 
Female albino rats (Swiss Wistar strain) were treated with FeSO .^THzO (100 mg/kg 
body weight, intraperitoneally) for three days consecutively. Rats were sacrificed on 4th 
day and ferritin was isolated from liver by the method of Granick (1942) with some minor 
modifications. 
Liver from two rats was homogenized using Ultra Tun^ ax T-25 for 30 sec. in distilled 
water. Dilute the suspension to 1 gm liver per 4 ml distilled water and heat rapidly with 
stirring to 70-80°C for 5 min. The suspension was filtered while hot through a muslin 
cloth. Adjust the pH of the filtrate to pH 4.6 with acetate buffer (0.5 M) and centrifuged 
at 1500 rpm for 30 min. After discarding the precipitate, ammonium sulphate (30 gm/100 
ml) was direclty added to clear red brown supernatant and kept at 4°C for overnight and 
the resultant precipitate was centrifuged and dissolved in measured volume of distilled 
water. Cadmium acetate (4 gms) was added per 100 ml suspension and centrifuged at 
1000 rpm for 10 min to remove any impurity. A red brown supernatant containing 
noncrystalline ferritin was obtained and this suspension was used to study the 
mobilization of iron from ferritin by 1,2,4-benzenetriol. Release of iron was measured in 
a total volume of 1.5 ml contained, 05 ml of sodium acetate buffer (0.1 M, pH 5.6), 330 
MM 1.2,4-benzenetriol, 0.5 mM ferrozine and 50 or 100 pi ferritin isolated from rat liver 
(0.4 and 0.8 mg equivalent protein). The formation of [Fe(ferrozine)3f* was monitored 
(Kadir et al., 1992) by recording the increase in absorbance at 562 nm with time and 
amount of iron released from ferritin is expressed as pM Fe^Vmin/mg protein. 
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Protein estimation 
Protein was estimated by the method of Lowry et al., (1951). Protein was 
precipitated with 10% ice-cold TCA. The precipitated protein was centrifuged at 3000 
rpm for 15 min and the protein pellet was dissolved in 1N NaOH. Finally suitable amount 
of dissolved protein was diluted to 1.0 ml with distilled water and 5.0 ml of alkaline 
copper reagent was added. After 10 min, 0.5 ml of Folin-Ciocalteu reagent was added. 
Absorbance was read at 750 nm after 20 min. Bovine serum albumin (BSA) was used 
as standard. 
To prepare alkaline copper reagent, solution (A) and (B) were mixed in 1:1 ratio just 
prior to use of the reagent. Solution (A) containing 8 gm sodium carbonate anhydrous 
dissolved in 100 ml of double distilled water, and (B) containing 120 mg sodium 
potassium tartrate and 60 mg of CUSO4.5H2O dissolved in 100 ml of double distilled 
water. 
Recovery of iron:polyphenol complex 
Recovery of iron:polyphenol complex from bone marrow lysate (1 mg protein 
equivalent) was monitored by assaying iron: polyphenol complex catalyzed bleomycin-
dependent degradation of DNA as compared to that without bone marrow lysate. Briefly, 
the assay system in total volume of 1.0 ml with or without bone marrow suspension (1 
mg protein) in phosphate buffer saline (0.1 M, pH 7.4) contained 250 yg calf thymus 
DNA, 50 |jg bleomycin and iron: hydroquinone or iron: 1,2,4-benzenetriol (24 |JM:48 pM) 
complex. The total reaction mixture was incubated for 30 min at 37°C and the reaction 
was terminated by adding 1.0 ml of 10% ice-cold TCA. The contents were centrifuged 
at 3000 rpm for 15 min and TBA colour was developed as described eariier. FeS04.7H20 
was used to prepare iron and iron:polyphenols by the addition of iron and polyphenol in 
1:2 ratio. Iron and iron: polyphenol solutions were prepared just before use. 
Optical spectra 
The optical spectra of polyphenols with or without the addition of Fe^ ^ were recorded 
on Perkin-Elmer Lambda 15 UVA/IS spectrophotometer in freshly distilled water. The 
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incubation mixtures contained 100 pM hydroquinone alone or 1,2,4-benzenetriol alone 
or with 200 pM Fe^* and scans were recorded every minute upto 4 min. 
Lipid peroxidation in liver homogenate 
Lipid peroxidation was estimated in 10% liver homogenate by the method described 
by Bemheim e^  al. (1948). Liver homogenate (10%) was prepared in 0.15 M KCI. Liver 
homogenate (10 ml) was taken in 25 ml conical flask and placed in metabolic shaker 
waterbath at 37°C. An aliquot of 1.0 ml of homogenate was taken out at different time 
interval (i.e. 0 hr and 1 hr) and precipitated by adding 1.0 ml of ice-cold 10% TCA. After 
waiting for few min the tubes were centrifuged at 3000 rpm for 15 min. Finally, 1.0 ml 
of clear supernatant was taken out and 1.0 ml of 0.67% (w/v) TBA was added. TBA 
chromogen colour was developed by boiling the tubes on water bath for 15 min and read 
at 532 nm. Results are expressed in terms of malonaldehyde equivalents nmoles/hr/gm 
liver using molar extinction coefficient 1.56x10* cm' M' at 532 nm. 
Sulphahydryl estimation 
Total and free sulphahydryl (glutathione) were estimated using the standard 
procedure described by Sedlak and Lindsay (1968). 
(a) Total sulphahydryl 
Liver homogenate in 0.15 M KCI containing 0.02 M EDTA (0.5 ml of 2%) was mixed 
with 0.2M tris buffer containing 0.02 M EDTA (pH 8.2), 0.1 ml of 5,5'-dithiobis-
(2-nitroben2oic acid) (DTNB) (99 mg/25 ml absolute methanol) and kept the reaction 
mixture at room temperature for 15 min. After centrifugation at 3000 rpm for 15 min, 
absorbance of the supernatant nitromercaptobenzoic acid anion was read at 412 nm. 
(b) Free sulphahydryl 
To 1.0 ml of 2% liver homogenate (in 0.15 M KCI containing 0.02 M EDTA) was 
added 1.0 ml of 10% ice-cold TCA. The test tubes were shaken intermittantly for 15 min 
at room temperature and centrifuged at 3000 rpm for 15 min. Supernatant (1.0 ml) was 
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mixed with 1.4 ml of 0.4 M tris buffer containing 0.02 M EDTA (pH 8.9). Finally, 0.1 ml 
of DTNB was added and mixed well. The absorbance of the nitromercaptobenzoic acid 
anion formed was taken at 412 nm. 
Sulphahydryl content was calculated from the standard plot of cysteine prepared in 
the same manner and expressed in terms oi mmoles/100 gm liver 
Haematological parameters 
Haemoglobin (Hb) content in male mice was estimated by cyanomethaemoglobin 
method (Drabkin and Austin, 1932). The basis of the method is dilution of blood in a 
solution containing potassium cyanide and potassium ferricyanide. Haemoglobin is 
converted into cyanomethaemoglobin in presence of Drabkin's cyanide - ferricyanide 
solution. The absorbance of the solution is then measured in a spectrophotometer at a 
wavelength of 540 nm. 
Drabkin's reagent was prepared by dissolving 100 mg potassium ferricyanide and 
25 mg potassium cyanide in 500 ml of distilled water. The reagent should be clear and 
pale yellow in colour and can be stored at room temperature in a brown glass bottle. 
When measured against water as blank in a spectrophotometer at wavelength 540 nm, 
the absorbance must read zero. 
Add 20 pi of blood into 4.0 ml of Drabkin's reagent and mixed well by inverting the 
tubes several times. After mixing, the tubes were allowed to stand at room temperature 
for atleast 10-20 min to ensure the completion of the reaction. Finally, the tubes were 
read at 540 nm against Drabkin's reagent as a blank using Spectronic-2001 
spectrophotometer. Cyanomethaemoglobin solution was used as a standard to calculate 
the haemoglobin content. 
Calculation 
A54o0f test sample Cone std. (mg/dl) x dilution factor 
Hb(g/dl)= X 
A540 of standard 1000 
Other haematological parameters, such as white blood cell count, differential 
leukocyte count and hematocrit value (%) were evaluated using standard procedures. 
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Packing of Sephadex G-10 column and elution profile of iron alone, 
1,2,4-benzenetriol alone and 1,2,4-benzenetriol:iron mixture 
Sephadex G-10 (4.0 gm/200 ml) in 0.1 M sodium acetate buffer saline, pH 5.6 was 
incubated overnight at room temperature. It was loaded to the column and allowed to 
settle down and the gel column volume was 12 ml (12 cm x 1 cm). The column was 
washed three times with acetate buffer and iron (as ferrous sulphate) (1 mM in 1.0 ml) 
was passed through the column and eluted with 0.1 M acetate buffer of pH 5.6. Flow rate 
of 2.5 ml/5 min was maintained and 1 to 30th fractions were collected at every 5 min. 
Similarly, ImM in 1.0 ml of 1,2,4-ben2enetriol and 1.0 ml of 1,2,4-benzenetriol : iron 
mixture (1 mM : 1 mM) were also passed through the column and 1 to 30th fractions were 
collected. 
In another set of experiment 1.0 ml of reaction mixture contained 100 pg horse 
spleen ferritin, 2mM of 1,2,4-benzenetriol and with or without 1 mM ethylene-
diaminetetraacetic acid (EDTA) were passed through column and fractions were collected 
at every 5 min. 
Estimation of 1,2,4-benzenetriol and iron 
1,2,4-Benzenetriol estimation was followed spectrophotometrically by recording the 
optical density at 287 nm using a Spectronic-2001 spectrophotometer and iron estimation 
was done according to the method of Peters et al., (1956) by using bathophenanthroline 
sulphonic acid. Briefly, 2.0 ml of reaction mixture contained, 0.5 ml of aliquot from each 
fraction, 1.5 ml of sodium acetate buffer (0.1 M, pH 5.6), 200 pg ascorbic acid and 50 
pg bathophenanthroline sulphonic acid. Reaction mixture was kept at room temperature 
for 5 min and absorbance was taken at 535 nm. 
Preparation of glutathionyl hydroquinone 
Equimolar concentration (200 pM) of 1,4-benzoquinone and glutathione reduced 
(GSH) were mixed in distilled water in 1:1 proportion by volume. The nucleophilic 
addition of GSH to 1,4-benzoquinone yields glutathionyl hydroquinone and its authenticity 
was confirmed by the absorption maximum at 303 nm. No absorption was observed at 
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248 nm which is the absorption maximum for 1,4-benzoquinone. Free GSH was also not 
demonstrable by Ellman's reagent. 
Glutathlonyl hydroquinone and iron dependent TBAR formation from 
DNA or glutamate or deoxyuridine 
of 
Iron catalyzed bleomycin-dependent release of TBAR from DNA in presence iron 
or iron + GSH or iron + GSH + 1,4-ben2oquinone was performed according to the method 
of Gutteridge (1987). Briefly, the assay system in a total volume of 1.5 ml consisted of 
0.033 M phosphate buffer (pH 7.4), 250 pg calf thymus DNA, 50 j^g bleomycin 
hydrochloride and with or without oxyradical scavengers, viz. thiourea (5mM), mannitol 
(50 mM), dimethylsulfoxide (33 mM), albumin, SOD and catalase (100 pg/ml). The 
reaction was initiated by the addition of 15 pM iron (as FeS04.7H20) or 15 pM iron + 15 
pM GSH or 15 pM iron + 15 pM GSH + 15 pM 1,4-t>enzoquinone. All these reactants 
were dissolved immediately before use. The contents were incubated at 37°C for 30 min 
and the reaction was terminated by the addition of 0.75 ml of 10% (w/v) ice-cold TCA. 
The contents were centrifuged at 3000 rpm for 15 min and to the clear supernatants an 
equal volume of 0.67% (w/v) TBA was added. TBA colour was developed by heating the 
tubes for 15 min in a boiling water bath. The resultant TBA chromogen was read at 532 
nm using a Spectronic-2001 spectrophotometer. The values are expressed as nmoles 
of malonaldehyde equivalents generated by using £532=1.56x10^ cm' MV 
Release of TBAR from L-glutamate or deoxyuridine was followed according to the 
method of Gutteridge (1981). Briefly, the reaction mixture (total volume 1.5 ml) 
contained, 0.033 M sodium phosphate buffer (pH 7.4)in 0.15 M NaCI, 4 mM glutamate 
monosodium or 3.2 mM deoxyuridine and the reaction was started by the addition of 
glutathlonyl hydroquinone (5.0 pM - 25.0 pM). The contents were incubated for 2 hr at 
37°C and the reaction was terminated by the addition of 1.0 ml of 10% (w/v) ice-cold 
TCA. TBAR was estimated as described in the case of release of TBAR from DNA. 
Recovery of glutathionyl hydroquinone 
Recovery of glutathionyl hydroquinone from bone marrow lysate (1 mg protein 
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equivalent) was monitored by assaying Iron- catalyzed bleomycin-dependent degradation 
of calf thymus DNA as compared to that without bone marrow lysate. 
Measurement of Oj' 
Release of Oj' from glutathionyl hydroquinone (30 \M) in a total volume of 1.5 ml 
was monitored by the superoxide dismutase inhibitable reduction of cytochrome c (80 
pM) at 550 nm at 25°C spectrophotometrically using the extinction coefficient value of 
reduced cytochrome c as 29,500 cm'M"' (Cumutte et al., 1974). Appropriate blanks were 
used to con"ect any cytochrome c reduction in the absence of glutathionyl hydroquinone. 
Reaction of glutathionyl hydroquinone with plasmid pUC 18 DNA 
Reaction mixture in 50 pi, contained 20 pM phosphate buffered saline (pH 7.4), 300 
ng plasmid pUC 18 DNA, 200 pM 1,4-benzoquinone alone or GSH alone or glutathionyl 
hydroquinone and with or without oxyradical scavengers, viz. superoxide dismutase, 
catalase (54 pg), mannitol, thiourea and sodium benzoate (2 mM). The contents were 
mixed well and incubated for 3 hr at 37°C. After 3 hr incubation, 5 pi of solution 
containing 40 pM EDTA, 0.05% bromophenol blue tracking dye and 50% (w/v) sucrose 
was added and the solution was subjected to electrophoresis on 1% agarose gels in TBE 
buffer (89 mM tris base, 89 mM boric acid and 2 mM EDTA, pH 8.0) for 3 hr at 60 mA 
current. The gels were stained with ethidium bromide (0.5 pg/ml) viewed and photo-
graphed on an UV-transilluminator. One single strand break in supercoiled DNA into 
relaxed open circular form or double strand break into linear form, respectively, run 
slower than undamaged supercoiled DNA as evidenced by 1% agarose gel 
electrophoresis (Toyokuni and Sapripanti, 1993). 
Isolation of rat liver nuclei 
Approximately 4 gm rat liver was homogenized in 30 ml of Tris-EDTA buffer (50 mM 
tris, 10 mM EDTA, pH 8.0) and centrifuged for 10 min at 2000 rpm. Pellet was washed 
twice in Tris-EDTA buffer and resuspended to 10 ml with 0.1 M phosphate buffered 
saline (pH 7.4) (Mahmutoglu and Kappus, 1987), 
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Release of TBAR from rat liver nuclei in the presence of different polyphenols and 
effects of different metal chelator and oxyradical scavengers 
The reaction mixture in a total volume of 1.5 ml contained, 0.1 M phosphate buffered 
saline (pH 7.4), 0.5 ml isolated rat liver nuclei suspension (12 mg protein), 330 J^M 
hydroquinone/1,2,4-benzenetriol/6-hydroxydopamine/dopamine and with or without 
copper (0.08 and 0.167 mM) or EDTA/DTPA (5 pM) or bathocuproine (5-25 pM) or 
different oxyradical scavengers, such as thiourea (2.5 and 5.0 mM)/mannitol (50 mM)/ 
catalase(150 pg/1.5 ml)/SOD (100 j^g/1.5 ml). The contents were incubated for 2 hr 
at 37°C with occasional shaking and the reaction was terminated by the addition of 0.5 
ml of 10% ice cold TCA. The contents were centrifuged and to 1.0 ml of supematant 0.5 
ml of 0.67% thiobarbituhc acid (TBA) was added and heated in a boiling water bath for 
15 min and the resultant malonaldehyde: TBA chromogen was read at 532 nm. The 
results were expressed as nmoles of TBAR formed per hour per gm protein by using 
extinction coefficient 1.56 x 10^ cm' M (Rao and Pandya, 1989; Quinlan and 
Gutteridge, 1987). 
Metal analysis 
Metals were analyzed in liver tissue and isolated rat liver nuclei of rats of benzene 
exposed and control group by the method of Berman (1980). Equal weight of liver tissue 
or 3.5 ml of isolated nuclei was added into the digestion flask containing 20 ml of 
digestion mixture (1:6:: Perchloric acid (60%): nitric acid). The flasks were boiled in the 
fuming chamber on hot plate till dry. The dry ash was dissolved in 5.0 ml of 0.1 N nitric 
acid and transfered into the test tube. The contents of iron and copper were read using 
atomic absorption spectrophotometer. Results were expressed in terms of pg metal/gm 
liver tissue or [jg metal/gm protein in liver nuclei. 
Nuclear DNA damage by hydroquinone or 1,2,4-benzenetriol 
Isolated rat liver nuclei were incubated with hydroquinone or 1,2,4-benzenetriol and 
DNA damage was evaluated by agarose gel electrophoresis. Briefly, 50 1^ of total 
reaction mixture contained, 20 fj| of isolated rat liver nuclei suspension (350 pg protein). 
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10 tJl of phosphate buffered saline (0.1 M, pH 7.4) and hydroquinone orl ,2,4-benzenetriol 
(0.5 mM and 1.0 mM). Reaction mixture was incubated for 4 hr at 37°C and finally mixed 
with 5 \i\ of solution containing 40 pM EDTA, 0.05% bromophenol blue tracking dye, 1% 
sodium dodecyl sulphate and 50% (w/v) suaose. Total reaction mixture was loaded on 
1% agarose gel for electrophoresis in TBE buffer (89 mM tris base, 89 mM boric acid 
and 2 mM EDTA, pH 8.0) for 3 hr at 75 mA current. The gels were stained with ethidium 
bromide (0.5 pg/ml), viewed and photographed on an UV-transilluminator. 
STATISTICAL ANALYSIS 
The statistical values and level of significance between the experimental and control 
groups of animals were computed by the following formulas : 
Standard deviation (SD) 
(X, - X)^ 
SD = 
n-1 
Where, 
X, = individual values 
X = arithmatic mean of individual values 
n = sample size 
Standard error 
SE 
t value 
t 
(SE) 
SD 
{T 
^A • '^B 
/ (SEJ^MSEB)^ 
Where, x^ and Xg are two sample means and SE^ and SEg are the standard 
errors. 
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Level of significance 
After calculating the 't' value the level of significance (p value) was found out from 
the table. The p values less than 0.05, 0.02, 0.01 and 0.001 were considered as just 
significant, significant, more significant and highly significant respectively. 
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Release of Iron from Ferritin 
by 1,2,4-benzenetriol 
Introduction 
Results 
Discussion 
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INTRODUCTION 
Iron (Fe) is an essential element for living organisms because of its role in major 
biological reactions such as the tricarboxylic acid cycle, electron transport, nitrogen 
fixation, DMA synthesis and toxication and detoxication reactions (Theil, 1987). Iron in 
aqueous solution has ready access to two stable oxidation states, the ferrous, Fe(ll) and 
the ferric, Fe(lll). This property underlies the participation of iron in reactions spanning 
all of biochemistry including those controlling the flow of electrons through bioenergetic 
pathways, the activation of molecular oxygen, the decomposition of noxious derivatives 
of oxygen such as peroxide and superoxide and binding of oxygen by haemoglobin, 
myoglobin and haemerythrins (Aisen and Listowsky, 1980) 
But, the same redox properties that make iron so useful in biocatalysis and oxygen 
transport present hazards to the organism. Throughout the biological universe, therefore, 
organisms have been compelled to evolve specific iron sequestering molecules to 
maintain the element in soluble form available for transport and for biosynthesis to 
essential iron proteins and enzymes. By suppressing the catalytic activity of iron in 
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one-electron redox reactions, such iron-binders may also reduce exposure of cells to 
potentially damaging species such as peroxide, superoxide and hydroxyl radicals 
(Willson, 1977). In the vertebrate world, these iron-binding functions are managed by 
transferrin and ferritin, the transport and storage protein of iron metabolism respectively. 
Each of these proteins bind iron sufficiently tightly to resist formation of insoluble 
hydroxylitic products. The binding of iron to these proteins is reversible so that the metal 
is available upon demand to cells with a specific need so that it is incorporated into its 
final biochemical form. The binding of iron by transferrin is to two specific sites with 
well-defined stoichiometry, but in fenritin iron exists as polynuclear aggregates of variable 
size and compositions (Aisen and Listowsky, 1980). 
Storage of iron occurs in two forms; as a soluble protein enveloped core of ferritin, 
and as a part of the nondescript insoluble hemosiderin. The latter consists of inorganic 
iron associated with protein and other substances in variable proportions, and in fact, 
may originate from degraded ferritin (Vidnes and Helgeland, 1973). Mammalian liver, 
spleen and bone marrow are especially rich in ferritin but the protein is found in most 
other tissues, in serum and in circulating blood cells. Ferritin is synthesized in response 
to iron, which it sequesters in accessible form to provide a mobilizable reserve. Thus, the 
protein can serve as a source or sink of iron to play a dynamic role in iron metabolism, 
with regulation occuning at the level of protein synthesis and turnover, and iron deposition 
and release (Aisen and Listowsky, 1980). 
Ferritin is a large protein having molecular weight of about 450 kilodatton. Apoferritin 
(protein moiety of ferritin only) consists of 24-polypeptide chains, made up of two types 
of subunits, H and L, with molecular weight of 22,000 and 19,000 respectively (Biemond 
et al.. 1988). The polypeptide chains are arranged in a spherical protein shell, with a 
central cavity. X-ray and electron microscopic studies show that the protein shell is 
nearly spherical with an external diameter of 120-130 A° and a central cavity of about 75 
A° (Hoare et al., 1975). The iron is encapsulated in the central cavity which has eight 
shallow pockets (Treffrye^ a/., 1977). The channels facilitate the movement of iron, and 
this constitutes an important function of femtin. One molecule of ferritin can store as 
many as 4,500 iron atoms (Harrison, 1977). Iron is present in ferritin largely in the form 
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of ferric oxyhydroxide (FeOOH) together with some phosphate (Theil et al., 1979). 
Clinicians monitor the level of ferritin in serum to obtain information about the state of the 
reticuloendothelial iron stores, or the presence and progress of some malignant diseases 
(Jacobs and Worwood, 1975; Worwood e^  a/., 1975). Several studies have indicated the 
involvement of free radicals in initiation and promotion processess of carcinogenesis 
(Wei and Frenkel, 1991). Large human prospective studies suggest that excess body 
iron stores estimated by serum ferritin level, serum transferrin level, or transferrin 
saturation are associated with carcinogenesis, such as primary hepatocellular carcinoma, 
colon cancer, lung cancer, bladder cancer, acute lymphocytic leukemia and neuro-
blastoma (Potaznic ef al., 1987; Evans ef a/., 1987). Thus, elucidation of the 
mechanisms of iron-mediated oxidative damage may be important for the prevention of 
carcinogenesis. 
Redox cycling is a characteristic of transition metals such as iron and is closely 
associated with the production of reactive oxygen species. In order to link the chemical 
reaction with biological system the concept of the "catalytic" or "free" form of iron 
(Gutteridge et al., 1982) is important. "Free" iron was originally measured as thiobarbitunc 
acid reactive products (TBAR) formation in an in vitro system that contains sample fluid, 
calf thymus DNA, bleomycin, ascorbate and HjOj. Bleomycin in the presence of Fe(ll) 
degrade DNA to form TBAR. The mechanism of bleomycin-dependent DNA degradation 
in presence of iron and reducing agent is shown in Figure-3.1. Although, other ions can 
bind to bleomycin, they do not result in DNA degradation (Gutteridge et al., 1982). 
Reactive oxygen species in biological system induce oxidative stress. Every cell, 
whether using oxygen or not, has elaborate inducible protective mechanisms against 
oxidative stress. There are almost always reducing agents, or enzymes associated with 
reductants. Reducing molecules or enzymes include ascorbate, glutathione reduced 
(GSH) and thiol-specific antioxidant (Chae et al., 1993; Yim et al., 1994). "Free" iron, if 
it exists in vivo, can, therefore, t>e quite harmful because there are many reducing agents 
mentioned above that can initiate the Fenton reaction via the production of H^ O^  as 
follows: 
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Fe(lll) + Reductant > Fe(ll) + Oxidized Reductant 
2Fe(ll) + O2 + 2H* > 2Fe(lll) + H A 
Fe(ll) + H2O2 > Fe(lll) + OH + OH 
The mechanism of iron uptake, mobilization, release and utilization are well 
understood (Crichton and Ward, 1992). Low molecular weight iron chelates which 
maintains a dynamic equilibrium fc>etween iron uptake, storage and utilization have been 
descrit>ed (Jacobs, 1977). Iron may be mobilized from ferritin by reduction with agents 
such as dithionite, thioglycolate, or other thiols (Crichton, 1973), with removal facilitated 
by chelators. Without reductants, chelating agents are either ineffective for releasing iron 
from ferritin or remove it only very slowly (Crichton and Roman, 1978). Although 
ascorbate, cysteine and reduced glutathione may serve as reductants in vitro, but they 
are not efficient enough to be considered possible physiological mediators of iron release 
from femtin. However, recently Baaderef a/., (1996) clearty demonstrated that ascorbic 
acid is capable of mobilizing iron from ferritin in the cellular system by reduction of the 
ferric ion core in neuroblastoma SK-N-SH cells. Superoxide anion radical generated by 
xanthine-xanthine oxidase system(Topham e^  a/., 1982) and many toxicological reductants 
which mobilize ferritin iron have been reported. In contrast, ferritin was able to stimulate 
free radical damage, possibly by the formation of hydroxyl radicals, in many test systems. 
A bulk of evidence obtained in vitro confirms that superoxide radical is also capable of 
mobilizing iron from ferritin (Reif, 1992; Monteiro and Winterbourn, 1989a). 
Several endogenous and xenobiotic agents have been reported to release Fe(ll) 
from ferritin Fe(lll) in vitro (Aust et al., 1985). Thomas et al.. (1985) demonstrated that 
xanthine/xanthine oxidase mediated generation of superoxide radical is able to reduce 
and release iron from ferritin and concomitantly promote liposome lipid peroxidation. 
Redox cycling of paraquat (Thomas and Aust, 1986a), the semiquinone radical of 
adriamycin (Thomas and Aust, 1986b), nitric oxide (Reif and Simmons, 1990), 6-
hydroxydopamine (Monteiro and Winterixium, 1989b) and therapeutic and physiological 
iron chelators (O'Connell et al., 1989) have been shown to promote mobilization and 
reductive release of iron from ferntin. Certain diphenols in the presence of a reductant 
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have also been shown to release iron from ferritin (Kadir e^  a/., 1992). It has been 
suggested in particular that iron is released from stores under conditions in which 
oxidative stress is involved in both systems in vitro (Thomas e^  a/., 1985) and isolated 
perfused organs (Healing et a/., 1990). Ferrali et al., (1992) reported that oxidizing 
agents viz. phenyl hydrazine, divicine and isouramil induced iron release and membrane 
damage in erythrocytes. The same oxidizing agents were also shown to release iron 
from ferritin (Monteiro and Winterboum, 1989a). 
Expression of benzene toxicity requires its metabolism to toxic metabolites and 
follows similar pathways in humans and animals. It is widely believed that the 
polyphenolic metabolites of benzene accumulate against the concentration gradient in 
bone marrow (Greenlee e^  a/., 1981a) and are responsible in the formation of reactive 
oxygen species which may play a role in benzene induced toxicity. Hydroquinone and 
1,2,4-benzenetriol, the two principal polyphenolic metabolites of benzene have been 
shown to be toxic due to their capability to undergo autooxidation (Rao and Pandya, 
1989). The suggested mechanism includes free radical formation via superoxide and 
covalent binding of semiquinones to DNA, RNA or other cellular macromolecules 
(Greenlee et al., 1981b). Although, the mechanism how benzene interferes with iron 
metabolism is not well known, but accumulation of bleomycin-detectable low molecular 
weight iron (LMI) compound in bone marrow was observed in experimental rats dunng 
benzene exposure (Rao et al.. 1990). Earlier studies showed that benzene inhibits heme 
biosynthesis at the level of 6-AU\ dehydratase (Freedman et al.. 1977; Rao and Pandya, 
1980) and increase in heme oxygenase activity, a rate-limiting enzyme for heme 
degradation (Abraham et al., 1986). As a result, depletion in regulatory heme content 
(Siddiqui etal., 1988) and accumulation of iron have been reported (Pandya etal., 1990). 
Superoxide dependent reductive release of iron from ferritin may increase the LMI pool 
capable of undergoing redox reactions (Topham et al.. 1982). 
With this available information that accumulation of polyphenolic metabolites of 
benzene and formation of reactive oxygen species due to autooxidation of polyphenolic 
metabolites, we investigated the efficacy of polyphenols to release iron from horse 
spleen ferritin in vitro, in the presence of hydroquinone or 1.2,4-benzenetriol and other 
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endogenously formed polyhydroxy compounds, and whether the iron released can 
catalyze oxidation reactions. 
RESULTS 
Release of iron from ferritin in the presence of polyphenols (hydroquinone or 
1,2,4-benzenetriol) and other reducing agents was recorded in Table-3.1. Addition of 
hydroquinone (330 pM) did not result in the release of iron from ferritin. However, the 
same concentration of 1,2,4-benzenetriol resulted in a significant release of iron (3.2 
pM/min) from ferritin. The release of iron was found to be linear upto 15 min and about 
20% of total ferritin iron was released. Presence of dopamine failed to release iron from 
ferritin, whereas 6-hydroxydopamine released large amounts of iron (4.6 [jM/min) from 
ferritin as was reported eariier (Monteiro and Winterbourn, 1989b). Significant amounts 
of iron release from femtin was observed in the nitrogen atmosphere, although to a lesser 
extent than in aerobic conditions (Table-3.1). The efficacy of other polyphenols such as 
1,2,3-t>enzenetriol (Pyrogallol) and 1,3,5-benzenetriol (phloroglucinol) to release iron from 
ferritin were studied. Except 1,2,4-benzenetriol, other tnhydroxy benzene derivatives 
failed to release iron from ferritin (Table 3.2). The release of iron from ferritin was 
concentration dependent on 1,2,4-benzenetriol as is shown in Figure-3.2, although the 
increase was not linear with the concentration of 1,2,4-t>enzenetriol under aerobic and 
anaerobic conditions. 
Table-3.3, represents the effect of oxyradical scavengers on the release of iron from 
ferritin in the presence of 1,2,4-benzenetriol The release of iron was substantially 
inhibited as was evident from the decreased formation of [Fe(ferrozine)3]^' in the 
presence of albumin, catalase and superoxide dismutase (SOD). Thiourea and mannitol 
which are hydroxyl radical scavengers were able to inhibit iron release to an extent of 
about 15%. This indicates that 1,2,4-benzenetno! mediated release of iron was not 
completely due to the mediation of active oxygen species generated during autooxidation 
of 1,2,4-benzenetriol. 
The effect of increasing concentrations of 1,2,4-benzenetriol on lipid peroxidation of 
2% rat brain homogenate in the presence of femtin is shown in Figure-3.3. The increase 
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Table 3.1 
Effect of benzene metabolites and other reducing agents 
on the release of iron from ferritin. 
Addition 
1,2,4-Benzenetriol (330 pM) 
Hydroquinone (330 (JM) 
1,4-Benzoquinone (330 [iM) 
Phenol (330 pM) 
Glutathionyl hydroquinone (330 pM) 
Uric acid (330 pM) 
6-Hydroxydopamine (125 pM) 
Dopamine (125 pM) 
pM Fe^ * released/min 
3.2+0.11 
2.1±0.18 (anaerobic) 
N.D. 
N.D. 
ND. 
N.D. 
N.D. 
4.6±0.15 
0.3+0.01 
Reaction mixture contained in a final volume of 1.5 ml, ferritin (100 pg/1.5 ml), differ-
ent polyphenols, and ferrozine (500 pM) in 0.1 M sodium acetate buffer of pH 5.6. 
Measurements of Fe^*- ferrozine complex followed at 562 nm due to iron 
mobilization from ferritin by different reducing agents. 
All values are average + SE of two sets of experiments conducted in duplicate. 
N.D. = None detectable 
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Table 3.2 
Effect of 1,2,4-benzenetriol and other trihydroxy benzene derivatives 
on the release of iron from ferritin 
Addition \iM Fe^* released/min 
1,2,4-Benzenetriol 3.2±0.11 
1,2,3-Benzenetriol N.D. 
1,3,5-Benzenetriol N.D. 
Reaction mixture contained in a final volume of 1.5 ml, fenitin (100 |jg/1.5 ml), 
polyphenols (330 pM) and ferozine (500 pM) in 0.1 M sodium acetate buffer of pH 
5.6. Measurements of Fe^*- ferrozine complex followed at 562 nm. 
N.D. = None detectable 
e ^1 
+ 
+ 
A —Aerobic atmosphere 
B —Anaerobic atmosphere 
330 
B T ( M M ) 
Figure 3.2 : 1,2,4-Benzenetriol concentration dependent iron release from 
horse spleen ferritin under (A) Aerobic, and (B) Anaerobic 
conditions. 
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Table 3.3 
Release of iron from ferritin by 1,2,4-benzenetriol and 
inhibition by oxygen radical scavengers 
Reaction mixture pM Fe'* released/min 
Complete reaction mixture 3.20±0.11 
+ Urea(5mM) 2.88±0.24(10) 
+ Thiourea (5 mM) 2.64+0.08(18) 
+ Mannitol (50 mM) 2.72±0.10 (15) 
+ Albumin (150 pg/l.5 ml) 2.32+0.02(28) 
+ Catalase(150[jg/1.5ml) 2.00±0.05(38) 
+ SOD (150 ^^g/^ .5 ml) 2.16±0.12(33) 
Complete reaction mixture contained in a final volume of 1.5 ml, ferritin (100 |jg/1 5 
ml), 1,2,4-benzenetriol (330 pM), fen-ozine (500 pM) and oxygen radical scavengers 
in 0.1M sodium acetate buffer of pH 5.6. 
All values are average ± S.E. of t\NO sets of experiments conducted in duplicate. 
Numbers in paraentheses are percent inhibition. 
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Table 3.4 
Release of iron from isolated rat liver ferritin 
1,2,4-Benzenetriol 
(MM) 
00 
330 
330 
Ferritin (mg 
equivalent protein) 
0.8 
0.4 
0.8 
by 1,2,4-benzenetriol. 
pM Fe^ * released/min/ 
mg protein 
0.00 
2.21 
3.80 
Complete reaction mixture contained in a final volume of 1.5 ml, isolated rat liver 
ferritin (0.4 and 0.8 mg equivalent protein), 1,2,4-t)enzenetriol and ferrozine (500 
(JM) in 0.1 M sodium acetate buffer of pH 5.6. 
All values are average of two sets of experiments conducted in duplicate with 
variations of 10% or less. 
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Figure 3.5 : Time course of formation of [Fe(ferrozine)3p* followed at 562 nm 
due to iron mobilization from bone marrow cell lysate by 
1,2,4-ben2enetriol. 
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in lipid peroxidation as measured by TBAR formation was almost linear with the increase 
in 1,2,4-benzenetriol concentration which shows that there is 1,2,4-benzenetriol 
concentration dependent increase in iron release from ferritin. Similarly, the iron release 
from ferritin in the presence of increasing concentrations of 1,2,4-ben2enetriol was tested 
for the iron catalyzed bleomycin-dependent degradation of calf thymus DNA. There was 
a linear increase in TBAR formation from the deoxyribose moiety of DNA with the 
increase in concentration of 1,2,4-benzenetriol (0-165 pM) (Figure-3.4). 
Ferritin was isolated from female rat liver after inducing the ferritin level by injecting 
FeS04.7H20 intraperitoneally. The time course of formation of [Fe(ferrozine)3]^* complex 
due to release of iron from isolated rat liver fenitin in presence of 1,2,4-benzenetriol was 
recorded. The release of iron from isolated ferritin was found to be linear with increase 
in the amount of ferritin (Table-3.4). 
Release of iron from bone marrow cell lysate in the presence of hydroquinone and 
1,2,4-benzenetriol showed that hydroquinone did not release any iron from bone marrow 
cell lysate (results not shown), whereas, 1,2,4-benzenetriol (330 pM) resulted in the 
release of iron from bone marrow cell lysate. The increase in the release of iron from 
bone marrow lysate in the presence of 1,2,4-benzenetriol as a function of time was also 
observed (Figure-3.5). 
DISCUSSION 
Benzene exposure interferes with iron metabolism which includes, decrease in 
incorporation of *®Fe into circulating erythrocytes (Lee ef a/., 1974). Exposure to benzene 
leads to decrease in heme biosynthesis enzyme particulariy. 6-AL.A dehydratase 
resulting in accumulation of 6-ALA in bone marrow (Rao and Pandya, 1980, Freedman, 
et al., 1977), Accumulation of low molecular weight iron (LMI) in bone marrow during 
benzene exposure has been demonstrated and it was shown that LMI catalyze 
bleomycin-dependent degradation of calf thymus DNA (Pandya ef a/., 1990). However, 
the mechanism of how benzene interferes with iron metabolism is not known. 
Polyphenolic metabolites of benzene have been shown to accumulate in bone marrow 
against the concentration gradient (Greenlee et al., 1981a; Rickert et al., 1979). 
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Autooxidation of 1,2,4-benzenetriol has been shown to generate superoxide radicals 
(Lewis et al., 1988b). Superoxide radical is a potent reductant of ferritin iron and causes 
release of iron from ferritin (Topham et al.. 1982). 
In the present investigation it was observed that the presence of 1,2,4-benzenetriol 
induced iron release from ferritin in a concentration dependent manner. The possible 
mechanism of iron release from ferritin by 1,2,4-benzenetriol is shown in Figure-3.6. The 
release of iron from ferritin during autooxidation of 1,2,4-benzenetriol in vivo may result 
in increased intracellular concentrations of free iron. The inability of 1,2,3-benzenetriol, 
1,3,5-benzenetriol, hydroquinone or dopamine to release iron in comparison to 1,2,4-
benzenetriol and 6-hydroxydopamine suggest that hydroxy hydroquinone moiety is 
essential. Similariy, dialuric acid, a tetrahydroxypyrimidine and isouramil, a trihydroxy-
pyrimidine have been shown to release iron from ferritin (Monteiro and Winterbourn, 
1989a). Although, the physiological mechanism of iron mobilization from ferritin is pooriy 
understood, the observed iron release from ferritin by 1,2,4-benzenetriol could occur 
through the direct reduction of iron by the hydroxyhydroquinone form or via its 
autooxidation intermediates i.e., superoxide radical and semiquinone. The semiquinone 
radicals of several antitumorigenic compounds have been shown to reduce and release 
ferritin iron (Thomas and Aust, 1986b; Butler et al., 1985). 
The presence of oxyradical scavengers i.e., albumin, catalase or superoxide 
dismutase caused 28, 38 or 33% inhibition, respectively of 1,2,4-benzenetriol dependent 
iron release from ferritin, with the enzymatic activities of catalase and superoxide 
dismutase (SOD) being of little importance relative to the protein effect of albumin. The 
oxyradical scavenger insensitive rate of iron release from ferritin by 1,2,4-benzenetriol 
is probably due to direct reduction of ferritin iron by 1,2,4-benzenetriol, as substantial 
amounts of iron were released in a nitrogen atmosphere also. Based on the present 
investigation, it is proposed that 1,2,4-benzenetnol induced iron release from ferritin might 
be due to direct reduction and the iron released may facilitate the reduction of O2 by 
1,2,4-benzenetriol resulting in the generation of superoxide radical. The autooxidation 
rate of 1,2,4-benzenetriol has been shown to be 92-fold higher than that of the parent 
hydroquinone which lacks an -OH substituent (Brunmark and Cadenas, 1988). The 
Ferritin 
shell 
/ \ / 
+ ^ 2e" ;+(2H ; 
OH r 
I 
I 
I 
Ferritin ' 
channel / 
Figure 3.6 : The possible mechanism of iron release from ferntin by 1,2.4-benzenetnol 
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presence of hydroquinone or dopamine did not result in iron release from ferritin, 
probably due to the lack of an -OH substituent and the resulting slow autooxidation. 
The results of the present study demonstrate that iron released from ferritin in the 
presence of 1,2,4-ben2enetriol is capable of inducing lipid peroxidation and catalyzing 
bleomycin-dependent calf thymus DNA degradation. The mechanism by which iron is 
released from bone marrow cells and whether it acts as a prooxidant during benzene 
toxicity is not known. However, earlier studies had demonstrated that enhanced lipid 
peroxidation was observed in experimental animals exposed to benzene (Rao and 
Pandya, 1978; Uysal at al., 1986). Polyphenolic metabolites of benzene have been 
shown to accumulate in bone marrow in millimolar concentrations during benzene 
exposure (Greenlee e/ al., 1981a; Rickert e/a/., 1979). The present study indicated that 
a much lower concentration of 1,2,4-benzenetriol (66 pM) is able to release iron from 
ferritin. In a recent study (Singh et al., 1994) it was shown that iron in the presence of 
1,2,4- benzenetriol was a potent agent to catalyze bleomycin-dependent degradation of 
calf thymus DNA. Similariy, the iron released from ferritin by 1,2,4-benzenetriol could 
catalyze bleomycin-dependent degradation of calf thymus DNA. 
Toyokuni (1996) hypothesized that increase in free iron in the cytoplasm or nucleus 
may be associated with an increased risk of cancer and suggested the possible 
mechanisms of iron-induced carcinogenesis (Figure-3.7 ). Our present study indicates 
that 1,2,4-benzenetriol is a potent reductant of ferric iron of ferritin and also mobilize and 
release iron from ferritin core. The release of iron from bone marrow lysate by 
1,2,4-benzenetriol may be of toxicological significance as this could lead to disruption of 
intracellular iron homeostasis in bone marrow cells. Similariy, iron release was noticed 
from ferritin isolated from liver in the presence of 1,2,4-benzenetriol. The release of iron 
from ferritin during autooxidation of 1,2,4-benzenetriol In vivo may result in increased 
intracellular concentrations of free iron which may attain to genotoxic levels. Involvement 
of similar mechanism In vivo as 1,2,4-benzenetriol dependent reduction and release of 
iron from storage sites could result in increased generation of active oxygen species which 
in turn damage cellular macromolecules and also can interfere in maturation and 
differentiation of erythroblasts. In summary, the present observations offer a new 
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mechanism that the iron released from ferritin by 1,2,4-benzenetriol could contribute to 
the better understanding of the toxicity of benzene. In the light of the present results, it 
is believed that iron release in bone marrow cells in vivo leads to generation of 
superoxide radicals, peroxidation of lipids and probably affects maturation and 
differentiation of bone marrow cells. 
Chapter - IV 
Prooxidant and Antioxidant Properties 
of Polyphenol - Iron Complex: 
an Implication for Benzene Toxicity 
Introduction 
Results 
Discussion 
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INTRODUCTION 
Chronic exposure to benzene is known to induce aplastic anemia, leukemia, and 
other related blood disorders (kalf, 1987). However, the precise mechanism by which 
benzene induces these effects are unknown. It has been shown that benzene itself is 
not actual toxicant. Expression of benzene toxicity requires its metabolism to reactive 
intermediate(s). The reactive intermediates responsible for benzene toxicity however, 
have not been definitly identified (Snyder et al., 1993). It is believed that the effect of 
benzene is likely to be exerted through the action of multiple metabolites on multiple 
targets through multiple biological pathways (Goldstein, 1989). 
Benzene is metabolized in liver as well as bone marrow by cytochrome P-450 
dependent mixed function oxidase enzymes (Huff etal., 1989). Although, the metabolism 
of benzene is complex but is well understood. Benzene is primarily metabolized to 
phenol, catechol, hydroquinone, 1,2,4-benzenetrio( (Porteous and Williams, 1949) and 
open ring products such as trans, trans-muconaldehyde and trans, trans-muconic acid 
Chapter - IV 56 
(Latriano ef a/., 1986). The pathway of benzene ring opening is not known, but a number 
of possible mechanism for oxidative benzene ring opening have t>een postulated (Grotz 
etal., 1994), 
Earlier reports have shown that hepatic metabolism of benzene results in 
accumulation of polyphenolic metabolites against the concentration gradient in bone 
marrow and exerts its toxic effects (Smith et al., 1989). Male Fischer rats exposed to 
benzene 500 ppm have been shown to accumulate about 1 mM polyphenolic metabolties 
in bone man-ow (Rickert et al., 1979). Hydroquinone and 1,2,4-benzenetriol have been 
shown to be potent toxic metabolite of t>enzene (Irons, 1985). In an in vitro study, Rao 
and Pandya (1989) observed that polyphenolic metakx)lites o1 benzene are autooxidized 
faster in the presence of copper ions and resulting in the formation of thiobarbituric acid 
reactive products (TBAR) from target molecules such as glutamate and calf thymus 
DNA. The suggested mechanism includes free radical formation via superoxide and 
covalent binding of the semiquinone metabolites of polyphenol to such molecules. 
Greenlee et al., (1981b) demonstrated that the triphenolic metabolite of benzene, 
1,2,4-benzenetriol, is the most reactive toward molecular oxygen. Its strong chemical 
reactivity toward O2 is consistent with a high biological potency. 1,2,4-Benzenetriol 
induces both single and double strand breaks in DNA (Kawanishi et al., 1989), causes 
sister chromatid exchange in human lymphocytes (Erexson et al., 1985) and gene 
mutations (6-thioguanine resistance) in V79 cells (Glatt, ef al., 1989). Currently in a series 
of studies by Zhang et al., (1994) reviewed the roles of quinone, oxygen and transition 
metal ions in the genotoxicity of 1,2,4-benzenetriol. Zhang et al., (1996) described the 
potential role of metal ions (iron and copper) in the oxidation of 1,2,4-benzenetriol and 
may play an important role in benzene-induced genotoxicity. 1,2,4-Benzenetriol has 
been shown to induce oxidative DNA damage (formation of 8- hydroxydeoxyguanosine) 
both in cultured human cells in vitro (Zhang et al., 1993) and in mouse bone marrow in 
vivo (Kolachana et al., 1993). Despite the evidence that 1,2,4-benzenetriol-induced 
active oxygen species are cytotoxic and genotoxic, surprisingly little is known regarding 
the mechanisms of its reaction with Oj. 
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Recent studies revealed that treatment of HL-60 cells with hydroquinone resulted 
in the formation of 8-hydroxydeoxyguanosine (8-OHdG) formation, suggesting that, 
hydroquinone can induce oxidative DNA base modification in cells (Kolachana et al., 
1993). Although, the mechanism by which hydroquinone causes the above effects, 
remains unclear. It is likely that some of these effects, if not all could be mediated by 
further oxidative activation of hydroquinone. Similar observation was also obtained in 
different cell lines whose peroxidase activation of hydroquinone results in the formation 
of DNA adducts (Levay et al,, 1993), Recently Pongracz and Boded (1996) reported the 
DNA adduct formation in HL-60 cell culture treated with hydroquinone. The synergistic 
interaction of benzene metabolites (i,e, hydroquinone and 1,2,4-ben2enetriol) in the 
production of DNA adduct may also play an important role in the genotoxic effects of 
benzene in vitro (Levay and Bodell, 1992), 
It has been suggested that iron is released from ferritin under conditions in which 
oxidative stress is involved in both in vivo and isolated perfused organs (Mazur and 
Carleton, 1965; Healing ef a/,, 1990), We observed during an/n wfro study that 1,2,4-
benzenetriol, a trihydroxy metabolite of benzene, was capable of releasing iron from 
horse spleen ferritin, which was mediated to a certain extent by superoxide radical 
(Ahmad et al., 1995), Similar results were observed by Oteiza (1995) where 8 -amino-
levulinic acid (a heme precursor) releases iron from horse spleen and rat liver ferritin in 
vitro via free radical formation, and affect iron metabolism in vivo. Available evidence 
indicates that benzene induced myelotoxicity and carcinogenicity involve superoxide 
radical formation during autooxidation of polyphenolic metabolites of benzene viz 
hydroquinone or 1,2,4-benzenetriol (Subrahmanyam et al., 1991b). A fraction of cellular 
non haem iron consisting of chelatable low molecular weight iron represent iron species 
catalytically active in initiating free radical reactions (Gutteridge, 1987). In various 
pathological conditions this decompartmentalized iron is "malplaced" which when bound 
to bleomycin and in the presence of oxygen can degrade DNA (Gutteridge et al., 1985). 
Conditions inhibiting heme synthesis and uncoupling of oxidative phosphorylation have 
been shown to cause a large increase in the low molecular weight iron (LMI) fraction in 
the cytosol (Bakkeren e/a/., 1985), Human normal cerebrospinal fluid and synovial fluid 
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from rheumatoid patients contain micromolar concentrations of non-protein bound LMI 
(<10,000) compounds which are active in catalyzing bleomycin dependent degradation 
of DNA and superoxide and hydroxyl radical reactions (Gutteridge et al., 1982). The 
presence of LMI pool in various cells and organs including intestinal mucosa, heart, bone 
marrow, liver, kidney, spleen, brain and in cultured Chang liver cells have been reported 
(Mulligan et al. 1986). LMI were isolated from guinea pig reticulocytes as AMP-Fe and 
ATP-Fe complexes which might be involved in cellular iron transport (Weaver and 
Pollack, 1989). The interaction between iron-bleomycin and different catecholamines 
have been reported (Lovstad, 1990) 
We propose in the present studies that the chelatable low molecular weight iron 
accumulated during benzene toxicity (Pandya et al., 1990) is the chelate of polyphenolic 
metabolites of benzene with iron. In the present study we investigated the efficacy of 
hydroquinone or 1,2,4-t)enzenetriol: iron complex to catalyze bloemycin dependent DNA 
degradation. We also studied the effect of polyphenol: iron complex to catalyze 
glutamate degradation and lipid peroxidation in vitro. 
RESULTS 
Iron catalyzed and bleomycin dependent degradation of calf thymus DNA was 
markedly greater in the presence of iron polyphenol complex than in the presence of iron 
alone (Table-4.1). Further, calf thymus DNA degradation was faster with iron: 1,2,4-
benzenetriol complex (2.4 fold) than with iron:hydroquinone complex (1.5 fold). The 
degradation of calf thymus DNA showed an increase with increasing concentration of iron 
(0-20 J^M) or iron:polyphenol complex (1:2 ratio) (Figure-4.1). 
The iron-dependent release of TBAR from glutamate exhibited a decrease in the 
presence of either hydroquinone or 1,2,4-benzenetriol. The inhibition of iron-dependent 
release of TBAR from glutamate was 81% in the presence of hydroquinone and 66% in 
the presence of 1,2,4-benzenetriol (Table-4.1). Similariy, the iron-dependent lipid 
peroxidation in brain homogenates was substantially inhibited in the presence of 
hydroquinone where it was 39% or 1,2,4-benzenetriol where it was 43% (Table-4.1). 
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Table 4.1 
Comparison of TBAR formation from DNA by Iron (20 ^M) and Iron: 
polyphenol (20:40 \ifA) complex in the presence of bleomycin 
Parameters Iron lron:HQ lron:BT 
Bleomycin dependent degradation 1.52 2.23 3.58 
of calf thymus DNA 
Iron dependent degradation of 8.25 1.56 2.83 
glutamate 
Lipid peroxidation 67.14 41.13 38.05 
Experimental conditions are as described in the Materials and Methods section. 
All values are represented as nmoles of TBAR formed and are averages of two sets 
of experiments conducted in duplicate with variations of 10% or less. 
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Figure 4.1 : Linearity of nmoles of TBAR formation from calf thymus DNA with increase 
in concentration of iron (t •), iron: hydroquinone complex (o—o) 
or iron; 1,2,4-ben2enetriol complex (A—A). The reaction was initiated by 
the addition of iron (0-20 pM) or ironpolyphenol (12 ratio) 
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Table 4.2 
Recovery of Iron : polyphenol complex (24:48 pM) added to bone marrow 
lysate by the bleomycin dependent degradation of calf thymus DNA. 
Addition lron:HQ lron:BT 
-Bone marrow lysate 2.71 5.73 
+Bone marrow lysate 3.33 7.67 
Bone marrow lysate (1 mg protein) was added to iron.polyphenol cx)mplex (for detail 
see Materials and Methods section). 
All values are expressed as nmoles of TBAR formed from DNA and are averages 
of two sets of expehments conducted in duplicate with variations of 10% or less. 
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Table 4.3 
Formation of TBAR from calf thymus ONA by bleomycin in the presence of 
Iron (20 pM) or iron with the potential iron chelator (1:2 ratio) 
Addition 
Iron alone 
Iron + HQ 
+ BT 
+ Citrate 
+ Glucose 
+ Fructose 
+ Glycine 
+ Glutamic acid 
+ Cysteine 
+ Aspartic acid 
+ AMP 
+ ADP 
+ ATP 
+ Dithiothreitol 
Expenmental conditions are as described in the Materials and Methods section. 
All values are averages of two sets of experiments conducted in duplicate with 
vanations of 10% or less. 
nmoles of TBAR formed/ 
30 min 
1.52 
2.67 
3.52 
0.19 
1.40 
1.29 
1.03 
1.53 
1.59 
1.09 
0.82 
0.92 
1.49 
0.49 
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The iron:polyphenol complex added to bone marrow lysate was 100% recoverable 
when assayed by the bleomycin-dependent degradation of calf thymus DNA (Table-4.2). 
Formation of TBAR from calf thymus DNA by bleomycin in the presence of iron, 
iron;polyphenol or iron with potential endogenous iron chelators is recorded in Table-4.3. 
The endogenous chelators viz. glucose, fructose, glutamic acid, cysteine and adenosine 
triphosphate (ATP) did not affect the iron catalyzed bleomycin-dependent TBAR 
formation from calf thymus DNA. Whereas, glycine, aspartic acid, adenosine mono-
phospahte (AMP) and adenosine diphosphate (ADP) caused a significant inhibition. The 
presence of citrate and dithiothreitol resulted in a drastic inhibition of bleomycin-
dependent iron catalyzed TBAR formation from calf thymus DNA (Table-4.3). 
The addition of FeSO^./HjO to hydroquinone or 1,2,4-benzenetriol in freshly distilled 
water revealed no change in the optical spectra of hydroquinone. However, that of 1,2,4-
benzenetnol revealed a new absorption peak at 259 nm (Figure-4.2A and 4.2B). 
DISCUSSION 
Benzene exposure has been shown to generate organic free radicals and superoxide 
radicals (Lewis et al., 1988b) and it is generally accepted that benzene requires 
metabolism to express its toxicity (Subrahmanyam et al., 1991a). Polyphenolic 
metabolites of benzene viz., hydroquinone and 1,2,4-benzenetriol have Ijeen shown to 
be toxic and the suggested mechanism includes free radical formation via superoxide 
during their autooxidation and the covalent binding of semiquinone to DNA, RNA and 
other cellular macromolecules (Wick, 1980; Rushmore et al., 1984). In addition, the 
active oxygen radical formed during autooxidation of polyphenolic metabolites has been 
shown to be involved in the cytotoxic effects of benzene (Irons, 1985; Karam and Simic, 
1989) Exposure to benzene resulted in decrease in antioxidant potential in serum 
(Ahmad et al., 1994) and may allow oxygen intermediates such as superoxide and 
hydrogen peroxide to survive in plasma long enough. Benzene exposure also leads to 
an accumulation of bleomycin sensitive iron in bone marrow (Pandya et al., 1990). 
1,2,4-Benzenetriol, a trihydroxy metabolite of benzene was capable of releasing iron from 
horse spleen ferritin, which was mediated to a certain extent by superoxide radical 
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(Ahmad et al., 1995), probably, this may also be the reason of accumulation of iron in 
bone marrow during benzene exposure, as the polyphenolic metalwlites are accumulated 
against the concentration gradient in bone marrow. 
Certain flavonoids aitin and quercetin as phenolic compounds have affinity for iron 
ions and act as iron chelators (Afanas'ev eif al., 1989). For example, plant phenolics 
quercetin and myricetin were found to enhance iron ion dependent damage to DNA by 
bleomycin (Afanas'ev et al., 1989). This was assumed to be due to reduction of feme 
bleomycin to the fen^ous form by the phenols and this ferrous bleomycin complex in the 
presence of oxygen, degrade DNA (Laughton et al., 1991). On the other hand, 
antioxidant effects of flavonoids rutin and quercetin to scavenge superoxide and form iron 
complexes have been reported. The cytoprotective activity of flavonoids catechin, 
quercetin and diosmetin have been attributed to their iron-chelating ability (Morel ef a/., 
1993). However,the cytotoxicity of some polyhydroxy pyrimidines viz. divicine, isouramil 
and dialuric acid has been attributed to their ability to release iron from fenitin and this 
iron was shown to promote lipid peroxidation (Monteiro and Winterbourn, 1989a). 
During benzene exposure of experimental animals many oxidation-reduction 
reactions have been shown to occur (Irons, 1985; Lewis et al., 1988b) which may release 
ferrous iron from ferritin. The ferrous iron may t>e chelated to the polyhydroxy 
metabolites of benzene, viz., hydroquinone and 1,2,4-t>en2enetriol. The tentative chemical 
structure of polyphenol iron complex for 1,2,4-t)enzenetriol:Fe(lll) is diagrammatically 
presented in Figure-4.3. 
We propose that the complex of polyphenol with iron (Figure-4.3) may be the low 
molecular weight iron in bone marrow which has been reported to accumulate selectively 
during the exposure to benzene (Pandya et a!., 1990). In the present study we observed 
increase in iron-catalyzed bleomycin-dependent degradation of calf thymus DNA in 
presence of hydroquinone or 1,2,4-benzenetriol. The iron.polyphenol complex appears 
to be stable and intact as the recovery from bone marrow lysate was complete. It is 
also possible that the hydroquinone or 1,2,4-benzenetriol possess combined iron-
chelating and iron ion reducing properties to stimulate calf thymus DNA degradation in 
the presence of bleomycin. Further, the iron polyphenol complexes have shown an 
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antioxidant activity by inhibiting iron-dependent lipid peroxidation in brain homogenate and 
glutamate degradation. This is similar to the antioxidant properties exhibited by 
flavonoids due to their ability to chelate iron (Afanas'ev et ai, 1989; Laughton et al.. 
1991). Thus the flavonoids and polyphenolic chelates limit the availability of iron for lipid 
peroxidation and at the same time facilitate bleomycin-dependent degradation of calf 
thymus DNA. 
It has been shown recently that upon mixing hydroquinone with Cu(ll) the 
absorbance of hydroquinone at 289 nm decreased with corresponding increase in 
absorbance at 247 nm due to the formation of 1,4-t)enzoquinone (Li and Trush, 1993b). 
However, the optical spectra of hydroquinone did not show any change in the presence 
of ferrous sulphate. This indicates that hydroquinone is not converted to 1,4-ben2o-
quinone and iron is kept in the ferous state to catalyze oxidation reactions. The addition 
of ferrous sulphate to 1,2,4-benzenetriol, on the other hand, revealed a new absorbance 
peak at 259 nm with a slight decrease at 286 nm. These observations suggest a 
complex formation of polyphenol with iron rather than reduction of iron and oxidation of 
polyphenol. 
It is concluded from the present study that the phenolic metabolites of benzene 
enhance the availability of Fe(ll) to bleomycin. Such Fe(ll) is possibly made available due 
to reduction of Fe(lll) by polyphenols, thus protecting the Fe(ll) from hydrolysis to 
hydroxides and consequent autooxidation. Recently, a few studies have explained the 
mechanisms underlying the involvement of iron in benzene toxicity. Zhang e^  al., (1995b) 
have suggested that benzene ring fission is stimulated by iron. Further, they demonstrated 
the oxidant-mediated genotoxicity of 1,2,4-t>enzenetriol in presence of metal ions 
(particulariy iron and copper) via production of oxygen-derived active species (Zhang et 
al., 1996). Accumulation of LMI and polyphenolic metabolites of benzene in bone man-ow 
are well established. Probably iron:polyphenol complex may be the potent toxic 
intennediate during the benzene exposure in bone marrow for its genotoxicity. However, 
the formation of such complex in vivo is yet to be characterized during benzene 
exposure. 
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INTRODUCTION 
The various facts and figures that has accrued so far from survey reports and 
experimental evidences has established that exposure of animals and human to benzene 
can result in damage to the haematopoietic system leading to leukemia (Snyder and 
Kocsis, 1975). Acute exposure to benzene has a strong toxic effect on the 
haematopoietic system of both laboratory animals (Tunek et al., 1982), and humans 
(Cohen et al., 1978) probably via interaction w/ith undifferen-tiated bone marrow cells. 
Chronic exposure is carcinogenic in rats and mice (Maltoni et al., 1989; Huff et al., 1989). 
Several studies have shown that benzene must be metabolized to exert its toxic effects 
and that the metabolites are responsible for the both its cytotoxic and genotoxic effects 
(Kalf, 1987). 
Benzene is metabolized in the liver mainly to one or more phenolic metabolites and 
accumulates against the concentration gradient in bone marrow and exerts its toxic effects 
(Smith ef al., 1989). Bioactivation of benzene in haematopoietic cells may be important 
for its leukemogenic effects (Andrews et al., 1979). Also, bioactivation of benzene by 
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bone marrow and liver microsomal enzyme system appears to be responsible for the 
haematopoietic toxicity possibly by covalent binding of a metabolite(s) to DNA (Snyder et 
al., 1981). Many studies have also shown that benzene produces both structural and 
numerical chromo-somal aberrations in the peripheral blood lymphocytes of occupationally 
exposed individuals (Ding et al., 1983). Because consistent chromosomal aberrations 
have tjeen observed in human leukemias and lymphomas, the induction of chromo-somal 
damage by benzene or its metabolites may be critical in the development of 
benzene-induced leukemia (Rothman et al., 1995). Although, haematotoxic and 
leukemogenic effects of benzene are generally believed to be caused by its metabolites 
as opposed to the parent compound, the ultimate reactive inter-mediate(s) responsible 
for benzene toxicity is not known (Goldstein and Witz, 1992). 
Hydroquinone and 1,2,4-benzenetriol the two principal polyphenolic metabolites of 
benzene have been shown to be toxic and the suggested mechanism include free radical 
formation via superoxide and covalent binding of the semiquinone to DNA, RNA and other 
cellular macromolecules (Irons, 1985). Eariier it was observed that polyphenolic 
metabolites of benzene are autoxidized faster to generate free radicals in the presence 
of transition metal ion and can release aldehydic products from target molecules such as 
glutamate, calf thymus DNA and damage human DNA (Rao and Pandya, 1989; Kawanishi 
etal., 1989; Singh e/a/., 1994). 
Many investigators have shown that benzene exposure interferes with iron 
metabolism and heme biosynthesis in experimental animals (Lee et al.. 1974; Freedman 
et a!., 1977; Rao and Pandya, 1980). Benzene administration also led to an accumulation 
of iron in bone marrow cell, which can catalyze the formation of aldehydic products (base 
propenal) from DNA in the presence of bleomycin (Rao et al., 1990). In all probability 
benzene alters heme metabolism of erythroid cells, resulting in the increased 
internalization of iron transferrin receptor complex and uptake of internalized iron is almost 
entirely restricted to erythroblasts. In the present studies it was observed (Chapter-I) that 
1,2,4-benzenetriol, a trihydroxy metabolite of benzene was capable of releasing iron from 
horse spleen ferritin, which was mediated to a certain extent by superoxide radical 
(Ahmad et al., 1995). We propose that the low molecular weight iron (LMI) accumulated 
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during benzene exposure (Pandya et al., 1990) is the chelate of polyphenolic metabolites 
of benzene with iron. We investigated the efficacy of hydroquinone and 1,2,4-benzenetriol 
in the presence of iron to catalyze bleomycin-dependent calf thymus DNA degradation. 
In the presence of hydroquinone or 1.2.4-benzenetriol, iron catalyzed bleomycin 
dependent degradation of DNA was markedly enhanced in comparison to alone. 
Available evidence indicates that benzene exposure leads to accumulation of LMI 
as well as polyphenolic metabolites of benzene in the bone marrow against the 
concentration gradient. In the present study we investigated the poly-phenol:iron complex 
formation in vitro and methodology standardized to fractionate these complexes by 
Sephadex G-10 column chromatography. To demonstrate the polyphenol:iron complex 
formation we utilized the system of iron released from ferritin by 1,2,4-benzenetriol. We 
further investigated the haematotoxicity of hydroquinone:iron mixture in male mice to 
evaluate the possible role of hydroquinone:iron complex in benzene induced 
haematotoxicity. 
RESULTS 
The elution profile of iron, 1,2,4-benzenetriol and 1,2,4-t>enzenetriol:iron mixture were 
studied by Sephadex G-10 column chromatography. Fractions were collected at every 
5 min. interval (flow rate 0.5 ml/min) and were scanned at 287 nm (the absorption 
maximum of 1,2,4-benzenetriol) using Spectronic 2001 spectrophotometer (Figure-5.1). 
When iron alone was subjected to Sephadex G-10 column chromatography, the eluted 
fractions did not show any peak in any fractions (1-30) at 287 nm. Whereas 
1,2,4-benzenetriol alone eluted fractions showed an absorption maximum at 287 nm in 
fraction number 21. However, when 1,2,4-t)enzenetriol:iron mixture was subjected to 
Sephadex G-10 column chromatography, fraction numt)er 3 showed absorbance 
maximum at 287 nm and fraction number 21 did not show any absorbance (Figure-5.1). 
Iron content was estimated using colouring reagent bathophenanthroline sulphonic acid 
in each fraction and absorbance was followed at 535nm (Figure-5.2). The fractions 
collected from 1,2,4-benzenetriol alone subjected to Sephadex G-10 column did not show 
any absorbance at 535 nm in any fraction (1-30). But, in case of iron alone and 
0.20-1 -O Fc:BT complex ( I ' D 
- • BT alone 
•* Fe alone 
FRACTION No 
Figure 5.1 : Elution profile of iron alone (x x), 1,2,4-benzenetnol 
alone (• •) and iron:1,2,4-benzenetriol mixture (O—0) 
subjected to Sephadex G-10 column Fractions were 
collected at every 5 min interval (flow rate 0.5 ml/mm) and 
were scanned at 287 nm 
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Figure 5.2 iron estimation using colounng reagent bathophenanthroline 
sulphonic acid in each fractions and absorbance was followed 
at 535 nm. Fe alone (x x), Fe:BT complex (1:1) (o o), 
and BT alone (• •). 
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1,2,4-benzenetriol.iron mixture showed an absorbance peak at 535 nm in fraction 
number 3. 
Further, the elution profile of 1,2,4-t)enzenetriol:iron complex formation was also 
studied in presence and absence of ethylenediaminetetraacetic acid (EDTA) during the 
release of iron from ferritin by 1,2,4-t3enzenetriol. In the preceding chapter it was reported 
that presence of 1,2,4-benzenetriol, a potent toxic metabolite of benzene, resulted in the 
release of iron from horse spleen ferritin in 0.1 M acetate buffer at pH 5.6 (Ahmad et al., 
1995). In the absence of EDTA we observed an absorbance peak at 287 nm in fraction 
number 3 during the iron release from femtin by 1,2,4-benzenetriol. In addition to 
absorbance peak of 1,2,4-benzenetriol.iron complex in fraction number 3, an absorption 
peak of low intensity may be due to unchelated 1,2,4-benzenetriol was also observed in 
fraction number 21. But in presence of iron chelator (EDTA) the iron released from femtin 
by 1,2,4-benzenetriol was chelated with EDTA and eluted in fraction number 3, whereas 
an increase in 1,2,4-benzenetriol peak intensity was observed in fraction number 21 at 
287 nm (Figure-5.3). This observation indicates that as iron is not available to 1,2,4-
benzenetriol due to the presence of EDTA, all the polyphenol was eluted in fraction 
number 21. However, in the absence of EDTA, all the iron released was accessible to 
1,2,4-benzenetriol and 1,2,4-benzenetriol eluted in fraction number 3 along with iron. 
Studies were conducted to evaluate the haematotoxicity of hydroquinone (25 mg/kg 
body weight), iron (25 mg/kg body weight) and hydroquinone:iron complex after exposure 
to male mice at 25 mg hydroquinone:25 mg iron complex/kg body weight i.p. in normal 
saline for 20 days (single exposure) and also 7 days (twice in a day). Normal saline 
treated group served as control. 
Enlargement in liver size was observed in hydroquinone:iron complex and iron alone 
treated groups compared to the control group. Whereas, increase in spleen weight was 
observed only in group treated with hydroquinone.iron complex for 20 days (Table-5.1), 
Similariy, significant increase in haemoglobin content was observed in all the three groups 
compared to the control group. But hematocrit (%) did not show any change in any group 
after 20 days exposure (Table-5.1). The above haematological parameters were also 
evaluated after 7 days of i.p. treatment of above mentioned groups, twice a day at the 
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Figure 5.3 : Elution profile of iron:BT complex formation during the iron release 
from ferritin by BT with or without the presence of EDTA Fractions 
were analyzed at 287 nm 
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Table 5.1 
Relative liver/spleen weight, haemoglobin and hematocrit (%) of 
male mice after 20 days treatment 
Group 
CONTROL 
HQ:lron 
complex 
Iron alone 
HQ alone 
Relative 
Liver wt. 
(per 100 gm) 
5.40±0.18 
6,84±0.34* 
6.15±0.28= 
5.02±0,16'^ s 
Relative 
Spleen wt 
(per 100 gm) 
0.58±0.06 
0.81±0.07= 
0.87±0.14^^ 
0.57±0.05'^' 
Haemoglobin 
(gm/dl) 
14.3+0.46 
17.2±0.45' 
16.2±0.25" 
16.710.58" 
Hematocrit 
(%) 
40.6+1.54 
44.2+1.33''5 
42.9+1.27^^ 
40.9+1.56^5 
Treatment through single injection daily (i.p. = 25 mg each/kg b.w. in 0.1 ml normal 
saline and control group received 0.1 ml normal saline only) for 20 days. Values are 
mean ± S.E. of six mice. 
Exposed groups were compared with their respective control. 
P values = a <0.01, b <0.02, c <0.05, NS = Not significant. 
70 
Table 6.2 
Relative liver/spleen weight, haemoglobin and hematocrit (%) of male mice 
after 7 days exposure, twice in a day 
Group Relative Relative Haemoglobin Hematocrit 
Liver wt Spleen wt (gm/dl) (%) 
(per 100 gm) (per 100 gm) 
CONTROL 
HQ.Iron 
complex 
Iron alone 
HQ alone 
4.83±0.17 0.57±0.06 15.7±0.54 
6.35±0.18^ 0.80±0.08^ 15.510.34^^ 
5.7110.23" 0.57±0.04'^ s 15.3+0.62^^ 
5.00±0.23''^ 0.66±0.08''s 14.810.31" 
36.5±0.93 
35.7±0.54^ 
35.3±0.83'« 
34.7+0.89^ 
Treatment through double injection daily (i.p. = 25 mg each/kg b.w. in 0.1 ml normal 
saline and control group received 0.1 ml normal saline only) for 7 days. Values are 
mean ± S.E. of six mice. 
Exposed groups were compared with their respective control. 
P values = a <0.001, b <0.02, c <0.05, NS = Not significant. 
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Table 5.3 
Total WBC and differential leukocyte count (OLC) of male mice 
after 20 days exposure. 
CONTROL HQ:lron 
Complex 
Iron alone HQ alone 
WBC (per Cum) 
DLC (%) 
Neutrophil 
Lymphocyte 
Eosinophil 
Monocyte 
Basophil 
8333±657 
25.7+2.17 
73.7+2.11 
0.50±0.12 
0.17±0.16 
NIL 
102861505" 10110±115r^ 9983+1174^ 
38.9+1.87^ 43.0±1.8r 
NIL NIL 
22.0+1.57'^ 
60.3±1.9r 56.211.83" 76.7±1.33'« 
0.1710.16''^ 0.33±0.2r^ 0.83±0.48'« 
0.83+0.17" 1.00+0.26" 0.50±0.22^ 
NIL 
Treatment through single injection daily (i.p. = 25 mg each/kg b.w. in 0.1 ml normal 
saline and control group received 0.1 ml normal saline only) for 20 days. Values are 
mean ± S.E. of six mice. 
Exposed groups were compared with their respective control. 
P values = a <0.001, b <0.05, NS = Not significant. 
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Table 5.4 
Total WBC and differential leukocyte count (DLC) of male mice 
after 7 days exposure twice in a day 
WBC (per Cum) 
DLC (%) 
Neutrophil 
Lymphocyte 
Eosinophil 
Monocyte 
Basophil 
CONTROL 
7492±320 
23.3±2.0 
74.7+1.6 
1.00±0.4 
1.00±0.4 
NIL 
HQrIron 
Complex 
127061626" 
45.912.1" 
52.8+1.9" 
0.2510.3'^ ^ 
1.13±0.4'^ s 
NIL 
Iron alone 
11717±1066' 
43.0±2.5" 
54.2±2.0" 
0.70±0.4''s 
2.20±0.7'^ s 
NIL 
HQ alone 
6950+539^ 
25.7±2.3'^ 
70.7±2.2^ 
2.20±0.8'^ 
1.50±0.5^ 
NIL 
Treatment through double injection daily (i.p. = 25 mg each/kg b.w. in 0.1 ml nonnal 
saline and control group received 0.1 ml normal saline only) for 7 days. Values are 
mean ± S.E. of six mice. 
Exposed groups were compared with their respective control. 
P values = a <0.001, b <0.01, NS = Not significant. 
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Table 5.5 
Lipid peroxidation, total and free -SH content in liver of male mice 
after 20 days exposure 
Assay CONTROL HQ:lron Iron 
Complex alone 
HQ 
alone 
Lipid peroxidation 19.3t1.47 46.3+2.44' 44.7±2.80' 19.6+1.72^  
(nmoles/hr/gm liver) 
Total -SH content 2.75±0.07 
(mmoles/100 gm liver) 
2.2910.06' 2.3710.08" 283±0.W^ 
Free -SH content 0.74±0.05 
(mmoles/100 gm liver) 
0.69±0.05''5 0.57±0.07''s 0.9110.04" 
Treatment through single injection daily (i.p. = 25 mg each/kg b.w. in 0.1 ml normal 
saline and control group received 0.1 ml normal saline only) for 20 days. Values are 
mean iS .E . of six mice. 
Exposed groups were compared with their respective control. 
P values = a <0.001, b <0.05, NS = Not significant. 
74 
Table 5.6 
Lipid peroxidation, total and free -SH content in liver of male mice 
after 7 days exposure twice in a day 
Assay CONTROL HQ.Iron Iron HO 
Complex alone alone 
Lipid peroxidation 11.1+2.52 22.3±3.25' 30.013.76" 14,9±1.58'* 
(nmoles/hr/gm liver) 
Total-SH content 3.27±0.07 3.01±0.08^ 2.9310.06" 3.18±0.09^ 
(mmoles/100 gm liver) 
Free-SH content 0.84±0.06 0.75±0.06''^ 0.73±0.05''s 0.74±0.05^ 
(mmoles/100 gm liver) 
Treatment through double injection daily (i.p. = 25 mg each/kg b.w. in 0.1 ml normal 
saline and control group received 0.1 ml normal saline only) for 7 days. Values are 
mean ± S.E. of six mice. 
Exposed groups were compared with their respective control. 
P values = a <0.001, b <0.02, c <0.05, NS = Not significant. 
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same dose. Similar pattern of results were observed all the three groups when compared 
to control group except the haemoglobin content (Table-5.2). The haemoglobin content 
did not show any significant alteration after 7 days exposure twice a day. 
Significant increase in WBC was observed in hydroquinone: iron complex treated 
male mice after single injection for 20 days exposure (Table-5.3). Similarly, significant 
increase in polymorph (%) and monocyte (%) in hydro-quinone:iron complex and iron 
alone treated groups with simultaneous decrease in lymphocyte (%) (P<0.001) were 
observed when compared to the control group after 20 days of exposure. Whereas, 
eosinophil (%) and basophil (%) did not show any alteration after 20 days of exposure. 
Further, after 7 days exposure, twice in a day, same pattern of results in WBC and DLC 
were observed. Significant increase in WBC was observed in hydroquinone:iron complex 
and iron alone treated groups compared to the control group. Similarly, significant 
increase in polymorph (%) with simultaneous decrease in lymphocytes were observed in 
the groups treated with hydroquinone:iron complex and iron alone. Whereas, eosinophil 
(%), monocyte (%) and basophil (%) counts did not show any alteration in any group 
(Table-5.4). 
We also studied the lipid peroxidation, total and free sulphahydryl content ( -SH 
group) in liver of both sets of experiments (Table-5.5 and 5.6). Significant increase in lipid 
peroxidation was observed in hydroquinone:iron and iron alone group with simultaneous 
decrease in total -SH content in both groups after 20 days (single injection daily) and 7 
days (twice in a day). Whereas, no significant alteration in free -SH content was observed 
in any group except for the group treated with hydroquinone alone for 20 days (single 
injection daily), where a marginal increase in free -SH content was observed (Table-5.5). 
DISCUSSION 
The haematotoxic effect of benzene in both humans and animals have been well 
documented (Snyder, 1987). Chronic exposure of humans to benzene is associated with 
vanous types of haematopoietic disorders including several types of leukemia. In 
laboratory animals particularly rodents, benzene exposure reduces the number of various 
bone marrow cells including the haematopoietic stem cells. The intensity of 
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haematotoxicity produced by benzene exposure differ between species and even between 
strains of the same species. There is abundant evidence that these differences in 
response are due to difference in benzene metabolism (Nakajima e^  a/., 1993). Neun et 
al.. (1992) suggested that differences in host target ceil susceptibility may also play a role 
in the differential haematotoxic responses to benzene. 
It was observed that chronic exposure to several strains of mice to high 
concentrations of benzene (100 or 300 ppm) produced a rapid decline in the number of 
circulating red cells, whereas the number of circulating granulocytes rose above the 
control levels (Snyder et al., 1982). Exposure to t»enzene resulted in a variety of change 
in the number of polymorph, lymphocytes, basophil, eosinophil and other bone marrow 
cell fractions. The longer exposure to a lower concentration of benzene results in a much 
greater haematotoxic effect (Cronkite et al., 1989). Exposure to 300 ppm benzene 
caused high mortality, lymphocyto-penia, anemia, neutrophilia, and reticulocytosis in the 
mice but only lymphocyto-penia in rats (Snyder et al., 1978). However, the metabolites 
of benzene responsible for these effects are not known. 
Earlier Greenlee et al., (1981 a) have shown that polyphenolic metabolites of benzene 
accumulated in bone marrow against the concentration gradient. We propose that the 
complex of polyphenol with iron may be the low molecular weight iron (LMI) in bone 
marrow which has been reported to accumulate selectively during the exposure to 
benzene (Pandya et al., 1990). In the present studies, we observed that the presence of 
polyphenolic metabolites of benzene enhanced iron-catalyzed bleomycin-dependent 
degradation of DNA. The polyphenoUron complex appears to be stable and intact as the 
recovery from bone marrow lysate was complete (Singh et al., 1994). Although, the 
benzene exposure lead to accumulation of iron as well as polyphenol metabolites of 
benzene in the bone marrow against the concentration gradient but formation of such 
complex in vivo is not known. In the present study, we standardized a methodology to 
fractionate these complexes by Sephadex G-10 column chromatography. Results clearly 
show the formation of polyphenoMron complex in in vitro condition. 
In order to evaluate the haematotoxicity of hydroquinone:iron complex we studied the 
effect of 25 mg hydroquinone; 25 mg iron or 25 mg hydroquinone or 25 mg iron/kg body 
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weight and normal saline in male mice administered i.p. daily for 20 days (single 
exposure) and significant alteration in various haematological parameters were observed. 
Increase in haemoglobin content, hematocrit and WBC were noticed whereas DLC 
showed increase in polymorphs and decrease in lymphocytes in hydroquinone:iron 
complex and iron treated groups in comparison to normal saline administered group. 
However, the effects were highly significant in hydroquinone:iron treated group and a 
marked alterations were also noticed in this group when compared to iron treated group 
only. However, no significant changes were observed in hydroquinone alone treated 
group m compahson to norma] saline treated group. 
The mortality rate in the case of hydroquinone;iron complex treated group was very 
high at the dose 50 mg/kg b.w. This shows that the complex formation some how 
increase the toxicity. Both absolute and relative organ weights of liver and spleen showed 
a significant increase in hydroquinone.iron and iron treated groups, whereas hydroquinone 
alone treated group did not show any change. Enlargement in liver and spleen size is one 
of the important symptom of blood related disorder. An increase in spleen weight in CD-1 
male mice exposed to benzene has also previously been reported (Green e^  a/., 1981a) 
with a concomitant increase in granulocyte count as a consistent finding (Green et al., 
1981b). Similar observations of increased spleen weight and granulocyte number were 
noticed in the group of mice treated with hydroquinone:iron complex. Total sulphahydryl 
content showed significant decrease, whereas increase in lipid peroxidation were noticed 
in both the groups without any change in hydroquinone treated group. This shows the 
formation of free radical in vivo during the exposure of such complex and may have 
toxicological implication. 
Eastmond et al., (1987) have demonstrated that repeated combined exposure of 
mice with phenol and hydroquinone led to decrease in bone marrow ceilularity in a 
manner similar to the haematotoxic effects expressed by benzene. Following similar 
experimental protocol (Guy et al., 1990), it was demonstrated that the radio iron uptake 
into erythrocytes was significantly decreased in the group of mice coadministered with 
phenol and hydroquinone. The combination of phenol and hydroquinone produced a 
decrease in bone marrow ceilularity similar to that produced by benzene. Further Guy et 
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a/., (1991) extended these observations to other metabolites of benzene, p-l)enzoquinone, 
muconaldehyde and hydroqui-none, that may affect haematopoiesis either singly or in 
combination. It has been suggested that reduced bone marrow cellulahty during the 
coadministration of phenol and hydroquinone might be due to phenol-induced stimulation 
of hydroquinone via the peroxidase-dependent metabolic activation in bone marrow and 
increased covalent binding of hydroquinone to tissue macromolecules of blood, bone 
marrow, liver and kidney (Smith et al., 1989; Subrahmanyam et al., 1990, 1991a). 
Muconaldehyde (Witz et al., 1985) and 6-hydroxy-trans, trans- 2,4-hexadienol (Zhang et 
al.. 1995b), the putative toxic intermediates of benzene have been shown to cause 
decrease in sulphahydryl content, ^'Fe incorporation into circulating erythrocytes. Rao 
and Pandya (1978) have shown that benzene increases lipid peroxidation 3 hr after 
exposure and it has been reported that lipid peroxidation leads to loss of heme from 
microsomes (De Matties and Sparks, 1973). Several fold increase in hepatic lipid 
peroxidation was also observed in albino rats of either sex after benzene exposure 
intrapehtoneally (0.5 ml/kg body weight) or subcutaneously (1 ml/kg body weight) for 10 
days (Ahmad ef a/., 1994). 
Similar observations comparable to above observations were noticed in mice treated 
with the same dose for 7 days daily i.p. twice in a day. Present studies clearly indicate 
that hydroquinone iron chelate showed marginal increase in haematotoxicity in 
experimental animals. But the precise mechanism of marginal, yet significant increase 
in haematotoxicity is not clear. Atleast some of the effects observed in hydroquinone.iron 
treated group showed similarities to some extent with what has been shown to occur 
following exposure of mice to benzene. Further studies are required to identify the 
complex formation in vivo dunng benzene exposure and to explain the mechanism of 
toxicity of such complexes and a possible role of such complexes in benzene toxicity. 
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INTRODUCTION 
Benzene is a well known leukemogenic and carcinogenic agent. Benzene induced 
cytogenetic effects including chromosome and chromatid aberration, sister chromatid 
exchanges and induction in micronuclei have been consistently found in in wVo animal 
studies (Erexson et al., 1986). Benzene exposure has also been associated with 
myelodysplasia and acute myelogenous leukemia (Snyder, et al.. 1993). Rodents 
chronically exposed to benzene display similar effects except that a wider range of 
carcinogenic responses have been reported (Maltoni et al.. 1985). Evidences for the 
genotoxicity of benzene in human comes from studies of occupationally exposed 
populations (Yardley-Jones et al., 1990) Since consistent chromosomal aberrations are 
often observed in human leukemias, the ability of phenolic metabolites of benzene to 
induce chromosomal damage in human implicates the benzene induced leukemia (Yager 
et al., 1990). The evidence linking benzene exposure with leukemia was considered 
sufficient proof of human carcinogenicity (Dosemeci ef a/., 1994). Despite extensive 
research, the molecular mechanisms responsible for the induction of bone marrow 
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toxicity and leukemia have yet to be fully elucidated. However, there is general 
agreement that expression of benzene toxicity requires metabolism and follows similar 
pathways in humans and animals exposed to benzene (Snyder e^  a/., 1993). 
Recent report indicates that several metabolites of benzene are capable of reacting 
with DNA (Levay and Bodell, 1992). Administration of metabolites of benzene induce 
sister chromatid exchanges, micronuclei induction (Zhang et al., 1994), oxidative DNA 
damage (Kolachana, 1993), and DNA strand breaks (Li and Trush, 1993a). One 
mechanism by which benzene induces these genotoxic effects may be mediated by the 
generation of one or more active oxygen species, such as superoxide anion radical 
(O2 ) hydrogen peroxide (4 Q). hydroxy! radical ('OH) and singlet oxygen (^t^Q^ 
(Subrahmanyam et al., 1991b). Damage to DNA is perhaps one of the most crucial 
events in cytotoxicity of reactive oxygen species (Halliwell and Aruoma, 1991). DNA 
lesions resulting from exposure to reactive oxygen species includes modified bases, 
abasic sites, single and double strand breaks and DNA protein crosslinks (Aruoma et al., 
1989a; Aruoma et al., 1989b), although, repair enzymes remove most but not all, of the 
lesions formed during endogenous DNA damaged by reactive oxidant (Ames et al.. 
1993). 
The majority of benzene metabolism occurs in liver to its major hydroxylated 
metabolites (Subrahmanyam et al., 1991a) and has been reported to accumulate against 
concentration gradient in bone marrow (Greenlee e^  al., 1981a). High levels of 
myeloperoxidase in the bone marrow facilitate autooxidation of the polyphenols to quinoid 
derivatives (Eastmond et al., 1986). The toxicity of quinoid metabolites of benzene has 
been associated with their ability to form adducts with thiols and undergo faster 
autooxidation to generate oxygen centered radicals (Subrahmanyam and O'Brien, 1985). 
The formation of polyphenolic metabolites of benzene in rabbit exposed to benzene 
and their accumulation in bone marrow against the concentration gradient and suggested 
mechanism of toxicity has been described earlier (Singh et al., 1994). However, the 
reactive intermediates responsible for benzene toxicity have not been definitly identified 
(Snyder ef a/., 1993). The toxic effect of benzene is likely to be exerted by multiple of 
metabolites through multiple of biological pathways (Goldstein, 1989). 
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Li and Trush (1993a) observed that hydroquinone/Cu(ll) and 1,2,4-benzenetriol/ 
Cu(ll), chemical metal redox were the two most efficient systems which induced strand 
breakage in ^  X-174 RF1 plasmid DMA. Recent studies revealed that treatment of HL-60 
cells with hydroquinone resulted in the formation of 8-hydroxyguanosine (8-OHdG) 
formation, suggesting that hydroquinone can induce oxidative DNA base modification in 
cells (Kolachana et al.. 1993), although, the mechanism by which it causes these effects 
remain unclear. It is likely that some of these effects, if not all could be mediated by 
further oxidative activation of hydroquinone. Similar observation was also obtained in 
different cell lines whose peroxidase activation of hydroquinone results in the formation 
of DNA adducts (Levay et al., 1993). 
The formation of 1,4-benzoquinone has been demonstrated from the oxidation of 
hydroquinone by horse radish peroxidase and H2O2 (Yamazaki et al., 1959). Formation 
of 1,4-benzoquinone by human myeloperoxidase and HjO; was also observed during the 
oxidation of hydroquinone (Smith et al., 1989). 1,4-Benzoquinone has been shown to 
induce single strand breaks in DNA of cultured cells (Pellak-Walker and Blumer, 1986), 
to decrease the ability of stromal cells to support granulocyte/monocyte colony formation 
(Gaido and Wierda, 1984), to form DNA adducts in all cell types tested (Levay et al., 
1993) and to inhibit DNA and RNA synthesis (Kalf, 1987), microtubule polymerization 
(Irons and Neptun, 1980) and mitogen stimulation of lymphocyte growth (Wierda and 
Irons, 1982). 
1,4-Benzoquinone reacts with glutathione (GSH) to form a conjugate, glutathionyl 
hydroquinone (Lunte and Kissinger, 1983). Macrophages from bone marrow have been 
shown to be capable of peroxidative bioactivation of hydroquinone to 1,4-benzoquinone 
which can either form a GSH-conjugate and/or covalently bind to protein or DNA (Thomas 
et al., 1990), 1,4-Benzoquinone is a direct-acting alkylating agent. It readily reacts with 
sulphahydryls and has been shown to inhibit microtubule assembly by blocking the 
thiol-sensitive GTP binding site (Irons et al. 1981). However, the DNA adducts formed 
in HL-60 cells treated with 1,4-benzoquinone were shown to be different from those 
formed on reaction of purified DNA with 1,4-benzoquinone (Levay e^  al., 1991), 
suggesting that the reactive intermediate in cells is the metabolite of 1,4-benzoquinone 
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rather than 1,4-benzoquinone itself. Glutathionyl hydroquinone has been isolated as one 
of the urinary metabolites of hydroquinone (Figure-6.1) indicating that glutathionyl 
hydroquinone formation occurs in vivo (Nerland and Pierce, 1990). Glutathionyl 
hydroquinone has been shown to autooxidize at several fold higher than the parent 
hydroquinone to glutathionyl benzoquinone (Brunmark and Cadenas, 1988). 
In the present study iron catalyzed bleomycin-dependent degradation of DNA was 
investigated in the presence of glutathionyl hydroquinone. We also investigated the 
potential of glutathionyl hydroquinone to damage supercoiled DNA in plasmid pUC 18. 
Glutathionyl-hydroquinone complex concentration dependent release of aldehydic 
products from glutamate or deoxyuridine was also observed. We further investigated the 
haematotoxicity of glutathionyl hydroquinone in male mice to evaluate the possible role 
of glutathionyl hydroquinone in benzene induced haematotoxicity. The studies revealed 
that glutathionyl hydroquinone is a potent prooxidant and this observation may be of 
toxicological importance in relation to benzene induced toxicity. 
RESULTS 
Glutathionyl hydroquinone conjugate was prepared by mixing 1,4-benzoquinone 
(BQ) and GSH in distilled water in 1:1 ratio (equimolar concentrations). The nucleophilic 
addition of GSH to 1,4-benzoquinone yields glutathionyl hydroquinone and its authenticity 
was confirmed by the absorption maximum at 303 nm. No absorption was observed at 
248 nm which is the absorption maximum for 1,4-benzoquinone (Figure-6.2). 
Iron-catalyzed and bleomycin-dependent degradation of calf thymus DNA was 
markedly enhanced (12 fold) in the presence of glutathionyl hydroquinone as compared 
to the other experiment in the presence of iron alone (Table-6.1). Presence of 1,4-
benzoquinone did not influence the iron-catalyzed bleomycin- dependent degradation of 
calf thymus DNA, however, presence of hydroquinone (HQ) or GSH influenced iron-
catalyzed bleomycin dependent degradation by 1 9 and 3.2 fold respectively (Table- 6.1). 
Glutathionyl hydroquinone (GHQ) concentration dependent release of TBAR from target 
molecules viz. L-glutamate or deoxyuridine was also observed (Table-6.2). The 
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Table 6.1 
Iron-catalyzed bleomycin-dependent release of TBAR from calf thymus 
DNA in the presence of 1,4-benzoquinone (BQ), hydroquinone (HQ), 
glutathione (GSH) or glutathionyl hydroquinone (GHQ). 
Addition nmoles of TBAR formed per 30 min 
Iron 1.38 
Iron + BQ 1.38 
Iron + HQ 2.67 
Iron + GSH 4.42 
GSH 0.00 
Iron + GHQ 16.20 
GHQ 0.00 
Experimental conditions are as described in Materials and Methods section. 
All values are averages of two sets of experiments conducted in duplicate with 
variations 10% or less. 
84 
Table 6.2 
Effect of varying concentration of glutathionyl hydroquinone on the 
release of TBAR from L-glutamate or deoxyuridine 
Glutathionyl hydroquinone 
(pM) 
5.0 
10.0 
15.0 
20.0 
25.0 
nmoles of TBAR formed per 2 hr 
L-glutamate 
0.27 
0.56 
0.81 
1.15 
1.21 
Deoxyuridine 
0.23 
0.46 
0.90 
1.17 
1.40 
Experimental conditions are as described in Materials and Methods section. 
All values are averages of two sets of experiments conducted in duplicate with 
variations of 10% or less. 
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superoxide anion released during autooxidation of glutathionyl hydroquinone (30 ^ JM) 
was found to reduce 2.4 nmoles of cytochrome c per min. 
Glutathionyl hydroquinone dependent release of TBAR during iron-bleomycin 
degradation of calf thymus DNA did not show any significant increase with the increase 
in iron concentration (5-15 [JM) (Table-6.3). Similarly, varying the concentration of 1,4-
benzoquinone did not influence the release of TBAR from calf thymus DNA. However, 
a linear increase in the release of TBAR from calf thymus DNA was observed with 
increase in GSH concentration (5-15 \M) (Table-6.4). Release of TBAR from DNA in 
the presence oi glutathionyl hydroquinone, iron and bleomycin was significantly inhibited 
(43-51%) on addtion of oxyradical scavengers, such as thiourea (49%), mannitol (46%), 
dimethylsulfoxide (43%), albumin (49%), superoxide dismutase (51%) and catalase 
(46%) (Table-6.5). The glutathionyl hydroquinone and iron added to bone marrow cell 
lysate was 100% recoverable when assayed by the bleomycin dependent release of 
TBAR from calf thymus DNA (Table-6.6). 
When the supercoiled plasmid pUC 18 DNA (300 ng) was incubated with 200 (JM 
of 1,4-benzoquinone, GSH or glutathionyl hydroquinone for 3 hr at 3 7 ^ , cleavage of 
plasmid DNA was observed only with glutathionyl hydroquinone resulting in the formation 
of both relaxed open circular and linear form of DNA respectively, which run significantly 
slower than supercoiled DNA on 1% agarose gels (Figure-6.3). Presence of DNA alone 
(lane a), 1,4-benzoquinone alone (lane b), or GSH alone (lane c) did not result in the 
nicking of pUC 18 DNA, Whereas, after 3 hr incubation at 37'C in the presence of 
glutathionyl hydroquinone (200 pM), all the supercoiled pUC 18 DNA showed a major 
damage in the form of single strand nick to give rise to open circular and a minor damage 
in the form of double cut to give rise to linear form of DNA (lane d). The single and 
double strand cleavage of pUC 18 DNA by glutathionyl hydroquinone (lane d) is 
compared with linear form of pUC 18 DNA obtained by double strand single cut after 
EcoRI digestion (lane e). Further, a linear increase in DNA damage was observed in the 
presence of increasing concentrations of glutathionyl hydroquinone. After 3 hr incubation 
at 37X, the DNA damage was increased with increasing concentrations of glutathionyl 
hydroquinone (0-200 \M) (Figure-6.4). 
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Table 6.3 
Effect of varying concentration of iron on the iron catalyzed 
bleomycin dependent release of TBAR from DNA In the 
presence of GHQ (15 pM) 
Concentration of Iron nmotes of TBAR formed 
( pM) per 30 min. 
5.0 13.24 
7,5 15,27 
10.0 16.00 
12.5 16.17 
15.0 16.20 
Experimental conditions are as described in Materials and Methods section. 
All values are averages of two sets of experiments conducted in duplicate with 
variations of 10% or less. 
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Table 6.4 
Effect of varying concentration of GSH on iron-catalyzed bieomycin-
dependent release of TBAR from calf thymus DNA in the 
presence of BQ (15 pM) and iron (15 pM). 
Concentration of GSH nmoles of TBAR formed 
(pM) per 30 min. 
5.0 4.49 
7.5 5.66 
10.0 9.66 
12.5 12.36 
15.0 16.20 
Experimental conditions are as described in Materials and Methods section. 
All values are averages of two sets of experiments conducted in duplicate with 
variations of 10% or less. 
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Table 6.5 
Effect of oxyradical scavengers on iron-catalyzed bleomycin-
dependent release of T6AR from calf thymus DNA in the 
presence of Iron (5 pM) and GHQ (S pM). 
Reaction mixture 
Complete reaction mixture 
+ Thiourea (5 mM) 
+ Mannitol (50 mM) 
+ Dimethylsulfoxide (33 mM) 
+ Albumin (100 MQ/ml) 
+ Catalase(100Mg/ml) 
+ SOD (100pg/ml) 
Experimental conditions are as described in Materials and Methods section. 
All values are averages of two sets of experiments conducted in duplicate with 
variations of 10% or less. 
* 
Number in parentheses are percent inhibition. 
nmoles of TBAR formed 
per 30 min. 
6.73 
3.46 
3.65 
3.85 
3.46 
3.27 
3.65 
* 
(49) 
(46) 
(43) 
(49) 
(51) 
(46) 
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Table 6.6 
Recovery of iron and glutathionyl hydroquinone added to bone marrow cell 
lysate for the bleomycin-dependent degradation of calf thymus DNA 
Addition nmoles of TBAR formed 
per 30 min. 
- Bone marrow lysate 5.38 
+ Bone marrow lysate 9.04 
Experimental conditions are as described in Materials and Methods section. 
All values are averages of two sets of expenments conducted in duplicate with 
variations of 10% or less. 
a b 
Figure 6.3 : Agarose gel electrophoresis of ethidium bromide stained 
pUC 18 DNA after treatment with BQ, GSH or GHQ (200 
|JM each). Lane (a) DNA alone, lane (b) DNA + BQ, lane 
(c) DNA+GSH, lane (d) DNA+GHQ, and lane (e) pUC 18 
DNA digested with EcoRI. Reaction mixtures were 
incubated at 37°C for 3 hr. The positions of supercoiled 
(SC), linear (LIN) and open circular relaxed (OC) DNA 
are indicated. 
Figure 6.4 : Cleavage of pUC 18 DNA by increasing concentrations of 
GHQ. Lane (a) DNA only, lane (b-f) DNA+GHQ (25, 50, 
75, 100 and 200 |iM), and lane (g) EcoRI digested ?^  DNA 
molecular marker (3530-21226 bp). Reaction mixtures were 
incubated at 37°C for 3 hr. 
a b 
Figure 6.5 : Cleavage of pUC 18 DNA by GHQ in presence of oxyradical 
scavengers. Lane (a) DNA only, lane (b) DNA+GHQ, and 
lane (c-g) DNA + GHQ+ SOD/catalase /mannitol/thiourea/sodium 
benzoate at 10 fold molar excess concentration. Reaction 
mixtures were incubated at 37°C for 3 hr. 
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Table 6.7 
Relative liver/spleen weight, haemoglobin, and hematocrit (%) of male 
mice after glutathionyl hydroquinone treatment 
Parameters Control Treated 
Relative liver weight 4.73±0.36 6.00+0.15' 
(per 100 gm) 
Relative spleen weight 0.62+0.08 O.SO+O.IO''^  
(per 100 gm) 
Haemoglobin (gm/dl) 13.9 ±0.65 14.4 ±0.31^^ 
Hematocrit (%) 41.8 ±1.07 40.5 ±1.10^^ 
Treatment through single injection daily (i.p. = 100 mg/kg b.w. in 0.1 ml normal 
saline and control group received 0.1 ml normal saline only) for one month. Values 
are mean ± S.E. of six mice. 
Exposed group were compared with respective control. 
P values; a <0.01, NS = Not significant. 
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Table 6.8 
Total WBC and differential leukocyte count (DLC) of male mice 
after glutathionyl hydroquinone treatment 
Parameters Control Treated 
WBC (per Cum) 
DLC (%) 
Neutrophil 
Lymphocyte 
Eosinophil 
Monocyte 
Basophil 
8000±582 
24.0±1.9 
71.5±1,9 
2.3+0.6 
1.3+0.4 
NIL 
9117±209''^ 
27.0±3.4^^ 
71.0±3.3^' 
1.8+0.4'^ ^ 
0.3+0.2^^ 
NIL 
Treatment through single injection daily (i.p. = 100 mg/kg b.w. in 0.1 ml normal 
saline and control group received 0.1 ml normal saline only) for one month. Values 
are mean + S.E. of six mice. 
Exposed group were compared with respective control. 
P values; NS = Not significant. 
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Table 6.9 
Lipid peroxidation, total and free -SH content in liver of mate 
mice after glutathlonyl hydroquinone treatment 
Parameters Control Treated 
Lipid peroxidation 25.0±4.6 33.8±4.5'^^ 
(nmoles/hr/gm liver) 
Total-SH content 3.25±0.13 3.27±0.05''^ 
(mmoles/100 gm liver) 
Free -SH content 0.73±0.07 0.85±0.05'^ ^ 
(mmoies/100 gm liver) 
Treatment through single injection daily (i.p. = 100 mg/kg b.w. in 0.1 ml normal 
saline and control group received 0.1 ml normal saline only) for one month. Values 
are mean ± S.E. of six mice. 
Exposed group were compared with respective control. 
P values; NS = Not significant. 
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The effect of oxyradical scavengers, such as superoxide dismutase (250 units) and 
catalase (1000 units), mannitol, thiourea and sodium t>enzoate (2mM) on pUC 18 DMA 
strand cleavage were investigated to evaluate the role of reactive oxygen species. The 
results shovi/ed that incubation of pUC 18 DNA with glutathionyl hydroquinone in the 
presence of superoxide dismutase (SOD), catalase, mannitol, thiourea and sodium 
benzoate showed a differential inhibition of cleavage of pUC 18 DNA (Figure-6.5). 
Protection offered by catalase was maximum (more than 80%) (lane, d), whereas 
protection by superoxide dismutase was only 30% (lane c) at 10-fold molar higher 
concentrations. Mannitol (lane e), thiourea (lane f) and sodium benzoate (lane g) were 
able to protect marginal at 10-fold molar excess concentrations to glutathionyl 
hydroquinone. 
Studies were also conducted to evaluate the haematotoxicity of glutathionyl 
hydroquinone after exposure of male mice at 100 mg glutathionyl hydroquinone/kg body 
weight i.p. in normal saline for one month. 
Significant increase in relative liver weight (P<0.01) was observed in glutathionyl 
hydroquinone treated mice compared to control group. Further, increased pattern of 
relative spleen weight was observed which was however not significant (Table- 6.7). 
Haemoglobin and hematocrit(%) values did not show any significant alteration (Table-6.7). 
Slight increase in WBC count was observed in glutathionyl hydroquinone treated mice but 
increase was not significant (Table-6.8). Neutrophil, lymphocyte, eosinophil, monocyte 
and basophil did not show any significant alteration in treated group (Table-6.9). Further, 
lipid peroxidation, total and iree -SH content in rat liver also did not show any significant 
alteration in treated group (Table-€.9). 
DISCUSSION 
Although, the metabolism of benzene is very well understood the metabolite(s) 
responsible for myelotoxicity of benzene is not known (Kalf, 1987). Benzene exposure 
has been shown to generate organic Uee radicals and superoxide radical and it is 
generally accepted that benzene requires metabolism to express its toxicity 
(Subrahmanyam ei a/., 1991b). In our earlier studies we proposed that hydroquinone: 
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iron complex may be the toxic intemfiediate of benzene metabolism (Singh et al., 1994). 
Recent studies have emphasized on 1,4-benzoquinone as toxic metabolite of benzene 
as it has been shown to fomi DMA adduds both in vitro and in vivo (Levay et a!., 1991; 
Levay et al., 1993). The additon of GSH to 1,4-ben2oquinone has been shown to catalyze 
1,4-reductive addition reaction of the Michael type involving a two-electron transfer to 
yield glutathionyl hydroquinone (Brunmark and Cadenas, 1988). It was also observed 
that dunng benzene exposure incorporation of iron into circulating erythrocytes was 
inhibited (Lee et al., 1974) which might lead to accumulation of LMI components in bone 
man-ow (Pandya et al., 1990). Since excess of both glutathionyl hydroquinone and iron 
are available in bone marrow cells during benzene exposure, the potential of glutathionyl 
hydroquinone to undergo autooxidation and promote iron catalyzed bleomycin dependent 
degradation of DNA was studied. Several fold increase in the release of TBAR from DMA 
indicates that glutathionyl hydroquinone autooxidation enhances the availability of Fe(ll) 
to bleomycin by reducing Fe(lll), thus limiting the Fe(ll) from hydrolysis to hydroxides and 
further oxidation. Superoxide release during autooxidation of glutathionyl hydroquinone 
can reduce feme iron to ferrous iron (Halliwell et al.. 1992). Earlier we have also shown 
that 1,2,4-benzenetriol was capable of releasing iron from horse spleen ferritin, in vitro, 
which was mediated to a certain extent by superoxide radical (Ahmad et al., 1995). Iron 
mediated generaion of reactive oxygen species have been implicated in the toxicity of 
2-bromo-(glutathion-S-yl) hydroquinone to LLC-PK1 cells due to DNA fragmentation and 
resultant cytotoxicity (Mertens et al., 1995). Recently, Lee et al., (1995) investigated 
that 1,2,4-benzenetriol even in the absence of metal ion resulted in double strand 
cleavage of pBR 322 plasmid DNA via active oxygen species formation. 
The GSH concentration dependent increase in TBAR release from calf thymus DNA 
in the presence of 1,4-benzoquinone and iron shows that the reaction is dependent on 
the concentration of reducing equivalents. This particular observation may be of 
toxicological importance as GSH is an important intracellular thiol present in millimolar 
concentrations (Meister, 1988). GSH is also present in the nucleus and 1,4-benzoquinone 
has been shown to form adducts with DNA, it is quite likely that 1,4-benzoquinone may 
conjugate with GSH and form adducts with DNA. Probably, for this reason the DNA 
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adducts, formed in 1,4— benzoquinone-treated HL-60 cells were different from those 
formed with purified DNA on reaction with 1,4-l)enzoquinone. As the autooxidation of 
glutathionyl hydroquinone is eight-fold faster than hydroquinone, it is quite likely that 
glutathionyl hydroquinone would cause DNA damage including chromosomal breaks 
leading to genotoxic and carcinogenic effects which have been reported to occur during 
benzene exposure. 
The complete recovery of glutathionyl hydroquinone and iron added to bone marrow 
lysate further indicates that both iron and glutathionyl hydroquinone are available to 
bleomycin to release TBAR from calf thymus DNA. Previous studies have suggested the 
involvement of iron or copper in benzene metabolites induced DNA damage through a 
mechanism involving the generation of reactive oxygen species (Rao and Pandya, 1989). 
Breakage in supercoiled pUC 18 plasmid DNA in the presence of glutathionyl hydro-
quinone was concentration dependent. This may have toxicological importance during 
benzene exposure where the metabolites of benzene specially 1,4-benzoquinone is 
accumulated in bone marrow cells. Since GSH is present at a relatively high 
concentrations in mammalian cells nuclei (Ca 19.2 mM) (Bellomo et al., 1992), it might 
be expected that the thiol can perform a similar function in v/vo during t)enzene exposure 
where 1,4-benzoquinone is converted to glutathionyl hydroquinone after reaction with 
GSH and resultant intermediate interact with nuclear DNA. The exact mechanism of 
DNA damage by glutathionyl hydroquinone is not known. The DNA damage may be due 
to free radicals generation in the reaction mixture or due to covalent modification of DNA 
bases by glutathionyl hydroquinone. Quinone-thioethers are known to exhibit redox 
cycle with the concomitant release of oxyradicals (Rao et al., 1988; Brown et al.. 1991). 
For this we investigated the protection offered by different oxyradical scavengers to DNA 
breakage. More than 80% protection was observed in the case of catalase and about 
30% by superoxide dismutase which selectively scavenges superoxide radical and 
hydrogen peroxide. However, mannitol, thiourea and sodium benzoate which selectively 
scavenge the hydroxy! radicals offered marginal protection (10-15%) even at 10-fold 
molar excess concentration with respect to glutathionyl hydroquinone (200 \M). This 
suggests that glutathionyl hydroquinone mediated strand scission in pUC 18 DNA is 
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mediated via superoxide radical and hydrogen peroxide rather than the involvement of 
iron-catalyzed Haber-Weiss reaction. These observations indicate that pUC 18 DNA 
damage by glutathionyl hydroquinone was not only mediated by free radical but some 
other mechanism might also he responsible for plasmid DNA damage in the presence of 
glutathionyl hydroquinone. 
To establish, glutathionyl hydroquinone as haematotoxin, we exposed male mice at 
dose 100 mg/kg body weight, intraperitoneally for one month. No mortality was observed 
at this dose in glutathionyl hydroquinone treated group. Inaeased pattern of relative liver 
weight (P<0.01) and spleen weight and WBC count were noticed, but these results were 
not conclusive to say glutathionyl hydroquinone as potent haematotoxic metabolite of 
benzene. The pharmacokinetics and distribution of administered glutathionyl hydro-
quinone is not known. Probably, it does not reach the target organ, bone marrow as 
glutathionyl hydroquinone form. Other reason may be due to difference in sensitivity of 
species towards different benzene metabolites. Chronic toxicity studies by the National 
Toxicology Program (Huff, 1983) have shown that B6C3F1 mice are more sensitive to 
the haematotoxic and carcinogenic effects to benzene than F344/N rats. The greater 
sensitivity of mice compared with rats to benzene toxicity may be related to a greater 
metabolism of benzene to toxic intermediates, differences in detoxification of toxic 
metabolites or greater inherent susceptibility of target tissues to the action of toxic 
metabolites. Earlier,Longacre et al., (1981) showed that there are strain differences in 
mice in the metabolism and toxicity of benzene and that saturation of metabolism may 
play a role in producing the differences in toxicity. 
However, it is concluded from the present in vitro studies that glutathionyl 
hydroquinone is a potent prooxidant and due to its faster autooxidation to glutathionyl 
t)enzosemiquinone may result in DNA damage. Our experiments showed that under mild 
conditions at 37°C with the presence of 200 pM concentration of glutathionyl 
hydroquinone, within 3 hr, all the supercoiled pUC 18 DNA has been converted to open 
circular relaxed and linear form. Interaction of glutathionyl hydroquinone with DNA may 
facilitate the formation of adducts with DNA which is one of the prerequisites of benzene 
toxicity and carcinogenicity. Anderson et al., (1995) reported the DNA-damaging ability 
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of benzene and its metabolites in human lymphocytes using the comet assay. Zhang 
et al., (1995) pointed out that interest has focused on the interactions of benzene 
metabolites and the toxicological significance of free radicals as ultimate toxic species 
mediating benzene toxicity since no single ring-hydroxylated metabolite of benzene can 
express all the known haematololgical effects of benzene. Further, experiments are 
needed to explain significance and the precise mechanism of DNA damage by 
glutathionyl hydroquinone, and the oxyradicals and semiquinone formed during its 
autooxidation, in the expression of benzene induced haematotoxicity. 
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Role of Transition Metal Ions (Fe, Cu) 
During Benzene Toxicity 
Introduction 
Results 
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INTRODUCTION 
Benzene exposure has been associated with many types of genetic damage 
including chromosomal aberrations in animals and man, sister chromatid exchanges, and 
micronuclei induction both in vitro and in vivo as well as aneuploidy in dividing cells. 
However, it has not generally produced point mutations in genotoxicity test system 
(Snyder and Kalf, 1994). Benzene is a substrate of cytochrome P-450 IIE1 (CYP2E1) 
(Seaton et a/., 1994) and metabolized to phenolic intermediates to exert its toxic effect in 
biological system (Kalf, 1987). Hydroquinone and 1,2,4-benzenetriol, the two principal 
polyphenolic metabolites of benzene have been shown to be toxic and the suggested 
mechanisms include free radical formation via superoxide and covalent binding of the 
semiquinone to DNA, RNA and other cellular macromolecules. 
Li and Trush (1993a) observed that hydroquinone/Cu(ll) and 1,2,4-benzenethol/ 
Cu(ll), chemical metal redox were the two most efficient systems which induced strand 
breakage in (t)X-174 RF1 plasmid DNA. Studies revealed that treatment of HL-60 cells 
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with hydroquinone resulted in the formation of 8-hydroxydeoxyguanosine (8-OHdG), 
suggesting that hydroquinone can induce oxidative DNA base modification in cells 
(Kolachana et ai. 1993). The role of DNA adduct formation in the myelotoxic effects of 
benzene exposure has not been defined. Levay and Bodell (1992) studies have 
suggested that the myeloperoxidase in HL-60 cells can activate hydroquinone to form 
DNA adducts. Later on Levay et ai, (1993) demonstrated that peroxidase activation of 
hydroquinone results in the formation of DNA adducts in HL-60 cells, mouse bone 
marrow, macrophages and human bone marrow. Recently, Pathak et ai, (1995) 
demonstrated the formation of DNA adducts in the tx)ne man-ow of B6C3F1 mice treated 
with benzene and later on Levay et ai, (1996) hypothesized that the adduct formation 
might depend on both the dose and duration of treatment. Low level of benzene 
administration failed to adduct fonnation in experimental animals. DNA adduct formation 
was also observed in HL-60 cell culture treated with hydroquinone for 16 hr at 250 \M 
concentration (Pongracz and Bodell, 1996). Zhang et ai, (1993) demonstrated the 
potential role of copper in micronuclei induction and oxidation of DNA damage in human 
lymphocyte and HL-60 cell by 1,2,4-benzenetriol. 
There are a number of both enzymatic and non-enzymatic mechanisms by which 
xenobiotic can be activated to reactive intermediates (Tnjsh and Kensler, 1991). Evidence 
is emerging that the generation of active oxygen species in biological systems, either 
through normal metabolic pathways or as a consequence of exposure to xenobiotics, such 
as chemical carcinogens, is involved in the multistage process of carcinogenesis, 
especially the promotion stage (Witz, 1991). Studies have provided evidence that 
transition metals including iron and copper are capable of directly mediating the activation 
or metabolism of several xenobiotics via a metal redox mechanism, which leads to the 
formation of more reactive oxygen and other organic free radicals (Ahmad et ai, 1992; 
Yamamoto and Kawanishi, 1992). 
Trace amount of the metal ions are present in biological system. An estimated, one 
third of all enzymes require a metal ion in one or more phases for their catalytic activity. 
Transition metal ions, most notably iron and copper can facilitate the transfer of electrons 
to biological macromolecules such as lipid, protein and DNA. In addition to their 
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biological function, metal ions are responsible for tissue damage. In the presence of trace 
metal ions the mutagenicity of polyphenolic metabolites of benzene showed an increase 
to the tester strain Salmonella typhimurium (Lee and Lin, 1994). Earlier Krsek-Staples 
and Webster, (1993) observed the iron-catalyzed oxygen resulting in the formation of 
carbonyl derivatives with concomitant loss of enzyme function. 
Maintenance of cellular iron homeostasis is a prerequisite for many essentia! 
biological processes and for the growth of organisms, and is also a central element in the 
regulation of immune function (Weiss et a!., 1995). Over the past decade, free 
radical-mediated processes have been established in the pathology of hepatic iron 
overload (Bacon and Britton, 1990), and unwinding of hepatic double-strand DNA in rats, 
with chronic dietary iron overload was reported (Ediing et al., 1990). Further, Toyokuni 
and Sagripanti (1993) demonstrated that Fe-citrate can constitute a powerful DNA 
damaging system under physiological conditions. 
The biological significance of copper has recently attracted with interest in 
connection with carcinogenicity and mutagenicity (Agarwal et a!., 1989). Copper is an 
essential component of chromatin (Saucier et al., 1991) and is known to accumulate 
preferentially in the heterochromatic regions (Bryan e^  al., 1976). Copper sulphate 
(CUSO4) showed clastogenic effects on the bone marrow cell chromosomes of mice in 
vivo (Agarwal et al., 1990). Li et al., (1991) reported that copper accumulated in liver 
tissues of LEC (Long-Evans Cinnamon) rats that has spontaneously developed 
hepatocellular carcinomas, suggesting that the abnormal copper metabolism is involved 
in hepatic carcinogenesis in LEC rats. The exposure of DNA to hydrogen peroxide in the 
presence of Cu(l) or Cu(ll) is known to result in the induction of a variety of oxidative 
lesions, including DNA strand breaks and base modifications (Kawanishi and Yamamoto, 
1991;ltoefa/., 1992). 
Previous studies have suggested the involvement of iron or copper in benzene 
metabolites induced DNA damage through a mechanism, involving the generation of 
reactive oxygen species (Kawanishi etal., 1989; Rao and Pandya, 1989). Although, iron 
is known to be capable of catalyzing oxidative damage to DNA, copper has been shown 
to be more potent. Copper is distributed throughout the body with liver and bone man-ow 
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being the two major storage organs. It is also closely associated with chromosomes and 
DNA bases (particularly guanine) and the possible role of copper as a mediator of reactive 
oxygen induced cytotoxicity as well as genotoxicity have been proposed (Li and Trush, 
1993b). In this respect, the present studies were conducted to quantitate the metal ion 
concentrations (iron and coper) in rat liver and isolated liver nuclei in benzene exposed 
rV 
albino rats. Further, we studied the potential role of polyphenolic metabolites of benzene 
to release thiobartDituric acid reactive products (TBAR) from isolated liver nuclei with or 
without the presence of metal chelators and oxygen radical scavengers to explain the 
possible role of metal ions in benzene induced genotoxicity and chromosomal aberration. 
RESULTS 
Total iron and copper contents were estimated in liver tissue of male and female rats 
exposed to benzene intraperitoneally (0.5 ml/kg body weight) for 10 days. The iron 
content only showed significant increase in male and female rats (P<0.02; P<0.05), which 
received benzene and no significant change in copper content was observed in either sex 
when compared to respective control groups (Table-7.1). Iron and copper contents were 
also analyzed in isolated rat liver nuclei of benzene exposed female rats (i.p). In isolated 
rat liver nuclei also only iron content showed significant increase (P<0.05), but no change 
was observed in copper content when compared to the respective control groups 
(Table-7,2). 
Formation of TBAR was observed from isolated rat liver nuclei in presence of 
polyphenolic metabolites of benzene, such as hydroquinone and 1,2,4-benzenetriol and 
other polyphenols, such as 6-hydroxydopamine and dopamine at 330 pM concentration. 
Significant release in TBAR was observed in all cases but the release was maximum in 
the presence of hydroquinone (34.6 nmoles TBAR/hr/gm protein) (Table-7.3). Increased 
pattern of TBAR formation was observed with increase in hydroquinone concentrations 
(0-330 pM), but the release was not linear with increase in hydroquinone concentrations 
(Table-7.4). 
Further, nuclear DNA damage was evaluated by agarose gel electrophoresis. Rat 
liver nuclei were incubated with hydroquinone/1,2,4-benzenetriol (0.5 or 1.0 mM) and 
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Table 7.1 
Effect of benzene* administration on total iron and copper 
metal contents in liver of albino rats 
Iron 
(pg/gm tissue) 
Copper 
(pg/gm tissue) 
Male rat 
Control 
i.p. 
Female rat 
Control 
i.p. 
91.50±1.90 
118.00+7.85^ 
115.00±8.58 
143.0018.10" 
3.24±0.12 
3.67+0.19'^ ^ 
4.86±0.68 
4.86±0.38''5 
^Benzene was administered through single injection daily (i.p. = 0.5 ml/kg b.w.) for 
10 days. Values are mean ± SE of five rats. 
Exposed groups were compared with their respective control. 
P values : a < 0.02; b < 0.05; NS = Not significant. 
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Table 7.2 
Effect of benzene* administration on total iron and copper metal content 
in isolated liver nuclei of albino rats. 
Iron (\iglgm protein) Copper (pg/gm protein) 
Female rat 
Control 
l.p. 
41.28+4.20 
61.10+6.15* 
36.70±3.28 
42.40±3.9r^ 
*Benzene was administered through single injection daily (i.p. = 0.5 ml/kg b.w.) for 
10 days. Values are mean ± S.E. of five rats. 
Exposed groups were compared with their respective control 
P values: a < 0.05; NS = Not significant 
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Table 7.3 
Effect of polyphenolic metabolites of benzene and other polyphenols (330 
pM) on release of TBAR from isolated rat liver nuclei. 
Addition nmoles of TBAR formed/ 
hr/gm protein 
None 0.0 
Hydroquinone 34.6 
1,2,4-Benzenetriol 19.8 
6-Hydroxydopamine 27.2 
Dopamine 18,4 
Experimental conditions as described in Materials and Methods section. 
All values are average of two sets of experiments conducted in duplicate with 
variations 10% or less. 
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Table 7.4 
Release of TBAR from isolated rat liver nuclei in the presence of 
increasing concentration of hydroquinone 
Hydroquinone { pM) nmoles of TBAR formed/ 
hr/gm protein 
33 10.9 
107 14.1 
182 18.9 
256 27.0 
330 34.6 
Experimental conditions as described in Materials and Methods section. 
All values are average of two sets of experiments conducted in duplicate with 
variations 10% or less. 
Figure 7.1 : Agarose gel electrophoresis of ethidium bromide stained 
rat liver nuclei treated with HQ/BT (0.5 or 1.0 mM). Lane 
(a) liver nuclei only, lane (b and c) liver nuclei + HQ (0.5 
or LQinM), lane (d-e) liver nuclei + BT (0.5 or 1.0 mM) 
respectively, and lane (f) EcoRI digested ^DNA molecular 
marker (3530-21226 bp). Reaction mixtures were 
incubated at 37°C for 3 hr. 
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Table 7.5 
Effect of externally added copper on TBAR release from Isolated rat 
liver in presence of hydroquinone 
Addition nmoles of TBAR formed/hr/gm protein 
Hydroquinone alone 34.6 
+ Copper (0.08 mM) 37.9 
+ Copper (0.167 mM) 36.7 
Experimental conditions as described in Materials and Methods section. 
All values are average of two sets of experiments conducted in duplicate with 
vanations 10% or less. 
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Table 7.6 
Release of TBAR from rat liver nuclei in the presence of hydroquinone 
and increasing concentration of bathocuproine (0-25 pM) 
Components nmoles of TBAR formed/ 
hr/gm protein 
Hydroquinone alone 34.6 
+ 5 pM Bathocuproine 16.5 (52%) 
+ 10 " " 15.8(54%) 
+ 15 " " 14.9(57%) 
+ 20 " " 12.9(63%) 
+ 25 " " 11.5(67%) 
Experimental conditions as described in Materials and Methods section. 
All values are average of two sets of experiments conducted in duplicate with 
variations 10% or less. 
Number in parentheses are percent inhibition. 
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Table 7.7 
Release of TBAR from isolated rat liver nuclei in presence of hydroquinone 
with or without the addition of EDTA and DTPA (5 pM) 
Components nmoles of TBAR formed/ 
hr/gm protein 
Hydroquinone alone 34.6 
+ EDTA 17.3 (50%) 
+ DTPA 15.5 (55%) 
Experimental conditions as described in Materials and Methods section. 
All values are average of two sets of experiments conducted in duplicate with 
vanations 10% or less. 
Number in parentheses are percent inhibition. 
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Table 7.8 
Effect of oxyradical scavengers on release of TBAR from isolated 
rat liver nuclei in presence of hydroquinone 
Components nmoles of TBAR formed/ 
hr/gm protein 
Hydroquinone alone 34.6 
+ Thiourea (2.5 mM) 6.4(81%)' 
+ Thiourea (5.0 mM) 3.2(91%) 
+ Mannitol (50 mM) 25.1(27%) 
+ SOD(100Mg/1.5ml) 28.8(15%) 
+ Catalase(150Mg/1.5ml) 34.5(0%) 
Expenmental conditions as described in Matenals and Methods section. 
All values are average of two sets of experiments conducted in duplicate with 
variations 10% or less. 
'Number in parentheses are percent inhibition. 
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electrophoresis was done on 1% agarose gel (Figure-7.1). When isolated rat liver nuclei 
were incubated with hydroquinone for 3 hr at 37°C, nuclear DMA damage was observed 
(lane b and c) at 0.5 or 1.0 mM concentration compared to the control nuclei (lane a). Gel 
pattern also indicates some damage in nuclear DNA in presence of 1,2,4-benzenetriol 
(lane d and e), however hydroquinone is more potent to cause damage to rat liver nuclear 
DNA. Lane (f) is EcoRI digested DNA marker (3530-21226 bp) (Figure-7.1). 
Externally added copper (0.08 and 0.167 mM) did not show significant increase in 
TBAR formation when isolated rat liver nuclei incubated together with hydroquinone (330 
pM) at 37°C (Table-7.5). However, inhibition in TBAR fromation was observed in presence 
of bathocuproine (5-25 pM) in hydroquinone induced TBAR fonnation from rat liver nuclei. 
At 5 pM concentration of bathocuproine, 52% inhibition was observed. Increase in the 
concentration of bathocuproine did not show linear decrease in TBAR formation and only 
about 67% inhibition was observed at 25 pM concentration of bathocuproine (Table-7.6). 
Further, only 50-55% inhibition was observed in TBAR release in the presence of 
EDTA/DTPA (5 pM), when isolated rat liver nuclei incubated with hydroquinone (330 pM) 
at 37°C (Table-7.7). 
Inhibition of TBAR formation from isolated rat liver nuclei was also studied in the 
presence of different oxyradical scavengers, such as thiourea (2.5 and 5.0 mM), mannitol 
(50 mM) catalase (150 pg/1.5 ml) and SOD (100 pg/1.5 ml). Presence of thiourea 2.5 
mM and 5.0 mM resulted in the inhibition of TBAR release from rat liver nuclei to the 
extent of 81% and 91% respectively (Table-7.8). Inhibition by mannitol and SOD were 
only 27% and 15% respectively. However, presence of catalase failed to exhibit any 
inhibition of TBAR formation from rat liver nuclei in the presence of hydroquinone 
(Table-7.8). 
DISCUSSION 
studies related to the effect of hydroquinone or 1,2,4-benzenetriol on isolated rat liver 
nuclei were conducted to monitor the damage to DNA, as copper ion is associated with 
the heterochromatin. This particular study would help in better understanding of the 
chromosomal aberrations/abnormalities associated with benzene exposure. Exposure to 
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benzene resulted in significant increase in total iron content in liver tissue, however copper 
content did not shov\/ any alteration. Earlier it was observed that benzene exposure 
resulted in alteration of heme metabolism (Rao and Pandya, 1980) and accumulation of 
low molecular weight iron components (LMI) in bone marrow (Pandya et al., 1990). The 
elevated level of LMI in the bone marrow during benzene toxicity may lead to formation 
of tissue damaging species like lipid peroxide radical, superoxide anion (Oj), oxyferryl 
species and hydroxyl radical which may form reactive metabolite(s) and may react 
immediately if they occur in the vicinity of vital molecules like nucleic acids (Lown and Sim, 
1977) and polymerase enzymes (Rushmore et al., 1984) which may be responsible for 
the ultimate cytotoxicity. During in vitro study Rao and Pandya, (1989) observed that 
polyphenolic metabolites of benzene are autooxidized faster in the presence of metal ions 
and resulting in the formation of TBAR from target molecules such as glutamate and calf 
thymus DNA. The suggested mechanism includes free radical formation via superoxide 
and the covalent binding of the semiquinone metabolites of polyphenols to such 
molecules. Significant increase in metal ions in rat liver and rat liver nuclei during 
benzene exposure may have toxicological implications for cytotoxicity of liver cells and 
liver nuclear DNA damage in vivo. 
Further in vitro studies revealed that hydroquinone or 1,2,4-benzenetriol at 330 pM 
concentrations, released significant amount of TBAR from rat liver nuclei and only 50-55% 
inhibition was observed in the presence of iron chelator such as EDTA or DTPA at 5 pM 
concentration. Iron overload affects hepatic heme metabolism. However, the biochemical 
mechanisms whereby iron overload affects heme metabolism are not completely 
understood. Earlier Mahmutoglu and Kappus (1987) demonstrated the DNA damage in 
isolated rat liver nuclei in the presence of redox cycling of bleomycin-Fe(lll) complex by 
NADH dependent enzyme and suggesed that the enzymatic reduction of a 
bleomycin-metal complex in the cell nucleus may be an essential step in the cytotoxic 
activity of bleomycin. 
Earlier, we demonstrated the prooxidant and antioxidant properties of iron: hydro-
quinone and iron: 1,2,4-benzenetriol complex and suggested that iron catalyzed and 
bleomycin-dependent degradation of DNA was markedly enhanced in the presence of 
Chapter - VII 
^ 112 
hydroquinone or 1,2,4-benzenetriol than in iron alone (Singh et al.. 1994). We 
demonstrated the formation of iron: polyphenol complex in vitro and fractionated on 
Sephadex G-10 column (Chapter-Ill) and proposed that iron; hydroquinone complex may 
play role in haematotoxicity of benzene. However, formation of such complex in vivo is 
not known. 
To demonstrate the possible role of copper in TBAR formation in presence of 
hydroquinone, the isolated rat liver nuclei were incubated with or without the presence of 
bathocuproine, a specific copper ion chelator. In the presence of bathocuproine, about 
67% inhibition was observed. Increase in the concentration of bathocuproine (5-25 pM) 
resulted in only marginal increase in inhibition of TBAR formation (52-67%). This may be 
due to permeability of bathocuproine to cross the nuclear membrane is limiting with 
increasing concentrations of bathocuproine as it contains two methyl groups (Mellow-Filho 
and Meneghini, 1991). Copper, a natural constituent of cell nuclei has been suggested 
to play a key role in structural organization and function of chromosomes (Hu et a/., 1990). 
In this context, it appears important to focus attention also on the redox activity of copper 
in the vicinity of DNA. Li and Trush, (1993a) demonstrated that Cu(ll) strongly induces 
the oxidation of hydroquinone as such may be factor involved in the oxidative action and 
toxic to primary bone marrow stromal cells at DBA/2J mice. They further observed that 
Cu(ll) is capable of directly reacting with hydroquinone, causing the one electron oxidation 
of hydroquinone to semiquinone radical (SQ) and reactive oxygen species generated in 
chemical metal redox system were responsible for in vitro plasmid DNA damage (Li ef al.. 
1995). The oxidative activation of hydroquinone to the electrophilic 1,4-benzoquinone 
through a peroxidase/H202 system has been suggested to play an important role in the 
hydroquinone-induced bone marrow target cell injury (Smith ef al.. 1989). 
Earlier, Pnjtz (1993) has shown that Cu(ll)-induced oxidation of certain compounds 
such as ascorbate, catechol and o-phenylenediamine was enhanced by orders of 
magnitude in the presence of DNA. DNA in combination with copper could promote the 
bioreductive activation of genotoxic compounds and their progeny in the most vulnerable 
cell compartment, the nucleus. Recently, Zhang et al., (1996) demonstrated the important 
role of Cu^* in 1,2,4-benzenetriol-induced genotoxicity. 
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Endogenously generated oxidants that could lead to cellular DMA damage Include 
superoxide radicals and H2O2. There have been many reports to indicate that the human 
genome is potentially vulnerable to damage (or mutation) by H2O2 (Meneghini and Martin, 
1993). Furthermore, with formation of DNA-Cu(l), the DNA becomes predisposed to 
oxidative damage by H^Oj via Fenton type reaction that generate strongly oxidizing 
radicals such as hydroxyl radical or CuOzH (Masarwa et al., 1988) in situ, i.e. near the site 
of Cu(l) fixation within the DNA (Aruoma et al., 1991); 
DNA + Cu(l) + H2O2 > DNA:OH + Cu(ll) + OH" 
I 
1 
DNA damage 
Copper ions are much more efficient at promoting DNA damage by H2O2 than iron ions 
(Aruoma et al., 1991), and this is probably due to the high affinity of DNA for Cu (I). 
Presence of thiourea, 2.5 mM and 5.0 mM resulted in the inhibition of TBAR release 
from rat liver nuclei to the extent of 81% and 91% respectively. Studies by Hanna and 
Mason (1992) have shown that thiourea acts as a copper chelator. This further indicates 
the possible role of copper in TBAR formation from rat liver nuclei incubated in the 
presence of hydroquinone. Further, externally added copper (upto 0.176 mM) to the 
reaction mixture did not result in any significant increase in the release of TBAR from rat 
liver nuclei by hydroquinone. This particular observation indicates that the copper 
associated with nuclear DNA was only responsible to catalyze autooxidation of 
hydroquinone or 1,2,4-benzenetriol, during which oxyradicals are released and caused 
degradation of the deoxyribose moiety of DNA, resulting in the formation of TBAR 
products. Marginal inhibition in TBAR release was observed in the presence of other 
oxyradical scavengers, such as mannitol (27%) and SOD (15%) However, catalase did 
not show any inhibition in TBAR formation from rat liver nuclei in the presence of 
hydroquinone. Probably, nuclear membrane selectively prevent these oxyradical 
scavengers to reach the target site. The present in vitro studies, clearly demonstrate that 
benzene metabolites (particularly hydroquinone) induced genotoxic effect in presence of 
copper which is associated with the nuclear DNA. However, further studies are needed 
to explain the precise mechanism of DNA damage and chromosomal aberration in vivo 
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during benzene exposure and effect of transition metal ions in benzene induced 
genotoxicity and human leukemia. 
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Small amounts of a large variety of substances normally regarded as foreign to the 
body are always existent in the environment. These are often toxic and occur frequently 
In the modem world, man is increasingly dependent upon the use of synthetic chemicals 
and other domestic products in larger number. 
Benzene is frequently used as an industrial solvent of the modem time. Its excellent 
solvent properties and its use as a starting material for wide ranging chemicals and 
domestic products of commercial importance has made it indispensable. Its value in our 
modem society is great, but due to its toxic nature, the use of benzene would undoubtedly 
have an impact on our way of life. The use of benzene has been on the rise and 
obviously the risk of exposure is also increasing. Though the exposure levels to benzene 
can be brought down to acceptable levels but can not be eliminated. 
Benzene is a well known genotoxic and carcinogenic agent. But the precise 
mechanism of its genotoxicity and carcinogenicity are yet to be known. Therefore, in this 
study an attempt has been made to explain the probable metabol(te(s) of benzene to 
induce haematotoxicity and role of transition metal ions (iron and copper) to explain the 
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possible biochemical mechanisms of genotoxicity and carcinogenicity expressed during 
benzene exposure. 
Release of iron from ferritin by 1,2,4-benzenetriol 
Iron is a vital metallic cofactor of several important biomolecules. It is normally 
localized in ferritin (main iron storage protein) or transferrin (iron transport protein). But 
this iron, when it gets decompartmentalized manifests lethally by triggering off free radical 
reactions by means of Fenton and Haber-Weiss type of reactions: 
Fe(lll) + Reductant > Fe(ll) + Oxidized Reductant 
2Fe(ll) + O2+ 2H* > 2Fe(lll) + H A 
Fe(ll) + H2O2 > Fe(lll) +-0H + OH 
Large human prospective studies suggest that excess body free iron is associated 
with carcinogenesis, such as primary hepatocellular carcinoma, colon cancer, lung cancer, 
bladder cancer, acute lymphocytic leukemia and neuroblastoma. Bleomycin detectable 
iron has been shown to accumulate in significant concentrations in the bone marrow of 
benzene exposed rats. Polyphenolic metabolite of benzene, particulariy 1,2,4-
benzenetriol (a trihydroxy benzene) was found to release significant amount of iron from 
horse spleen ferritin under aerobic and anaerobic conditions. The release of iron from 
ferritin during autooxidation of 1,2,4-benzenetriol in vivo may result in increased 
intracellular concentrations of free iron. Although, the physiological mechanism of iron 
mobilization from ferritin is pooriy understood, the observed iron release from ferritin by 
1,2,4-benzenetriol could occur through the direct reduction of iron by the hydroxy 
hydroquinone form or via its autooxidation intermediates i.e., superoxide radical and 
semiquinone. It was observed that the iron released from ferritin in the presence of 
1.2,4-benzenetriol was capable of inducing lipid peroxidation and catalyzing 
bleomycin-dependent calf thymus DNA degradation. The mechanism by which iron is 
released from bone marrow cells and whether it acts as a prooxidant during benzene 
toxicity is not known. However, the present observation offer a new mechanism that the 
iron released from ferritin by 1,2,4-benzenetnol could contribute to the better 
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understanding of the toxicity of benzene. Further, elucidation of the mechanisms of 
iron-mediated oxidative damage may be important for the prevention of carcinogenesis. 
Prooxidant and antioxidant properties of iron: polyphenol 
complex 
Polyphenolic metabolites of benzene viz. hydroquinone and 1,2,4-benzenetriol have 
been shown to be toxic and the suggested mechanism includes free radical formation via 
superoxide during their autooxidation and the covalent binding of semiquinone to DNA, 
RNA and other cellular macromolecules. Benzene exposure also leads to an 
accumulation of bleomycin sensitive iron in bone marrow. 1,2,4-Benzenetriol, a tnhydroxy 
metabolite of benzene was capable of releasing iron from horse spleen ferritin, which may 
lead to accumulation of iron in bone marrow during benzene exposure, as the 
polyphenolic metabolites are accumulated against the concentration gradient in the bone 
man^ow. The ferrous iron may be chelated to the polyhydroxy metabolites of benzene viz. 
hydroquinone and 1,2,4-benzenetriol. 
Studies carried out with hydroquinone/1,2,4-benzenetriol and iron showed several 
fold increase in iron-catalyzed bleomycin- dependent degradation of calf thymus DNA as 
compared to iron alone. Complex formation some how increase the availability of iron to 
degrade DNA. It is also possible that the hydroquinone and 1,2,4-benzenetnol possess 
combined iron-chelating and iron ion reducing properties to stimulate DNA degradation 
in the presence of bleomycin. Further, iron:polyphenol complex appears to be stable and 
intact as the recovery from bone marrow lysate was complete. On the other hand, 
iron:polyphenol complexes have shown an antioxidant activity by inhibiting of 
iron-dependent lipid peroxidation in rat brain homogenate and glutamate degradation. 
This is similar to the antioxidant properties exhibited by flavonoids due to their ability to 
chelate iron. Thus the polyphenolic chelates limiting the availability of iron for lipid 
peroxidation and at the same time facilitate bleomycin- dependent degradation of DNA. 
Summary 118 
Polyphenol-iron complex: A probable toxic metabolite of benzene 
An attempt was made to examine in vitro formation of polyphenol:iron complex. 
Complex formation was fractionated on Sephadex G-10 column chromatography. Results 
clearly show the formation of polyphenoUron complex under in vitro condition. Polyphenol 
iron complex formation was also observed during the release of iron from ferritin in the 
presence of 1,2,4-benzenetriol. Although, benzene exposure leads to accumulation of 
iron as well as polyphenoiic metabolites of benzene in the bone marrow against the 
concentration gradient, the formation of such complex in vivo is yet to be identified. 
We evaluated the haematotoxicity of hydroquinone.iron complex as a possible 
haematotoxic intenmediate during benzene exposure. Results indicate that hydroquinone 
iron chelate showed marginal increase in haematological parameters in experimental 
animals. But the precise mechanism of marginal, yet significant increase in haema-
tological indices is not clear. Atleast, some of the effects observed in hydroquinone:iron 
treated group showed similarities to some extent with what has been shown to occur 
following exposure of benzene to mice. 
Glutathionyl hydroquinone: A possible toxic metabolite of 
benzene 
Glutathionyl hydroquinone has been isolated as one of the urinary metabolites of 
hydroquinone, indicating that glutathionyl hydroquinone formation occurs in vivo and 
autooxidized at several fold higher than the parent hydroquinone to glutathionyl 
benzoquinone. We noticed that glutathionyl hydroquinone is a potent prooxidant to 
damage both calf thymus as well as plasmid pUC 18 DNA and this observation may be 
of toxicological importance in relation to benzene induced genotoxicity. 
Haematotoxicity of glutathionyl hydroquinone was studied in male mice at dose 100 
mg/kg body weight, intraperitoneally for one month. Increased pattern of relative liver and 
spleen weight and WBC were noticed, but these results were not conclusive to explain 
GHQ as potent haematotoxic metabolite of benzene. The pharmacokinetics and 
distnbution of administered GHQ is not known. Whether GHQ administered i.p. reaches 
Sujiimary 
the target organ i.e. bone marrow is yet to be evaluated. Other reason may be due to 
difference in sensitivity of species towards different t^ enzene metabolites. 
Role of transition metal ions (Fe,Cu) during benzene toxicity 
Earlier studies have provided enough evidence that transition metals including iron 
and copper are capable of directly mediating the activation or metabolism of several 
xenobiotics via a metal redox mechanism, which leads to the formation of more reactive 
oxygen and other organic free radicals. We observed that exposure to benzene leads to 
increase in total iron content in liver and isolated rat liver nuclei. Benzene metabolites 
induced the DNA damage particularly in the presence of iron and copper. This study 
would help in better understanding of the chromosomal aberrations/abnormalities 
associated with benzene exposure. Copper which is associated with DNA, may play a 
potential role in nuclear DNA damage in presence of hydroquinone. However, the 
molecular mechanism of its damage is not well understood. Significant increase in iron 
content in liver and in isolated liver nuclei during benzene exposure and the copper which 
IS associated with DNA may have toxicoiogical implications for cytotoxicity of liver cells 
and liver nuclear DNA damage in vivo. 
In the light of our investigations following conclusions can be made: 
• 1,2,4-Benzenetriol is a potent reductant of feme iron of ferritin and releases iron from 
ferritin core. The release of iron from bone marrow lysate by 1,2.4-benzenetriol may 
be of toxicoiogical significance during benzene exposure as this could lead to 
disruption of intracellular iron homeostasis in bone marrow cells 
• The iron:polyphenol chelate, on one hand, is a more potent DNA cleaving agent in 
the presence of bleomycin, and on the other hand, it is a less effective free radical 
generator as compared to iron alone. However, the formation of such a complex in 
vivo is not known. Further studies are needed to characterize such complexes in 
vivo and evaluate their toxicoiogical significance during benzene exposure. 
• Polyphenol forms complex with iron under in vitro condition and may be a possible 
haematotoxic intermediate during benzene exposure 
Summary ,_. 
IZO 
The present in vitro studies revealed that glutathionyl hydrcK|uinone is a potent toxic 
metabolite of benzene and acts as a prooxidant due to its faster autooxidation to 
glutathionyl benzoquinone and oxyradicals which may induce DNA damage. 
Exposure to benzene resulted in significant increase in total iron content in liver 
tissue and in isolated liver nuclei. 
Benzene metabolites (particularly hydroquinone) induced genotoxic effect in 
presence of copper which is associated with the nuclear DNA. However, further 
studies are needed to explain the precise mechanism of DNA damage and 
chromosomal aberration in vivo during benzene exposure and effect of transition 
metal ions in benzene induced genotoxicity and human leukemia. 
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